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In most western societies, cardiovascular disease such as coronary artery disease, 
aortic aneurysm, and arterial disease of the lower extremities, are still a major cause 
of high mortality, of many quality adjusted years of life lost, and claim large parts of 
health budgets.1,2 In 2000 in The Netherlands, approximately 50,000 persons died of 
cardiovascular disease, accounting for 36% of the total mortality.3 From the nineteen-
seventies onwards, there is a decrease in the age adjusted cardiovascular mortality 
rate, partly due to the improved technical and medical abilities to diagnose and treat 
disease. About 50% of the marked decline in mortality from coronary heart disease 
between 1980 and 1990 in the United States of America, could be attributed to 
treatment, 25% to secondary prevention and 25% to primary prevention.2 However, 
these improvements have also led to an increase of the absolute numbers of patients 
with chronic heart failure.4 A thus continuing large impact on health commits us to 
next generations to search for new possibilities to reduce the burden of 
cardiovascular disease. 
The complex and chronic process that eventually causes clinically manifest 
cardiovascular disease, is called atherosclerosis.5 It is a generic term for the 
thickening and hardening of the walls of the arteries. In 1911, Klotz and Manning6 
introduced their study of the aorta of 90 cases between 1 and 73 years of age with 
this statement: “It is quite useless to argue the questions concerning the 
development of intimal sclerosis if we study the late stages of the disease alone....... 
If we wish to gain a true insight into the complex question of arterio-sclerosis we must 
attempt to follow the lesion from its early beginning.” In those days, fatty streaks were 
considered as the earliest lesion of atherosclerosis. Klotz and Manning found a high 
prevalence of fatty streaks already in individuals below 30 years of age. 
Initiation of potentially reversible fatty streaks occurs in childhood and adolescence 
(figure 1.1).5,7 Monocytes start to migrate from the blood into the arterial wall, become 
lipid-laden macrophages. Fatty streaks are formed by an increase of intracellular 
lipids, multiplying macrophages and smooth muscle cells. Around the third decade of 
life, the lipids locate extracellularly and the fatty streaks progress to intermediate and 
advanced lesions, which increase the arterial wall thickness. Fibrous plaques 
covering macrophages, lipid and debris, are formed around the fourth decade of life, 
and the amount of smooth muscle cells and collagen is increased. Rupture of the 
fibrous cap easily occurs, causing thrombotic deposits, hematoma’s, fissures and the 
known clinically manifest cardiovascular diseases. From around the fifth decade in 
life, the process of arterial lumen blocking is enhanced. 
The initiation and early process of atherosclerosis is accelerated by several risk 
factors.7,8 Table 1.1 shows a number of classic and putative new cardiovascular risk 
factors at young age. 
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Figure 1.1 Development of atherosclerosis9 
 
Birth weight and intra-uterine environment as cardiovascular risk factors 
It is postulated that low birth weight is associated with increased risk of chronic 
disease and mortality, also known as the “fetal origins hypothesis”. Although there 
have been a number of studies to support this hypothesis, these reports have also 
been criticized as being biased and for statistical error.10,11  
Furthermore, the mechanisms underlying the fetal origins hypothesis findings is 
debated. Initially, it was postulated that an unfavorable nutritional intra-uterine 
environment programs the fetus to adapt itself resulting in decreased fetal growth 
and chronic disease in later life.12 Alternatively, fetal and parental genes may 
influence both size at birth and adverse future outcome.13-16 
 
Blood pressure as risk factor in the young 
Primary preventive medication benefits have been proven worthwhile in case of 
hypertension.17 However, preventive actions in the young and particularly in children 
have not been attempted in The Netherlands. To start preventive strategies in the 
young, first, individuals with increased risk of cardiovascular disease need to be 
identified. Studies showed that elevated blood pressure at late adolescence and 
young adulthood predicts high risk of future cardiovascular events.18-20 Also, 
epidemiological investigations, such as the Bogalusa Heart study and the Muscatine 
study, suggest that childhood blood pressure predicts adult blood pressure.21-24 
However, it is unknown whether adolescent blood pressure as routinely measured by 
school health care, predicts hypertension or total cardiovascular risk in adulthood 
sufficiently accurate, to justify large-scale blood pressure screening. 
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Table 1.1 Classic and putative new pathofysiological factors associated with 
accelerated atherosclerosis at young age 8 
 
Genetic heredity  
Low birth weight: - caused by genetic programming (polymorphism in promoter region of 
the insulin-like growth factor-I gene, mutations in glucokinase gene and 
D allele of the angioconverting enzyme) 
- caused by an unfavorable intra-uterine environment (undernutrition, 
toxins, maternal disease during pregnancy and maternal diet during 
gestation) 
Insulin resistance and hyperinsulinemia  
Glucose intolerance  
Relative high blood pressure/hypertension  
Obesity/high waist-hip ratio  
Dyslipidemia: - high levels of LDL-cholesterol, lipoprotein (a), apolipoprotein B-100 
- atherogenic dyslipidemia (hypertriglyceridemia, low level of HDL-
cholesterol, and small dense LDL-cholesterol) 
- low level of apolipoprotein A 
Life style-related factors: - smoking and chewing tobacco 
- low physical activity 
- unfavorable dietary profile (high dietary fat and energy intake, low 
intake of antioxidants) 
- (parental) socio-economic status 
Microalbuminuria  
Elevated plasma levels of homocysteine  
Prothrombotic state: - elevated plasminogen activator inhibitor-1 activity  
- high serum viscosity 
- high levels of plasma fibrinogen, tissue plasminogen activator antigen, 
and factors V, VII, and VIII 
- increased platelet aggregation 
Leptin  
Bilirubin  
Inflammatory markers: - elevated level of C-reactive protein and other markers 
Endothelial dysfunction: - indicated by elevated levels of Von Willebrand factor antigen and 
vascular and cellular adhesion molecules 
 
LDL: low-density-lipoprotein; HDL: high-density-lipoprotein. 
 
Two Dutch cohorts of the Atherosclerosis Risk in Young Adults (ARYA) study 
presented in this thesis, obtained data at birth, childhood and adolescence from the 
Dutch health care system. Around the age of 30 years the subjects were recently 
invited for re-examination of the cardiovascular risk. These data provided a unique 
opportunity to investigate some of the still unanswered etiologic and prognostic 
questions in the field of early determinants of cardiovascular disease. 
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In this thesis, the presented studies are based on two Dutch population based 
cohorts of the Atherosclerosis Risk in Young Adults (ARYA) study (chapter 2). 
Characteristics recorded at birth and cardiovascular risk factors noted at 
adolescence, were obtained. Recently, they where screened for cardiovascular risk 
factors and vascular damage at young adulthood. The data of these two cohorts 
were studied on early determinants of cardiovascular risk in adolescents and young 
adults. 
In chapter 3.1 we investigated whether a functional polymorphism in the promoter 
region of the insulin-like growth factor-I (IGF-I) gene, was observed as a genetic 
cause of the relation between birth size and cardiovascular risk at adolescence and 
young adulthood. The risk was determined by risk factors, arterial wall thickening and 
stiffness. Furthermore, in chapter 3.2 we comment on the relation between the 
genotype of the parents and the birth size of their first newborns. 
The role of body mass index in the relation between birth weight and blood 
pressure at young adulthood, was assessed as an intermediate variable, a 
confounding variable and an effect modifier in chapter 4.1. In chapter 4.2 we related 
birth weight, -height and ponderal index to the absolute 10-year risk of coronary heart 
disease, using the Framingham risk score. 
In chapter 5.1 the adolescent blood pressure was independently associated with 
the intima-media thickness of the carotid artery, a marker for life long exposure to 
atherosclerotic risk factor levels. Also we examined whether tracking and detracking 
of blood pressure levels from adolescence into young adulthood was associated with 
arterial wall thickening. Moreover, in chapter 5.2 we studied whether adolescent 
blood pressure as routinely measured by youth health care practice, predicts 
hypertension or total cardiovascular risk in adulthood with sufficient accuracy to 
warrant blood pressure screening. 
The main results of the studies described in this thesis are reviewed in chapter 6. 
Also, the practical relevance is discussed and suggestions for future research are 
provided. 
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2.1 Abstract 
Background: Despite recent advances in treatment, cardiovascular disease (CVD) is 
still health problem number one in western societies. Aiming at specific prevention 
strategies for high-risk individuals and shifting the available prevention programs 
towards younger age groups might increase the success of primary prevention. 
However, before addressing age-specific prevention programs, more insight in the 
determinants of early vascular damage and increased cardiovascular risk is 
warranted as well as insight in determinants of increased cardiovascular risk, 
including vascular damage, at an early age. The Atherosclerosis Risk in Young 
Adults (ARYA) study was specifically designed to address this issue. The ARYA 
study started off with studies evaluating 1) whether it is possible to predict 
cardiovascular risk at young adulthood by routinely measured adolescent data, and 
2) evaluating the role of birth characteristics and adolescent characteristics to the 
development of vascular damage at young adulthood. 
Methods: The ARYA study comprises of two cohorts of young adults. The cohort 
of Utrecht includes 750 young adults, aged 27-30 years. The cohort of The Hague 
includes 262 young adults born between 1963-1968. Data on birth characteristics, 
growth in early infancy as well as adolescent anthropometry, blood pressure, lipids, 
body mass index were obtained from the original medical records of the youth health 
care practice. In 1999/2001, the extent of subclinical vascular damage was measured 
using carotid wall thickness and aortic stiffness. Also, data on adult cardiovascular 
risk profile, bone density and central blood pressure were assessed, fasting blood 
was drawn and timed overnight urine samples were collected.  
Conclusion: The ARYA study is aimed to provide data on early determinants of 
cardiovascular risk, including vascular damage, at an early age. This knowledge 
enhances the understanding of atherosclerosis development and cardiovascular 
disease risk and is needed to improve the available primary prevention programs.  
 
2.2 Introduction 
Despite recent advances in treatment, leading to a considerable reduction in 
cardiovascular mortality, cardiovascular morbidity is still health problem number one 
in the industrialized countries and rapidly increasing in the rest of the world. Aging of 
the population and an improved survival after non-fatal cardiovascular disease 
(CVD)-events bear heavily on medical costs. An improvement in primary prevention 
of CVD is essential in the fight against the cardiovascular epidemic as it may delay 
the development of atherosclerosis and hence reduce the incidence of CVD. 
However, before addressing age-specific prevention programs, more insight in the 
determinants of early vascular damage and increased cardiovascular risk is 
warranted as well as insight in determinants of increased cardiovascular risk, 
Chapter 2 
26 
including vascular damage, at an early age. The Atherosclerosis Risk in Young 
Adults (ARYA) study was specifically designed to address this issue. The ARYA 
study started off with studies evaluating 1) whether it is possible to predict 
cardiovascular risk at young adulthood by routinely measured adolescent data, and 
2) evaluating the role of birth characteristics and adolescent characteristics to the 
development of vascular damage at young adulthood. In addition, the ARYA study 
enables studies on genetic traits as determinants of cardiovascular risk, assessed by 
measurement of risk factors and vascular damage. The rationale for these studies 
came from a number of observations.  
Elevated blood pressure at late adolescence and young adulthood has been 
associated with an increased risk of cardiovascular morbidity and mortality.1-3 In 
addition, several studies showed that a single standardized adolescent blood 
pressure relates to a relatively high blood pressure in young adulthood, and that 
combining several bi-annually blood pressure measurements improved the 
prediction.4-6 Also, other adolescent determinants appear to be related to future 
hypertension.7 Yet, whether routinely collected blood pressure measurements at 
adolescence predict elevated blood pressure at young adulthood is less clear, but 
relevant for routine clinical practice.  
In 1989, Barker suggested that maternal undernutrition during sensitive periods of 
rapid growth results in a permanent change in infants’ physiology and metabolism 
that lead to intrauterine growth retardation and an increased risk to develop chronic 
diseases, among others cardiovascular disease, in adult life.8 Since then this 
association has been confirmed in cohort studies among middle-aged and elderly 
subjects, from a range of countries.9-12 However, the Barker’s hypothesis is subject of 
heated debate in literature. Critics suggest that the observed relation between low 
birth weight and increased risk of cardiovascular disease in later decades should not 
be interpreted as causal. Selection bias, confounding, inconsistencies within and 
across studies as well as the influence of both genetic predisposition and postnatal 
growth are the most frequently raised objections.13-17As far as we know, studies 
evaluating the relation between birth characteristics and vascular damage in young 
adulthood are scarce.18-22 The use of various vascular measures to further explore 
this relation in the young would add important information as subclinical vascular 
damage reflects the impact of cumulative exposure to adverse cardiovascular risk 
factors in preceding years. Furthermore, it may help to bridge the gap between 
studies in the young looking at the relation between birth characteristics and risk 
factors and studies in middle-aged mainly looking at the association between birth 
characteristics and CVD-events. 
Longitudinal studies of children followed into young adulthood suggest that 
adverse life style and cardiovascular risk profile tend to ‘track’ into adulthood.23-30 
Tracking refers to the relative stable position of an individual parameter, like body 
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mass index or blood pressure, within the group distribution over time. Reports from 
the Bogalusa Heart study showed positive associations between obesity in childhood 
and/or adolescence and an adverse cardiovascular risk profile at young 
adulthood.27,31-33 In addition, recent reports showed that childhood obesity was 
positively related to cardiovascular morbidity and mortality years hereafter.34-37 
However, data on the relation between adolescent level of cardiovascular risk factors 
and early manifestation of vascular damage are limited but highly needed to enlarge 
the understanding in the etiology of cardiovascular disease. 
The ARYA study population allows studies into the role of genetic traits in which 
the role of genetic traits can be evaluated on cardiovascular risk development at 
adolescence and young adulthood, both ages at which subjects are free from 
advanced cardiovascular disease. For instance, genetic traits involved in insulin 
resistance have been related to a low birth size, type 2 diabetes and cardiovascular 
diseases in later life.38-40 Such findings may partly explain association found in ARYA.  
The ARYA study was designed to evaluate the early determinants, measured in 
these 3 predefined age-periods, of (subclinical) elevated blood pressure, vascular 
damage, and cardiovascular risk in healthy young adults. 
 
2.3 Methods 
Study population and selection procedure 
The ARYA study comprises of two cohorts of young adults. The Utrecht-cohort 
includes 750 young adults born between 1970-1973, who attended secondary school 
in the city of Utrecht in The Netherlands and of whom original medical records were 
available from the youth health care practice. In The Netherlands virtually all children 
regularly visit the child health facilities of the Home Care Organizations and the 
Municipal Health Services, starting at four weeks until leaving secondary school at 
the age of 16 to 19 years. Information is routinely collected in health records by 
school doctors and nurses and kept at the Municipal Health Service. The ‘The 
Hague-cohort’ includes 262 young adults born between 1963-1968, who attended a 
particular secondary school in the city of the Hague, The Netherlands and of whom 
repeated adolescent lipid- and blood pressure measurements were available. The 
enrollment schemes of both cohorts are shown in figure 2.1. The ARYA study was 
approved by the Medical Ethical Committee of the University Medical Center Utrecht, 
The Netherlands. All participants gave written informed consent. The general 
characteristics of the ARYA population are described in table 2.1 and 2.2. 
 The ARYA study participants are planned to be followed up by having repeated 
measurements over time (5 year intervals) of risk factors and vascular measures of 
functional and structural arterial characteristics and for the occurrence of 
cardiovascular events.  
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Figure 2.1 Selection procedures of the ARYA participants 
 
  Cohort 
       
  Utrecht  The Hague 
       
Birth 
(1970-1973) 
 N = ±16,000    
       
Adolescence 
 Single routine 
screening MHS 
N = ±16,000 
 Standardized biennial 
screenings MHS 
N = 404 
       
 Complete data birth 
and blood pressure 
N = 4,208 
   
      
 Invitation letter  Invitation letter 
      
Undeliverable: 726 
Refusals: 416 
Logistics: 36 
Other reasons: 18 
No response at all: 2191 
  Loss to follow-up: 31 
Refusals: 111 
  
      
 N = 821  N = 262 
      
Pregnant/recent delivery: 14 
Secondary withdrawal: 57 
 Pregnant/recent delivery: 13   
      
Young adulthood 
 ARYA participants 
N = 750 
 ARYA participants 
N = 249 
 
MHS: Municipal Health Service. 
 
The Utrecht cohort 
To enroll the ARYA participants in Utrecht a stepwise procedure was used (figure 
2.1): all available Municipal Health Service charts (n=±16,000) were checked for the 
presence of adequately registered birth weight (birth weight notations with a ± sign 
were excluded) and at least one blood pressure measurement during adolescence. 
All young adults with a complete chart (n=4208; 26.9%) were invited by mail (last-
known parental address) to participate in the study. 2191/4208 (52.1%) individuals 
did not respond despite regular mailings, 726/4208 (17.3%) letters were returned due 
to an inadequate address, 470/4208 (11.2%) subjects declined to take part and 
821/4208 (19.5%) were willing to participate. Of the eligible 821 young adults, 14 
were excluded because of pregnancy and 57 declined to participate after they had 
given informed consent. Ultimately, 750 young adults completed participation in the 
Utrecht part of the ARYA study. From October 1999 to October 2000, the participants 
visited our research center twice, with a mean interval of 20.4 days (SD: 10.7), for 
evaluation of their cardiovascular risk profile and the extent of subclinical vascular 
damage.  
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To evaluate whether selection bias might be an issue we collected information 
about birth weight, systolic- and diastolic blood pressure as well as weight and height 
during adolescence from all charts matching our inclusion criteria in birth cohort 
1970. None of these parameters was significantly different between responders and 
non-responders. Besides, the social economical status as well as the educational 
level of our participants was comparable to mean population levels as provided by 
the Central Office for Statistics in The Netherlands (www.cbs.nl). 
 
The The Hague cohort 
The Municipal Health Service of The Hague invited all first-year students starting in 
1978 and 1979 at the Aloysius College, a secondary school. Of all invitees, 98% 
attended the study, one refused participation and five refused venipuncture. 
Information was biennially collected in a standardized way during seven years. At 
adolescence, an examination of the total cohort occurred at the end of September 
and March of each year between 9.00 and 15.00 hour within one week time. Blood 
pressure was measured three times within three minutes in sitting position at the right 
upper arm. A dynamap (Physiometrics SR-2) with a cuff of 13x23.5 cm was used. 
Body weight and height were measured without shoes. Blood was drawn 15 minutes 
after the blood pressure measurement. Total cholesterol was measured by the 
enzymatic CHOD-PAP method by Röschlau and the level of high-density-lipoprotein 
(HDL-) cholesterol was measured by the NA-P-wolframaat and MgCl2-precipitation by 
Prindler. A second WHO-recognized laboratory showed similar results for total 
cholesterol (n=172, r=0.9733) and HDL-cholesterol (n=168, r=0.9450). Recently, we 
invited all participants to measure cardiovascular risk factors at young adulthood. Of 
the 404 subjects initially attending the study, 262 (65%) subjects were willing to 
participate. 31 young adults were lost to follow-up, 111 subjects did not respond to 
the invitation, did not want to participate in the study or did not show up at the 
appointments (figure 2.1). Of these 262 subjects, 10 women were pregnant and 3 
women gave birth less than five months ago. This resulted in a total of 249 (62% of 
the initially 404) participants in the cohort of The Hague. The participants were 
examined between November 2000 and February 2001 at their former secondary 
school in The Hague (n=196) or in the outpatient clinic of the Julius Center in Utrecht 
(n=35) by either one of the two first authors (LEV, AO). Of 16 subjects (of the 249), 
both visits took place elsewhere. Two young adults were not able to come over and 
sent results of two recent medical check ups. For the latter, the general practitioners 
and nurses were instructed by letter to examine the participants according to the 
overall protocol of the ARYA study. The blood pressure measurements, 
anthropometry and lipid values were recorded on standardized forms.  
To evaluate possible selection, we compared adolescent data (visit 3) of the 249 
participating and 155 non-participating and pregnant young adults. Both groups were 
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similar with respect to age, anthropometry, and single, double and triple blood 
pressure readings. Also, 49 of the 155 non-participating young adults completed a 
shortened questionnaire. Data at young adulthood was similar for gender, age, 
smoking habits, socio-economic status of the young adults and fathers, and 
cardiovascular diseases of the young adults and first-degree family members. 
 
Birth characteristics and anthropometry in early infancy (Utrecht cohort only) 
In The Netherlands, virtually all babies attend the Home Care Organization, a part of 
the youth health care practice, in their first 4 years of life. Growth and development 
are monitored, vaccinations are given and parental advice is given when needed. 
The first contact is scheduled when the newborn is about 4 weeks old and at that 
time data, provided by the mother, on pregnancy, delivery and birth characteristics 
are recorded.  
For the purpose of the ARYA study, birth weight, birth length, gestational age, 
information about the delivery and data on weight and height in the first 4 years of life 
were obtained from the original charts of the Municipal Health Service. Since the 
presence of information on birth weight was one of the inclusion criteria for 
participation in the ARYA study, it was known in all participants but one, who was 
included by mistake. In contrast, length at birth and gestational age were known in 
581/750 (77.5%) and 599/750 (79.9%) participants, respectively. Premature birth 
(n=32) was defined as birth before 37 weeks of gestation.  
 
Adolescent parameters 
Routine physical examinations of all Dutch children are performed by the Municipal 
Health Services during primary and secondary school period. Data at adolescence is 
shown in table 2.2.  
For each Utrecht ARYA participant, information about adolescent blood pressure 
(a single measurement using a manual sphygmomanometer), -weight, -length and 
puberty (Tanner) stage was available from the original school health records. Data on 
smoking status, alcohol and the use of oral contraceptives at adolescence was 
present but had considerable number of missing values. Adolescent parameters 
were collected over minimally one and maximally four different points in time between 
the ages of 12-16 years. The number of individuals with multiple adolescent 
measurements declined gradually (n=750, n=291, n=38 and n=1 with at least 1, 2, 3 
and 4 measurements, respectively).  
For the The Hague cohort, blood pressure measurements, as described earlier, 
were available from baseline (1978-1979) until 1991-1992. During these visits also 
serum lipids and body mass index were assessed. 
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Table 2.1 General characteristics of the ARYA participants at adolescence 
 
 Utrecht cohort The Hague cohort 
Adolescent parameters Men (n=352) Women (n=398) Men (n=223) Women (n=164) 
     
Age (years) 13.5 (1.1) 13.4 (1.2) 13.2 (0.7) 13.1 (0.7) 
Systolic blood pressure (mmHg) 111.7 (12.5) 109.0 (11.3) 119.9 (12.4) 118.1 (11.9) 
Diastolic blood pressure (mmHg) 67.4 (9.6) 66.0 (10.1) 67.4 (8.4) 67.7 (7.3) 
Weight (kg) 49.2 (10.5) 49.9 (9.9) 46.8 (8.3) 47.9 (8.1) 
Height (cm) 163.0 (10.3) 161.2 (8.0) 159.3 (8.9) 159.3 (7.0) 
Body mass index* (kg/m2) 18.3 (2.4) 18.9 (2.9) 18.3 (2.0) 188 (2.4) 
Genital development (breast)*   3.6 (1.1)  -  
Genital development (penis)* 2.9 (1.2)  -   
Pubic hair development* 2.9 (1.3) 3.7 (1.4) -  -  
Menstruation (%)  60%   -  
Time between adolescent & 
adult measurement (years) 
14.9 (1.3) 14.9 (1.3) -  -  
 
Values are expressed as mean (standard deviation). 
*According to Tanner stage. 
 
Cardiovascular risk profile at young adulthood 
Data at young adulthood is presented in table 2.2. At young adulthood (mean age: 
28.4 years) cardiovascular risk factors were measured at our research center. All 
investigators were similarly instructed and blinded for data in the medical school 
health records. After a five minutes rest in sitting position, blood pressure was 
measured with a semi-automated device (Dynamap) without replacing the cuff 
between the two measurements at the left upper arm. After 5-15 minutes rest the 
measurement was repeated. The same procedure was followed at the second visit 
with a mean interval of 20.4 days (SD 10.7). Mean systolic- (SBP) and diastolic 
(DBP) blood pressure were calculated as the average of the 4 measurements. Pulse 
pressure was calculated as the difference between systolic and diastolic blood 
pressure. Peripheral (i.e. brachial) mean arterial pressure (MAP) was calculated as 
(2*DBP+SBP)/3. In the ARYA study, the correlation between the duplicate adult 
blood pressure measurement at the first and second visit was 0.7 and 0.6 for SBP 
and DBP, respectively.  
According to the JNC V definitions41, hypertension at young adulthood was defined 
as the average systolic blood pressure ≥140 mmHg and/or diastolic blood pressure 
≥90 mmHg and/or use of anti-hypertensive medication (stages I-IV).  
Body height was measured in standing position - without shoes - to the nearest 0.1 
cm. Body weight was measured with indoor clothes - without shoes - to the nearest 
0.5 kg. To compensate for clothes we subtracted 0.5 kg. Waist-to-hip ratio was 
measured with indoor clothes. 
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Table 2.2 General characteristics of the ARYA participants at young adulthood 
 
 Cohort of Utrecht Cohort of The Hague 
Young adulthood Men 
(n=352) 
Women 
(n=398) 
Men 
(n=142) 
Women 
(n=107) 
Age (years) 28.4 (0.9) 28.4 (0.9) 34.3 (0.8) 34.3 (0.7) 
Systolic blood pressure (mmHg) 131 (12) 121 (12) 134 (14) 121 (14) 
Diastolic blood pressure (mmHg) 73 (8) 71 (8) 75 (9) 70 (9) 
% of hypertensives* 24.7% 6.3% 29.6% 12.1% 
Mean arterial pressure (mmHg) 92 (8) 87 (9) 95 (10) 87 (9) 
Pulse pressure (mmHg) 58 (9) 50 (8) 59 (10) 51 (11) 
Weight (kg) 83.5 (13.6) 71.3 (14.9) 85.4 (13.0) 69.5 (12.8) 
Height (cm) 183.9 (6.7) 170.2 (6.4) 182.9 (7.0) 169.0 (6.4) 
Body mass index (kg/m2) 24.7 (3.7) 24.7 (5.0) 25.5 (3.5) 24.3 (4.0) 
Waist-hip ratio 0.88 (0.06) 0.81 (0.06) 0.92 (0.06) 0.83 (0.07) 
Total cholesterol (mmol/l) 4.8 (1.0) 4.8 (0.8) 5.3 (1.1) 4.9 (0.8) 
HDL-cholesterol (mmol/l) 1.3 (0.3) 1.6 (0.4) 1.2 (0.3) 1.6 (0.3) 
Triglycerides (mmol/l) 1.4 (0.9) 1.2 (0.6) 1.1 (0.7) 0.9 (0.4) 
LDL-cholesterol (mmol/l) 2.9 (0.9) 2.7 (0.8) 3.6 (0.9) 3.0 (0.8) 
Glucose (mmol/l) 5.2 (1.2) 4.8 (0.4) 5.3 (0.7) 5.0 (0.5) 
Current smoker (%) 36% 27% 34% 25% 
# Daily cigarettes in current smokers 12.9 (8.4) 14.5 (8.8) 13.7 (9.9) 11.8 (7.2) 
# Years smoked in current smokers 9.6 (3.6) 10.3 (3.5) 13.8 (5.5) 14.3 (5.6) 
Parental history myocardial infarction (%) 3.5% 3.9% 19.2% 17.9% 
Parental history for diabetes (%) 5.6% 4.9% 7.4% 10.8% 
Speed of sound (m/s) 1568 (30) 1566 (31) 1564 (26) 1564 (32) 
Broadband ultrasound attenuation 
(dB/MHZ) 
76.7 (16.1) 71.1 (14.7) 80.7 (14.5) 74.5 (14.2) 
Quantitative ultrasound index 103.3 (18.1) 99.9 (17.8) 103.2 (15.9) 100.6 (18.1) 
Urinary sodium excretion (mmol/24h) 131 (79) 127 (68) 125 (74) 111 (60) 
Urinary potassium excretion (mmol/24h) 47 (22) 41 (17) 48 (19) 36 (14) 
Urinary calcium excretion (mmol/24h) 3.8 (2.7) 3.2 (2.3) 3.9 (2.4) 3.5 (2.2) 
Urinary total protein (mg/24h) 47 (37) 50 (60) 56 (27) 45 (22) 
Urinary albumin excretion (mg/24h) 12 (19) 14 (54) 13 (8) 15 (18) 
Urinary creatinine excretion (mmol/24h) 17 (5) 13 (9) 17 (4) 12 (3) 
CIMT (mm) 0.49 (0.05) 0.48 (0.05) -  -  
Common carotid lumen diameter (mm) 6.19 (0.40) 5.66 (0.36) -  -  
Aortic PWV** (m/s) 6.5 (1.5) 5.5 (1.3) -  -  
10-year CHD risk {273} 3.1 (1.9) 0.3 (0.2) 4.9 (3.0) 0.7 (0.5) 
 
Values are means with standard deviation. 
LDL: low-density-lipoprotein, HDL: high-density-lipoprotein, CHD: coronary heart disease, PWV: pulse 
wave velocity. 
*Hypertension is defined according to the JNC V definitions41: systolic blood pressure ≥140 mmHg or 
diastolic blood pressure ≥90 mmHg (hypertension stages I-IV). 
**Adjusted for adult mean arterial pressure. 
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Fasting total cholesterol, HDL-cholesterol, triglycerides and glucose were 
determined using Vitros950 dry-chemistry analyzer (Johnson & Johnson, Rochester, 
New York, USA); LDL-cholesterol was calculated using the Friedewald formula. In 
timed-overnight urine samples sodium, potassium and calcium were determined 
using Beckman-Coulter Synchron LX20. The urinary excretions of creatinine and 
total protein were assessed by a Bio Rad Protein Assay, and microalbuminuria was 
assessed by ELISA (DAKO, Glostrup, Denmark). Blood-, urine- and DNA-samples 
were stored at –80°C for future research questions. In the cohort of The Hague, 
fasting blood was drawn of 240 young adults. Samples were kept at 4 oC and the lipid 
profile and glucose level were determined within 4 hours. In The Hague, 187 samples 
were determined (LX-20 (Coulter-Beckman), in Utrecht 40 samples (Vitros950 dry-
chemistry analyzer) and 13 samples were determined in laboratories elsewhere. 
Serum triglycerides values were logarithmically transformed to obtain a normal 
distribution in the analysis. 
Information on smoking habits, alcohol intake, medical history, drug use and family 
history was obtained by a standardized written questionnaire. We obtained further 
information of the young adults by a written questionnaire on the highest education 
level (low/middle/high) as a measure of socio-economic status and cardiovascular 
family risk: hypertension of the first degree family members (n=859), myocardial 
infarction, stroke, diabetes and hypercholesterolemia. 
In addition, all participants of the Utrecht cohort underwent a measurement of 
bone density at the right calcaneus assessed by the Sahara Clinical Bone Sonometer 
(Hologic, Waltham, USA).  
Based on the information on the risk factors, the 10 years risk of the ARYA 
participants is estimated using the Framingham Heart Study risk score.42 
 
Common carotid intima-media thickness (CIMT) (Utrecht cohort only) 
B-mode ultrasonography of both the left and right common carotid arteries was 
performed using a 7.5 MHz linear array transducer (Acuson Aspen, Mountain View, 
California, USA). When an optimal longitudinal image was obtained, it was frozen on 
the R-wave of the electrocardiogram and stored on S-VHS videotape.43 This 
procedure was repeated at 4 predefined angles per side (180°, 150°, 120°, 90° for 
the right carotid artery and 180°, 210°, 240°, 270° for the left carotid artery) using the 
Meijer’s Arc (figure 2.2), allowing the collection of detailed information in a highly 
standardized and reproducible way. The ARYA study images were performed by 6 
sonographers, which completed a uniform certification program. This program 
included a detailed training session in which the sonographer was familiarized with 
the ultrasound protocol and the ultrasound equipment, followed by the performance 
of 20 pre-certification scans in which a high level of proficiency had to be 
demonstrated. The actual measurements were performed off-line. The frozen images  
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Figure 2.2 Meijer’s arc 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
on the videotape were digitized and displayed on a screen using additional dedicated 
software as described in detail.43 In short, the interfaces of the distal common carotid 
artery were marked over a length of 10-mm using an automated edge detection 
approach. The beginning of the dilatation of the distal carotid artery served as a 
reference point for the start of the measurement. The average of the intima-media 
thickness of the 8 predefined angles (each angles includes one image from the near 
wall and one image from the far wall) were used for each subject as a measure for 
current wall thickness of the common carotid artery. Two readers were engaged in 
the reading procedure of the echographic images. The reproducibility of the CIMT-
measurement was assessed by scanning 21 subjects on a second occasion by 
another sonographer but read by the same reader. Absolute mean difference (SE) of 
the repeated measurements between visits was 0.012 mm (0.004) for mean intima-
media thickness of both carotid arteries. The intraclass correlation coefficient was 
0.84. 
 
Aortic pulse wave velocity (PWV) (Utrecht cohort only)  
In the ARYA study, PWV was measured non-invasively in the carotid-femoral 
segment using the SphygmoCor device (PWV Medical, Sydney, Australia) after 
extensive training. Due to equipment failure, usable PWV-data were available in only 
524 participants of the Utrecht part of the ARYA cohort. As the subjects with PWV-
measurement did not significantly differ from those without PWV-data in respect to 
Rationale and design of the ARYA study 
35 
cardiovascular risk profile (except for age), we concluded that missing values were a 
random phenomenon. Participants were asked to lie down for 10 minutes before 
starting and to refrain from talking during the procedure. Two distances were 
measured in a straight line using a compass to reduce the influence of body 
contours: (a) from the sternal notch to the proximal sampling site on the carotid artery 
and (b) from the sternal notch to the distal sampling site on the femoral artery. The 
carotid to femoral path length was estimated by subtracting distance (a) from 
distance (b). PWV was determined by sequential acquisition of pressure waveforms 
from the carotid and the femoral arteries by applanation tonometry (Millar SPT 301 
pressure transducer, Millar Instruments). The timing of these waveforms was 
compared with that of the R-wave on the simultaneously recorded ECG. PWV was 
determined by calculation of the difference in carotid to femoral path length divided 
by the difference in R-wave to waveform foot times (figure 2.3). The average of 10 
successive measurements was used in the analyses to cover a complete respiratory 
cycle. The whole procedure was repeated 3 times per subject and the average PWV-
value was used for the analyses. The reproducibility of the PWV-technique was 
assessed by repeating the procedure in a subset of 25 participants several weeks 
after the first visit. Absolute mean difference (+SE) in PWV of the repeated 
measurements between visits was 0.12 m/s (0.45). The intraclass correlation 
coefficient for repeated measurements was 0.67. Since the repeated measurements 
were performed on two different occasions and we failed to measure the blood 
pressure during the repeated visit, the moderate correlation could be explained in 
part by the variability in blood pressure over time (as described earlier). 
 
Figure 2.3 Measurement of aortic pulse wave velocity44 
 
 
 
 
 
 
 
 
 
∆d = distance between the carotid artery and the femoral artery 
∆t = time delay between arrival of the pulse wave in the carotid artery and the femoral artery 
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Determinants of central blood pressure indices from peripheral waveforms 
The arterial pressure waveform varies throughout the arterial tree due to differences 
in vessel compliance and the phenomenon of wave reflection.45 The pressure 
waveform at any point is a composite of the forward-going and reflected wave. 
O’Rourke et al. developed the technique of pulse wave analysis (PWA), making non-
invasive derivation of central pressure waveforms possible.46 This technique uses 
applanation tonometry to record pressure waves from peripheral arteries. 
In the ARYA study, peripheral pressure waveforms were recorded from the radial 
artery at the wrist using micromanometer (Millar SPT 301, Millar Instruments). 
Ascending aortic pressure was derived from the central pressure waveform, using a 
transfer function47 that is incorporated in the SphygmoCor device. Our results 
showed high correlation (Pearson’s correlation coefficient: 0.94) between the brachial 
MAP, calculated using the formula (2*DBP+SBP)/3, and the central MAP, estimated 
by the transfer function. Theoretically, invalid estimation of the central blood pressure 
parameters by the transfer function would bias the relations between the 
cardiovascular risk factors and PWV if the error in the central MAP estimate is 
differential (i.e. the magnitude of the ‘error’ depends on the level of blood pressure). 
To our knowledge, however, a validation study in a young population with a broad 
blood pressure range, in which central MAP calculated with either the transfer 
function or manually (as the area under the generated central waveform) were 
compared according to levels of peripheral blood pressure, has not been performed. 
 
2.4 Data analysis 
The predictive capacity of adolescent blood pressure readings to discriminate 
between presence and absence of hypertension in young adulthood was quantified 
using univariate logistic regression analyses and estimated as logistic regression 
coefficients with their 95% confidence intervals. Reliability (goodness of fit) of the 
models was estimated using the Hosmer & Lemeshow test.48 The prognostic ability 
to discriminate between young adults with and without hypertension was assessed 
using the Receiver Operation Characteristic curve (ROC-area). 
The relationships between birth characteristics, adolescent parameters or adult 
cardiovascular risk factors and the two measures of subclinical vascular damage 
were evaluated by univariate and multivariate linear regression models. Subgroup 
analysis was performed only when the added interaction term was significant in the 
multivariate model and if a biological plausible mechanism was present. Since there 
was a statistically significant difference in CIMT between the two readers, all 
analyses using CIMT as dependent variable were adjusted for reader. In the 
analyses with PWV as the outcome variable and cardiovascular risk factors as 
independent variables, failure to correct for blood pressure could leave room for 
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residual confounding as PWV is related to wall elasticity and by that to distending 
pressure49 while blood pressure is related to several cardiovascular risk factors such 
as body mass index, waist circumference, HDL-cholesterol and insulin. Mean arterial 
pressure is preferred to use for this correction because it remains constant between 
central and peripheral arteries while all other blood pressure parameters show 
pressure amplification along the arterial tree.50 
For analyses on genetic traits a multivariate linear regression model was used to 
study the relation between genotypes and cardiovascular risk factors, intermediate 
measures of vascular damage and birth characteristics as continuous variables. 
 
2.5 Statistical power 
Power calculations were performed for the main research questions of the ARYA 
study, i.e. the relation between birth weight and subclinical vascular damage at 
young adulthood, based on duplicate measurements of the vascular entities. In a 
study sample of 500 young adults, a CIMT-difference of at least 0.03 mm could be 
detected between subjects born at the lowest compared to subjects born at the 
highest quartile of the birth weight distribution, with a type-I error of 5% and a type-II 
error of 20%. Analogously, in a sample size of 500 subjects, a PWV-difference of at 
least 0.7 m/s was expected to be detected under identical limiting conditions. The 
sample size was increased from 500 up to 750 subjects after the decision to refrain, 
due to logistic reasons, from duplicate vascular measurements. 
 
2.6 Discussion 
The Atherosclerosis Risk in Young Adults (ARYA) study was specifically designed to 
evaluate 1) whether it is possible to predict cardiovascular risk at young adulthood by 
routinely measured adolescent data, and 2) evaluating the role of birth characteristics 
and adolescent characteristics to the development of vascular damage at young 
adulthood. In addition, the ARYA study enables studies on genetic traits as 
determinants of cardiovascular risk, assessed by measurement of risk factors and 
vascular damage.  
In the ARYA study we are not able to use clinical events as outcome, since these 
subjects will not suffer from events for a long time. Therefore, we choose several 
types of outcomes, which are assumed to be markers of cardiovascular risk, i.e., 
surrogate outcomes. These include absolute risk factor levels, dichotomized risk 
factors using a cut off point at a certain percentile or clinically standardized cut off 
levels, a 10-years risk of coronary heart disease using the Framingham risk score, 
and the CIMT and PWV as indicators of vascular damage.  
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A surrogate endpoint is a biomarker that is intended to substitute for a clinical 
endpoint or end-organ damage and is positioned on the time axis in between the 
causal pathway.51-53 There are two important reasons to use surrogate measures in 
stead of ‘hard’ endpoints in epidemiological studies. Firstly, the use of surrogate 
endpoints allows studies early in the process, i.e. before clinical manifestation of the 
disease of interest and thus at young age. Secondly, as surrogate endpoints can be 
measured in all participants, sufficient power can be attained in epidemiological 
studies with a smaller sample size. However, several criteria must be adhered before 
a measure can be used as a surrogate endpoint: 1) the measure must be valid and 
well reproducible 2) a biological plausible mechanism should underlie the pathway 3) 
the surrogate endpoint must be significantly related to both the risk factors and the 
disease of interest and 4) a change in risk factor level should induce change in the 
surrogate measure and 5) a change in the surrogate measure should be reflected in 
a change in risk of the disease of interest. 
The surrogate marker, CIMT, assessed by high-resolution B-mode 
ultrasonography, is a non-invasive, reproducible method to quantify arterial wall 
thickening, atherosclerosis progression and carotid plaques54. CIMT may be 
regarded as a valid marker of generalized atherosclerosis as it has been shown to be 
strongly associated with atherosclerosis in other parts of the arterial system55-59, with 
coronary calcification assessed by electron beam computer tomography60 and to a 
lesser degree with coronary angiography.58,61,62 In middle-aged and elderly subjects, 
CIMT has been shown to be a strong predictor of subsequent cardiovascular 
morbidity and mortality.63-67 Furthermore, several population-based studies, 
predominantly in middle-aged subjects and the elderly, have shown significant 
associations between unfavorable cardiovascular risk profile and increased CIMT.68-
72 Stevens et al.73 have shown that weight gain from early adulthood into middle 
adulthood was associated with increased CIMT. Similar results were observed for 
blood pressure and lipid levels.74 In addition, results from the Tromso study71 showed 
positive associations between important cardiovascular risk factors and increased 
CIMT 15 years later. Besides, several studies have been conducted in which various 
interventions were shown to affect progression and regression of CIMT.75-78 
However, data on the influence of change in CIMT on CVD-events as well as the 
usefulness of the CIMT-measurement in clinical care as a screening tool to improve 
risk assessment are scarce.79 Nonetheless, the available evidence indicates that 
CIMT is a meaningful outcome measure in observational and intervention studies. 
The surrogate marker PWV provides a non-invasive, reproducible and validated 
method to quantify arterial stiffness. Increased PWV has been shown to be a strong 
predictor of cardiovascular mortality in hypertensive subjects50,80, in patients with 
end-stage renal disease81 and in healthy elderly.82 Moreover, cross-sectional studies 
in middle-aged and elderly subjects have shown that an unfavorable cardiovascular 
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risk profile is associated with increased arterial stiffness.83-87 In the young, most 
studies evaluating arterial stiffness are performed in high-risk children like children 
with diabetes mellitus87, obesity88 and hypercholesterolemia.89 These studies had a 
cross-sectional design just like the two studies concerning healthy youngsters.91,92 
However, an important drawback in all studies is insufficient adjustment for blood 
pressure, leaving room for residual confounding. Some evidence is present for stiffer 
arteries in children with a positive family history of myocardial infarction92 and familial 
hypercholesterolemia93,94 compared to age-matched healthy controls. Results about 
the impact of parental hypertension are less congruent.95,96 Several studies, 
particularly in the elderly, showed positive associations between aortic stiffness and 
atherosclerosis at different sites in the arterial tree.97-100 However, longitudinal studies 
evaluating the determinants of the progression of arterial stiffness as well as studies 
exploring the association between changes in arterial stiffness (more compliant) and 
improved survival are scarce and restricted to high-risk populations.100,101 Such 
evidence is needed to enhance the validity of PWV as a surrogate endpoint for CVD.  
In summary, the ARYA study, together with two other cohort studies in children 
followed into adulthood, the Muscatine Study60 and the Bogalusa Heart Study27, is 
aimed to provide data on early determinants of cardiovascular risk, including vascular 
damage. This information will enhance our understanding of the underlying 
mechanism of atherosclerosis and CVD-development. Such knowledge is needed to 
improve the available primary prevention programs and to support discussion about 
new preventive strategies. Moreover, since the ARYA study disposes some other 
parameters, like urine samples, DNA and data on bone density, this cohort offers 
extensive possibilities for etiological research beyond those concerning 
atherosclerosis development. Finally, since the ARYA study includes young and 
healthy subjects, it provides an interesting cohort for further research on the 
development, differences and similarities of several manifestations of vascular 
damage characterized by different vascular measures, apart from CIMT and aortic 
PWV.  
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3.1.1 Abstract 
Background: A common functional polymorphism in the promoter region of the 
insulin-like growth factor-I (IGF-I) gene may play an important role in the 
development of type 2 diabetes and myocardial infaction, and both pre- and postnatal 
body growth. However, the studies are limited and show contradicting results. Our 
aim was to study the relation between a functional polymorphism in the promoter 
region of the IGF-I gene and cardiovascular risk in adolescence and young 
adulthood, and birth size. 
Methods: In a population based cohort study of 352 men and 398 women born in 
1970-1973, birth characteristics, adolescent blood pressure and anthropometry were 
collected from the school health records. At young adulthood, we determined also 
fasting blood glucose, total cholesterol, triglycerides, HDL- and LDL-cholesterol and 
the IGF-I genotype. The common carotid intima-media thickness and pulse wave 
velocity as measures of subclinical cardiovascular damage were performed. 
Results: Of the 729 subjects, 43% were homozygous carriers of the 19 CA repeat, 
44% were heterozygous carriers and 13% were non-carriers. We observed a lower 
blood pressure in homozygous carriers, and a less atherogenic lipid profile at young 
adulthood (test for trend of LDL-cholesterol: p=0.017). Homozygous and 
heterozygous carriers were on average a 2.1 cm taller than non-carriers (test for 
trend at young adulthood: p=0.030). We could not observe an association between 
IGF-I genotype, and subclinical cardiovascular damage or birth size. 
Conclusion: Homozygous carriers of a functional polymorphism in the promoter 
region of the IGF-I gene show a more favorable profile of cardiovascular risk factors 
in adolescence and young adulthood. A relation between the IGF-I gene and arterial 
wall thickness or wall stiffness could not yet be described at this young age. 
 
3.1.2 Introduction 
Cardiovascular diseases are still the major cause of morbidity and mortality in 
western countries. Already at young age, the development of the diseases is 
accelerated by cardiovascular risk factors such as hypertension, 
hypercholesterolemia and obesity.1-3 The insulin-like growth factor-I (IGF-I) plays an 
important role in the development of cardiovascular diseases4, and both pre- and 
postnatal body growth.5 Hattersley et al. suggested that genes involved in insulin 
resistance caused a low birth size, type 2 diabetes and cardiovascular diseases in 
later life.6 This hypothesis has recently been confirmed by a study in the elderly, 
showing that subjects without the wildtype allele in the promoter region in the IGF-I 
gene had an increased risk of type 2 diabetes and myocardial infarction, and also low 
circulating IGF-I levels, reduced body height and low birth weight.7,8 However, a 
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second study with young adults showed contradicting results; no relations were 
described except for an increase of the IGF-I levels in non-carriers.9 
To expand upon these conflicting results, we used data from the Atherosclerosis 
Risk in Young Adults (ARYA) study. We examined the relation between the functional 
polymorphism in the promoter region of the IGF-I gene and cardiovascular risk at 
adolescence and young adulthood, and birth characteristics. 
 
3.1.3 Methods 
The study population of the ARYA study comprises two cohorts: a cohort from the 
Dutch city of Utrecht consisting of 750 participants and a cohort from The Hague 
consisting of 262 participants. This report was restricted to the cohort of Utrecht 
because we determined the IGF-I genotype in this cohort only. The ARYA study was 
approved by the Medical Ethical Committee of the University Medical Center Utrecht, 
Utrecht, The Netherlands. Written informed consent was obtained of all 750 
participating young adults. 
 
Registered risk factors at birth and adolescence 
In The Netherlands virtually all children regularly visit the child health facilities of the 
Home Care Organizations and Municipal Health Service, starting at four weeks until 
leaving secondary school at the age of 16 to 19 years. Information was routinely 
collected and written down in health records by school doctors and nurses. Subjects 
of the ARYA study were born between 1970 and 1973 and attended secondary 
school in Utrecht. Records were selected on the presence of birth weight data and at 
least one adolescent blood pressure measurement, as previously described.10 A total 
of 750 subjects participated in the Utrecht cohort. Between the responders and non-
responders born in 1970 (n=967), there were no differences in mean birth weight, 
and adolescent blood pressure and anthropometry. 
We obtained information on birth weight (n=749), birth length (n=581), gestational 
age (n=599), delivery (n=688) and parity (n=736) noted one month after birth. Data 
from secondary school consisted of blood pressure measured by a 
sphygmomanometer (n=750), body height (n=750), weight (n=750) and sexual 
maturity determined by Tanner scale (n=656). 
 
Risk factors at young adulthood 
From October 1999 to December 2000 all participants underwent a physical 
examination during two visits at the outpatient clinic of the Julius Center. All 
investigators were similarly instructed and blinded for data in the medical school 
health records. After a five minutes rest in sitting position, blood pressure was 
measured by Dynamap at the left upper arm. After 5-15 minutes rest the 
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measurement was repeated. The same procedure was followed at the second visit 
with a mean interval of 20.4 days (SD 10.7). Body height was measured in standing 
position - without shoes - to the nearest 0.1 cm. Body weight was measured with 
indoor clothes - without shoes - to the nearest 0.5 kg. To compensate for clothes we 
subtracted 0.5 kg. 
Of the 750 participants, fasting blood of 730 participants and non-fasting blood of 8 
participants was drawn and stored at –20 oC. When all the participants finally visited 
our outpatient clinic, levels of glucose, total cholesterol, triglycerides, high-density-
lipoprotein (HDL-) cholesterol and low-density-lipoprotein (LDL-) cholesterol11 were 
determined by Vitros950 dry-chemistry analyzer (Johnson & Johnson, Rochester, 
New York, USA). 
We obtained further information on ethnicity, smoking (yes/no, packyears), alcohol 
consumption (yes/no), use of oral contraception (yes/no), cardiovascular family risk, 
and highest education level (low/middle/high) as a measure of socio-economic 
status, by a written questionnaire.  
 
Arterial wall thickness and stiffness at young adulthood 
The common carotid intima-media thickness of the right and left carotid artery was 
measured by six trained sonographers using a 7.5 MHz linear array transducer 
(Acuson Aspen). The common carotid intima-media thickness was measured at eight 
different angles (right carotid artery: 180, 150, 120 and 90 degrees, left carotid artery: 
180, 210, 240 and 270 degrees) using the Meijer’s Arc. A two dimensional image of 
the distal part of the common carotid artery was performed. An optimal image was 
frozen on the top of the R-wave of the electrocardiogram and recorded on tape. Two 
readers measured the common carotid intima-media thickness off line with a 
computerized analyzing system, over a length of 10 mm starting at the beginning of 
the dilatation of the bifurcation.12 To assess reproducibility, the common carotid 
intima-media thickness of 21 participants was repeated at the same visit by another 
sonographer, and showed an absolute mean difference of 0.012 mm (standard error 
0.004). The intraclass correlation coefficient for repeated measurements was 0.84. 
The pulse wave velocity was measured between the carotid artery and the femoral 
artery using the SphygmoCor device. (Pulse wave velocity Medical, Sydney, 
Australia, Millar SPT 301 pressure reducer, Millar Instruments). The participants lied 
supine for 10 minutes before starting the measurement and were asked to refrain 
from talking. The carotid-femoral distance was calculated by subtracting: a) the 
distance from the suprasternal notch to the proximal sampling site on the carotid 
artery from: b) the distance from the suprasternal notch to the distal sampling site on 
the femoral artery. A compass was used to avoid the impact of body fat at the waist. 
The timing of the pressure waveform was compared with the timing of the R-wave at 
the electrocardiogram. Pulse wave velocity was calculated, dividing the carotid-
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femoral distance by the difference in timing of the pressure waveform and R-wave. 
The average of 10 successive heartbeats was used to cover a complete respiratory 
cycle. To assess reproducibility, the pulse wave velocity of 25 participants was 
repeated within a mean time interval of three weeks. The absolute mean difference in 
pulse wave velocity was 0.12 m/s (standard error 0.45) and the intraclass correlation 
coefficient for repeated measurements was 0.67. Due to logistic reasons, the pulse 
wave velocity of only 524 subjects was measured and used in the analyses. 
 
IGF-I genotype 
Polymerase chain reaction was performed using oligonucleotide primers designed to 
amplify the polymorphic cytosine-adenine (CA) repeat 1 kb upstream of the human 
IGF-I gene.13 The reaction was carried out in a final volume of 10 µl containing 50 ng 
of genomic DNA obtained from peripheral blood cells, 0.5 nmol/l forward primer 
(5´-ACCACTCTGGGAGAAGGGTA-3´), 0.5 nmol/l reverse primer 
(5´-GCTAGCCAGCTGGTGTTATT-3´), 0.25 mmol/l 2´-dNTP, 2.2 mmol/l MgCl2, 
0.01% W1 (Gibco BRL), and 0.4 Taq DNA polymerase (Gibco BRL). Polymerase 
chain reaction was performed in 384 well plates (94oC 10 min; 35 polymerase chain 
reaction cycles of 30 s at 94oC, 30 s on 55oC, and 30 s on 72oC; 72oC 10 min; 4oC 
hold). Forward primers were labeled with FAM, HEX, or NED to determine the size of 
polymerase chain reaction products by autosequencer (ABI 3100, POP 4, filter set D, 
collecting time array 36 cm 7 s, peak-height between 100 and 2000, each lane 
containing three samples). The size of the polymerase chain reaction products was 
determined in comparison with internal ROX 500-size standard (Perkin Elmer). 
 
3.1.4 Data analysis 
The characteristics of men and women of the ARYA population were expressed as 
means with their standard deviation (SD). The Independent T-test was used to 
analyze gender differences. A multivariate linear regression model was used to study 
the relation between genotypes and cardiovascular risk factors, intermediate 
measures of vascular damage and birth characteristics as continuous variables. 
Because of the differences between men and women, gender was always included. 
We used a chi-square test to study the differences of IGF-I genotype between the 
babies in the lowest birth size stratum and the babies in the other strata. Therefore, 
all participants were categorized according to deciles of the birth size distribution. 
At young adulthood, the mean of four blood pressure readings, sixteen carotid 
intima-media thickness measurements and three pulse wave velocity measurements 
were used for the analyses. Triglyceride values were logarithmically transformed to 
obtain a normal distribution. All analyses regarding the carotid intima-media 
thickness were adjusted for reader because of interobserver variation. Because pulse 
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wave velocity is related to wall elasticity and by that depend on blood pressure14, the 
analyses were adjusted for mean arterial pressure, calculated as: diastolic blood 
pressure + 1/3*(systolic blood pressure – diastolic blood pressure). 
Analyses were carried out with the statistical analysis software SPSS 9.0. We 
used a cut off level of p=0.05 for statistical significance. 
 
3.1.5 Results 
Table 3.1.1 shows the general characteristics of the ARYA cohort according to 
gender. Men (46.9%) were born significantly heavier and taller and had a lower 
ponderal index. At adolescence, boys had a higher blood pressure and a lower body 
mass index. At young adulthood blood pressure, weight, body height and levels of 
fasting glucose, LDL-cholesterol and triglycerides were higher in men, and HDL- 
 
Table 3.1.1 General characteristics of men and women of the ARYA cohort 
 
 Men (n=352) Women (n=348) 
Birth characteristics     
Birth weight (kg) 3.48  (0.54) 3.37  (0.55) 
Birth length (cm) 51.3  (2.5) 50.4  (2.5) 
Ponderal index (kg/cm3) 25.9  (3.1) 26.5 (3.1) 
Gestational age (weeks) 39.8  (1.8) 39.8  (2.0) 
Adolescence     
Age (years) 13.5 (1.1) 13.4 (1.1) 
Systolic blood pressure (mmHg) 111.7 (12.5) 109.0 (11.3) 
Diastolic blood pressure (mmHg) 67.4 (9.6) 66.0 (10.1) 
Weight (kg) 49.2 (10.5) 49.9 (9.9) 
Height (cm) 163.0 (10.3) 161.2 (8.0) 
Body mass index (kg/m2) 18.3 (2.4) 18.9 (2.9) 
Young adulthood     
Age (years) 28.4 (0.9) 28.4 (0.9) 
Systolic blood pressure (mmHg) 130.8 (12.0) 120.6 (12.3) 
Diastolic blood pressure (mmHg) 73.1 (7.8) 70.9 (8.5) 
Weight (kg) 83.5 (13.6) 71.3 (14.9) 
Height (cm) 183.9 (6.7) 170.2 (6.4) 
Body mass index (kg/m2) 24.7 (3.7) 24.7 (5.0) 
Total cholesterol (mmol/l) 4.8 (1.0) 4.8 (0.8) 
LDL-cholesterol (mmol/l) 2.9 (0.9) 2.7 (0.8) 
HDL-cholesterol (mmol/l) 1.3 (0.3) 1.6 (0.4) 
Triglycerides (mmol/l) 1.4 (0.9) 1.2 (0.6) 
Glucose (mmol/l) 5.2 (1.2) 4.8 (0.4) 
Common carotid intima-media thickness (mm) 0.50 (0.05) 0.48 (0.05) 
Pulse wave velocity (m/s)* 6.5 (1.5) 5.5 (1.3) 
Values are means with standard deviation. 
LDL: low-density-lipoprotein, HDL: high-density-lipoprotein. 
*Pulse wave velocity is adjusted for mean arterial pressure. 
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Table 3.1.2 Allele distribution of the IGF-I promoter functional polymorphism 
 
Allele: number of base pairs Genotype Men (n=340) Women (n=389) 
      
176 (X)  0 (0) 2 (0.3) 
186 (X)  2 (2.9) 0 (0) 
188 (X)  6 (0.9) 12 (15.7) 
190 (X)  29  (4.3) 46 (5.9) 
192 (Z)  439 (64.6) 493 (63.4) 
194 (X)  142 (20.9) 146 (18.8) 
196 (X)  49 (7.2) 58 (7.5) 
198 (X)  13 (1.9) 21 (2.7) 
Z/Z: 192/192 Homozygous 145 (42.7) 158 (40.6) 
Z/X: 192/X Heterozygous 149 (43.8) 177 (45.5) 
X/X Non-carrier 46 (13.5) 54 (13.9) 
 
Data are n (%). The allele distribution is based on 2 alleles per participant. 
IGF-I: insulin-like growth factor-I, Z: most frequent allele/wildtype, X: all other alleles. 
 
cholesterol was lower than in women. The common carotid intima-media thickness 
and pulse wave velocity were higher in men. The mean time-interval between the 
measurements at adolescence and young adulthood was 14.9 years (SD=1.3). 
 
IGF-I genotype 
The IGF-I genotype was determined of 729 (97.2% of the 750) participants. Table 
3.1.2 shows that eight alleles were identified. Genotype and allele distribution were in 
Hardy-Weinberg equilibrium (p=0.44). The most frequent allele in the promoter region 
of the IGF-I gene had a length of 192 base pairs, which is equivalent to a repeat of 
19 cytosine-adenine (CA) base pairs. 86.5% of the population was either 
homozygous or heterozygous for the 192 base pair allele, suggesting that all other 
alleles originate from this so called wildtype allele (Z). All other seven alleles (X) were 
pooled and three possible genotypes were determined; of all subjects, 43% were 
homozygous by carrying two wildtype alleles, 44% were heterozygous carriers of the 
19 CA repeat and 13% were non-carriers. 
 
Blood pressure, lipid levels, body size, arterial wall thickness and stiffness 
Table 3.1.3 describes that homozygous carriers had the lowest systolic and diastolic 
blood pressure, although statistical significance was only reached for adolescent 
diastolic blood pressure. The lipid profile was less atherogenic in homozygous 
carriers, showing a statistically significant test for trend in LDL-cholesterol. 
 Homozygous and heterozygous carriers were taller compared to non-carriers, a 
difference that was statistically significant at young adulthood. The mean body mass 
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Table 3.1.3 A functional polymorphism of the IGF-I gene and blood pressure and 
lipids 
 
 Genotype 
 Homozygous Heterozygous P* Non-carrier P* 
P (test 
for trend)
Adolescence      
Systolic blood pressure (mmHg) 110 (0.68) 111 (0.95) 0.27 110 (1.37) 0.59 0.39
Diastolic blood pressure (mmHg) 66 (0.56) 68 (0.78) 0.006 67 (1.13) 0.33 0.07
Weight (kg) 49.3 (0.58) 49.6 (0.80) 0.67 49.5 (1.16) 0.80 0.72
Height (cm) 162.8 (0.53) 162.5 (0.73) 0.69 161.2 (1.05) 0.12 0.17
Body mass index (kg/m2) 18.4 (0.15) 18.7 (0.21) 0.24 18.9 (0.30) 0.14 0.10
Young adulthood      
Systolic blood pressure (mmHg) 125 (0.69) 125 (0.96) 0.99 127 (1.39) 0.23 0.35
Diastolic blood pressure (mmHg) 72 (0.47) 72 (0.65) 0.46 73 (0.94) 0.15 0.39
Weight (kg) 76.2 (0.81) 78.0 (1.13) 0.11 75.6 (1.63) 0.71 0.75
Height (cm) 176.9 (0.37) 177.0 (0.52) 0.91 164.8 (0.75) 0.005 0.030
Body mass index (kg/m2) 24.3 (0.25) 24.9 (0.35) 0.07 24.7 (0.50) 0.46 0.20
Total cholesterol (mmol/l) 4.77 (0.05) 4.90 (0.07) 0.06 4.87 (0.10) 0.32 0.13
LDL-cholesterol (mmol/l) 2.69 (0.05) 2.89 (0.07) 0.003 2.84 (0.10) 0.11 0.017
HDL-cholesterol (mmol/l) 1.47 (0.02) 1.42 (0.03) 0.10 1.47 (0.04) 0.96 0.55
Triglycerides (mmol/l)** 1.18 (1.12-
1.24) 
1.17 (1.04-
1.33) 
0.95 1.11 (0.95-
1.29) 
0.23 0.33
Glucose (mmol/l) 4.98 (0.05) 5.04 (0.07) 0.41 4.95 (0.10) 0.79 0.91
 
Values are means (standard error of the mean) adjusted for gender. 
IGF-I: insulin-like growth factor-I, LDL: low-density-lipoprotein, HDL: high-density-lipoprotein. 
*P-values: genotype group versus homozygous carriers. 
**Triglyceride values were logarithmically transformed and therefore 95% confidence interval is used. 
 
index at both ages was the lowest in homozygous carriers, although not statistically 
significant. The common carotid intima-media thickness and pulse wave velocity did 
not materially differ between the genotypes (table 3.1.4). Adjusting for age did not 
alter the relations. 
 
Birth size 
We did not find a relation between the functional polymorphism in the promoter 
region of the IGF-I gene and birth weight, birth length, ponderal index, in the crude 
analyses or after additional adjustments for characteristics at birth, of the parents and 
participant. Homozygous carriers had a mean birth weight of 3.41 kg (standard error 
of the mean (SE)=0.03), which was not statistically significantly different from the 
birth weight of heterozygous carriers (3.43 kg (SE=0.04))(p=0.66) and of non-carriers 
(3.43 kg (SE=0.06))(p=0.66). The analyses with birth length and ponderal index as  
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Table 3.1.4 A functional polymorphism of the IGF-I gene and arterial wall thickness 
and stiffness 
 
 Genotype 
 Homozygous Heterozygous P* Non-carrier P* 
P (test 
for trend) 
Common carotid intima-
media thickness (mm) 
adjusted for reader 
0.487 (0.002) 0.489 (0.004) 0.57 0.481 (0.005) 0.22 0.45 
Pulse wave velocity (m/s) 
adjusted for mean arterial 
pressure 
6.01 (0.05) 5.92 (0.07) 0.18 6.07 (0.10) 0.51 0.98 
 
Values are means (standard error of the mean) adjusted for gender. 
IGF-I: insulin-like growth factor-I. 
*P-values: genotype group versus homozygous carriers. 
 
independent variables showed similar results. One exception is that the participants 
in the lowest decile of birth length, had a significantly lower percentage of 
homozygous carriers (27% of 49 individuals) than the other deciles (45% of 514 
individuals)(p=0.03). 
 
3.1.6 Discussion 
Our findings show an association between a functional polymorphism in the promoter 
region of the IGF-I gene and cardiovascular risk factors at adolescence and young 
adulthood. Homozygous carriers had a lower blood pressure, a less atherogenic lipid 
profile and were taller than non-carriers. The impact of these risk factors was not yet 
reflected in arterial wall thickness and stiffening. 
To appreciate the findings of this report, four issues of the ARYA study need to be 
addressed. A strong feature of the ARYA study is that measurement error is 
minimized by using birth- and adolescent characteristics obtained from medical 
health records, instead of parental recall and self-report. Secondly, although only 750 
of the 4208 invited subjects ultimately entered the study, and 70% of the young 
adults underwent the pulse wave velocity measurement, we have several reasons to 
assume that selection bias regarding the relations under study did not occur: the 
invited young adults were unaware of their IGF-I genotype, 87% of our participants 
had a 19 CA repeat in the promoter region of the IGF-I gene similar to other 
population based studies7,8,15-17, data at birth and adolescence did not differ between 
the responders and non-responders born in 1970, and the obtained data between the 
participants with and without a pulse wave velocity measurement were similar. Third, 
in adults and elderly subjects, type 2 diabetes, myocardial infarction and mortality 
have repeatedly been related to the common carotid intima-media thickness18-21 and 
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pulse wave velocity.22-24 It is very likely to assume that these relations also exist in 
young adults. At young age, the common carotid intima-media thickness is 
associated with previous and current cardiovascular risk factors, such as a high 
blood pressure and a suboptimal lipid profile.1,10,25 Also, these risk factors are 
associated with cardiovascular diseases and mortality.3,26,27 Fourth, the 
polymorphism in the promoter region of the IGF-I gene appeared to be functional, as 
studies showed that it is related to the IGF-I level and body height.8,15,17 
The main finding of this report is that subjects with the wildtype of the functional 
polymorphism in the promoter region of the IGF-I gene show a more favorable profile 
of the cardiovascular risk factors at a young age. To our knowledge, one group from 
Rotterdam, The Netherlands7,8 has previously published on this specific functional 
polymorphism and cardiovascular risk factors. In contrast to our findings, they did not 
show a relation between genotypes, blood pressure and lipid profile, although 
homozygous carriers had a lower risk to develop type 2 diabetes and myocardial 
infarction. These contradicting results may be explained by the large differences 
between the two population based studies. In our study, participants had an age 
below the 30 years, where as the Rotterdam study was based on elderly subjects 
with a mean age of 66 years. When we use the same definition for hypertension  
(systolic blood pressure >160 mmHg or diastolic blood pressure >95 mmHg or use of 
antihypertensive drugs), 2.3% of the 750 young adults in the ARYA study had 
hypertension, in contrast to 39% of the 900 participants of the Rotterdam study. Our 
participating young adults had a lower mean body mass index, waist-hip ratio, level 
of total cholesterol and were more often smokers (31%) than the participants from 
the Rotterdam (25%). Also, elderly are known to use a large variety of drugs, which 
may change the levels of the risk factors. Another explanation is that environmental 
or nutritional factors differ between our two study populations which also may 
interfere in the relation between the IGF-I genotypes and cardiovascular risk factors, 
for instance by the IGF-I level.28 If so, environmental or nutritional factors act on the 
relation for decades longer in elderly subjects than in young adults. 
Our findings show that the IGF-I gene was related to body height. Similar to us, 
the Rotterdam study8 and the U.K. study9 found that homozygous carriers were the 
tallest subjects. The fact that we found a statistically significant association at young 
adulthood but not at adolescence, may be explained by the different stages of 
maturity at time of measuring the body height. A fourth study did not mention the 
values of body height per genotype, but only described that the test for trend in 
women was not significant (p=0.47).17 
We could not disclose an association between a functional polymorphism in the 
promoter region of the IGF-I gene and arterial wall thickness and stiffness at young 
adulthood as intermediate measures of cardiovascular damage. If a longer exposure 
to a high blood pressure and an unfavorable lipid profile is needed to develop 
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changes of the arterial wall, associations between the IGF-I genotype, carotid intima-
media thickness and pulse wave velocity may emerge in the future. 
Like Frayling et al.9 we could not confirm the results of Vaessen et al.7 who found 
that non-carriers had a low birth weight. Only when we stratified birth length in 
deciles, homozygous carriers had less often a low birth length. This result is based 
on a small subgroup with a low birth length and thus may be a chance finding. 
Nevertheless, Arends et al.29 showed in a cohort of 124 short children with a mean 
age of 7 years and born small for gestational age, an association between birth 
characteristics and an intronic repeat in the promoter region of the IGF-I gene. 
In conclusion, our findings show that homozygous carriers of a functional 
polymorphism in the promoter region of the IGF-I gene show a more favorable 
cardiovascular risk factor profile at adolescence and young adulthood. No impact on 
intermediate measures of vascular damage could be demonstrated at young 
adulthood. 
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3.2.1 Introduction 
Low birth weight and other measures of decreased fetal growth have been related to 
future cardiovascular morbidity and mortality.1 It is postulated that an unfavorable 
nutritional intra-uterine environment programs the fetus to adapt itself resulting in 
decreased fetal growth and chronic disease in later life.2 Alternatively, genes may 
influence both size at birth and adverse future outcome.3 Several studies have shown 
that a low birth weight of the newborn is related to increased maternal risk of 
ischaemic coronary disease, and increased risk of prenatal complications such as 
pre-eclampsia.4 Others described that birth weight in a newborn may be modified by 
a glucosekinase mutation initiating maternal hyperglycemia.5 These findings suggest 
that the maternal genotype may change the intra-uterine environment and indirectly 
affect birth weight. 
Studies implied that non-carriers of a functional polymorphism in the promoter 
region of the insulin-like growth factor-I (IGF-I) had a low birth size and subsequently 
decreased adult height, type 2 diabetes and myocardial infarction.6,7 Findings of the 
Atherosclerosis Risk in Young Adults (ARYA) study previously suggested that the 
polymorphism of the young adults may be associated with cardiovascular risk, but 
not with their own birth weight. In this present study we used data of the ARYA study 
to examine associations between the polymorphism in the promoter region of the 
IGF-I gene in the ARYA participants and their first child’s birth weight. 
 
3.2.2 Methods and Results 
The study population comprises 352 men and 398 women born between 1970 and 
1973. Data on birth characteristics, blood pressure and anthropometry at 
adolescence were collected from the school health records. At age 27 to 30 years 
they were recently invited for re-examination and blood sampling. The IGF-I 
genotype was determined by polymerase chain reaction, using oligonucleotide 
primers designed to amplify the polymorphic cytosine-adenine (CA) repeat 1 kb 
upstream of the human IGF-I gene.8 Birth weight of the newborns was collected by 
written questionnaire. A multivariate linear regression model was used for the 
analyses. 
The ARYA participants had 129 first-born children. Of 42 participating men and 72 
women, both the IGF-I genotype was determined and the birth weight of the first 
newborn had been documented. Of the 114 parents, 43% were homozygous carriers 
of the 19 CA repeat, 40% were heterozygous carriers of the 19 CA repeat and 18% 
were non-carriers of the 19 CA repeat. These proportions were similar to that of all 
750 young adults participating the ARYA study, and other population based 
studies.7,9,10 Table 3.2.1 shows an association between infant’s birth weight and the 
polymorphism in the promoter region of the IGF-I gene of one of its parents: the first- 
Chapter 3.2 
64 
Table 3.2.1 Associations between a polymorphism in the promoter region of the 
IGF-I gene of the parents, and birth weight of the first-born 
 
 Birth weight of the first-born (g) 
 
Genotype of the parents 
Of all parents 
(n=114) 
Of the male parents 
(n=42) 
Of the female parents 
(n=72) 
      
Homozygous (n=49) 3496 (94) 3490 (145) 3500 (125) 
Heterozygous (n=45) 3504 (136) 3341 (227) 3577 (174) 
Non-carrier (n=20) 2912 (175) 3023 (272) 2839 (231) 
       
 P=0.001* P=0.09* P=0.006* 
 
Values are means (standard error). 
*P-values: mean birth weight of the first-born of non-carrier parents versus homozygous parents. 
 
born children of our non-carrier participants weighed on average 584 gram lower 
than of homozygous parents. This was more pronounced in the newborns of the 
female participants. 
Adjustment for weight, height or body mass index of the parents had little effect on 
the difference in birth weight of newborns between carriers and non-carrier parents 
(data not shown). Also, other possible confounding variables of the young parents, 
such as weight, height, body mass index, level of education as a measure of socio-
economic status, diabetes, hypertension, smoking and use of alcohol could not 
explain the observed association between parental genotype and birth weight in their 
offspring. Adjustment for gender of the first-born (n=103) did not change the results. 
 
3.2.3 Comment 
We show that the parents who were non-carriers of the 19 CA repeat had first-born 
children with a lower birth weight, than the children of homozygous and heterozygous 
parents. Birth weight was particularly lower in the first-born children of the non-carrier 
women. The relation between paternal genotype and birth weight of the newborn was 
in the same direction but not statistically significant. 
This report provides evidence for the view that parental genotype may influence 
fetal growth. This may impact the risk of cardiovascular disease in later life. To 
understand the determinants and prognosis of a low birth weight, studies on both 
genetic and environmental causes of fetal growth and chronic disease programming, 
merit further investigation. 
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4.1.1 Abstract 
Background: Most reports in children and young adults only show inverse 
associations between birth size and blood pressure after adjustment for attained 
body mass index or other measures of body size. This may have led to spurious 
conclusions about the relation between birth weight and cardiovascular risk. We have 
attempted to clarify the role of attained body size along recently proposed analytical 
guidelines. 
Methods: The ARYA study is a cohort that comprises 750 participants (46.9% 
men) born between 1970 and 1973. Birth characteristics and a single routine blood 
pressure measurement, weight and height in adolescence were available from the 
school health records of the Municipal Health Service. Recently, at young adulthood, 
blood pressure was measured twice at each of two visits. 
Results: Inverse but non-significant relations between birth weight and systolic 
blood pressure were found at adolescence (linear regression coefficient: 
-1.2 mmHg/kg; 95% confidence interval -2.8 to 0.3) and at young adulthood 
(-0.7 mmHg/kg; -2.4 to 1.1). These relations became stronger after adjustment for 
attained body mass index (adolescence: -1.5 mmHg/kg; -3.0 to -0.01, young 
adulthood: -0.9 mmHg/kg; -2.5 to 0.8). There was a significant interaction between 
birth weight and body mass index in relation to young adult blood pressure levels. 
However, particularly in the highest tertile of body mass index at young adulthood 
was an inverse relation between birth weight and blood pressure observed (systolic 
blood pressure: -2.6 mmHg/kg; -5.3 to 0.2, diastolic blood pressure: -2.5 mmHg/kg; -
4.3 to -0.6). In multivariate models, systolic blood pressure at young adulthood was 
more strongly related to a change of post-adolescent body mass within 15 years 
(1.1 mmHg/kg/m2; 0.8 to 1.3) than to birth weight (-0.7 mmHg/kg; -2.4 to 0.9). 
Similarly, systolic blood pressure was stronger related to young adult body mass 
index (0.8 mmHg/kg/m2; 0.6 to 1.0) than to birth weight (-0.9 mmHg/kg; -2.5 to 0.8). 
Conclusion: Where the proposed analyses of our data seem to generally support 
the fetal origins hypothesis, results of additional analyses show a relation between 
low birth weight and high blood pressure particularly in young adults with high relative 
body weights. An unfavorable intra-uterine environment may be less important for 
future hypertension than excess change to high relative body weight in later life. 
 
4.1.2 Introduction 
In support of the fetal origins hypothesis, many studies in children and adults have 
reported inverse associations between birth size and cardiovascular risk factors and 
diseases.1 The most frequent finding is a relation between low birth weight and high 
systolic blood pressure in later life.2,3 However, there are inconsistencies.4-7 One 
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frequently raised issue is about the role of attained body size in the relation between 
birth weight and blood pressure in later life.8-10 Relations between low birth size and 
high blood pressure often only became statistically significant after adjustment for 
measures of attained body size. Some longitudinal studies reported an intermediate 
role for attained body size, as a causal link in the chain of events leading from low 
birth weight to later high blood pressure, suggesting that postnatal body growth 
partially or totally explains the relation.7 This raises questions about whether or not 
attained body mass should be adjusted for as, theoretically, adjustment for 
intermediate variables leads to biased results.11 In order to avoid false conclusions 
about the relation between birth size and later cardiovascular outcome and to 
facilitate comparability of results, it was recently proposed to use an analytical 
procedure for future studies on this subject.8 In a previous study which was analyzed 
along these lines it was found that predominantly birth weight, not later weight 
measures, was associated with blood pressure.12 Using the same procedure, we 
have analyzed data from the Atherosclerosis Risk in Young Adults (ARYA) cohort to 
explore the role of attained body size in relation to birth weight and blood pressure. 
 
4.1.3 Methods 
Study design and population 
The principal objective of the Atherosclerosis Risk in Young Adults (ARYA) study is to 
investigate early determinants of cardiovascular risk profiles in adolescence and 
young adulthood. The present study pertains to a cohort of subjects that was 
selected as follows. Dutch children are regularly screened at Home Care 
Organizations and Municipal Health Services for physical, mental, or behavioral 
disorders, starting at four weeks of age until leaving secondary school at the age of 
16 to 19 years. Records of visits are kept in files stored in Municipal Health Service 
archives. From the archives in Utrecht, we screened all 16,000 files of subjects born 
between 1970 and 1973. Of these, 4208 files were eligible for ARYA as these 
contained both birth weight and adolescent blood pressure data. Using the latest 
available addresses, all 4208 now young adult subjects were invited in writing to be 
re-examined, and 2017 (47.9%) letters returned. Of these, 726 were undeliverable. 
Of the responders, 416 were not interested, 36 lived too far away, and 18 had other 
reasons. Out of 4208 invitees, 821 (19.5%) were willing to participate. Women who 
were pregnant at the time of the study or who gave birth less than 6 months 
preceding the study (n=14) were excluded. Despite initial agreement, 57 subjects did 
not enter the study. This left a total of 750 participants. Between the responders and 
non-responders born in 1970, there were no mean differences in birth weight, and 
adolescent blood pressure and anthropometry. The ARYA study was approved by 
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the Medical Ethical Committee of the University Medical Center Utrecht, The 
Netherlands. Written informed consent was obtained from all participants. 
 
Measurements at birth and adolescence 
From the records we retrieved data on birth weight (n=749), birth length (n=581), 
gestational age (n=599), delivery (n=688) and parity (n=736) noted one month after 
birth. Data extracted from routine secondary school screenings were included: blood 
pressure (measured by a sphygmomanometer, n=750), height, weight, sexual 
maturity determined by Tanner scale (n=656), occurrence of menstruation (n=350), 
and year of menarche (n=259). 
 
Measurements at young adulthood 
From October 1999 to December 2000 all participants had a physical examination at 
two visits in an outdoor clinic by two research nurses and two physicians. All were 
similarly instructed and blinded for all data in the medical files. After a five minutes 
rest in sitting position, blood pressure was automatically measured at the left upper 
arm by Dynamap (Dynamap Compact T critical Vital Answers and Vital Signs Monitor 
8100) with a cuff size 51x15 cm or of 64x17 cm for participants weighing over 95 
kilograms. After a 5 to 15 minutes rest the measurement was repeated. The same 
procedure was used at the second visit that followed after a mean 20.4 days (SD 
10.7). The mean of the four blood pressure readings obtained at the two separate 
visits was used for the analyses.  
Body weight and body height were measured with indoor clothes - without shoes - 
to the nearest 0.5 kg and 0.1 centimeter, respectively. We subtracted 0.5 kg from 
body weight to compensate for clothing.  
Further information was obtained by written questionnaires. ARYA participants 
were asked to contact their parents and inquire for parental weight and height, weight 
gain and illnesses of the mother during pregnancy, smoking of the parents during 
pregnancy, and the delivery. Participants were asked about their own place of birth 
(The Netherlands, yes/no), current smoking (yes/no), alcohol use (yes/no), use of 
medication and oral contraception, and cardiovascular disease of the first-degree 
family members. Socio-economic status during adolescence and young adulthood 
was estimated by the highest education level reached, profession and annual income 
of the household of the parents and the participant. 
 
4.1.4 Data analysis 
General characteristics of the ARYA population are given as means and standard 
deviations. Along the proposed analytic procedure shown in figure 4.1.18, we used 
linear regression models to examine the relation between blood pressure (dependent 
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variable) and birth weight (independent variable), separately for adolescence and for 
young adulthood. To study the effect of statistical adjustment for attained body size, 
body mass index (kg/m2) was added as an independent variable. To assess effect 
modification, we added the body mass index and an interaction term (birth 
weight*body mass index) as independent variables.  
Some additional analyses were performed. To further examine the role of attained 
body size, we used linear regression to determine the relation between birth weight 
and blood pressure within each tertile of attained body mass index. In order to 
assess the role of previous body mass index in the relation between birth weight and 
blood pressure, we regressed young adult blood pressure on both birth weight and 
adolescent body mass index and separately on birth weight and post-adolescent 
body mass index change (young adult body mass index – adolescent body mass 
index).  
All results are expressed as linear regression coefficients with corresponding 95% 
confidence intervals. All analyses were performed using the statistical analysis 
software SPSS 9.0. 
 
4.1.5 Results 
Table 4.1.1 shows the characteristics of the participants at birth, in adolescence and 
young adulthood. In the crude analysis (figure 4.1.1: early model) we found negative 
but non-significant relations between birth weight and blood pressure, both in  
 
Figure 4.1.1 Recommended regression models 
 
Analytical procedure adapted from Lucas et al.8 to deal with the role of current size in the relation 
between birth weight and outcome. 
Interaction model: adds the interaction of early and 
later size to the combined model. The interaction term 
is calculated as the product of early and later size
Combined model: include both early and later size, 
obtained by adding later size to the early model 
Late model: later size alone is related to outcome, 
which helps to interpret the relative importance of 
early and later size separately and together
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adolescence and in young adulthood (table 4.1.2). Adjustment for attained body 
mass index (figure 4.1.1: combined model) resulted in a more negative and now 
statistically significant inverse relation between birth weight and systolic blood 
pressure in adolescence, while it slightly increased the regression coefficient in 
young adulthood. Using attained weight or height as measures of body size showed 
similar results (data not shown). Table 4.1.3 shows that coefficients for the interaction 
terms birth weight*body mass index in relation to systolic blood pressure and 
diastolic blood pressure (figure 4.1.1: interaction model) were statistically significant 
in young adulthood. This result is graphically shown for systolic blood pressure in 
figure 4.1.2. The relation between young adult systolic blood pressure and body 
mass index (figure 4.1.1: late model) was 0.8 mmHg/kg/m2, 95% CI 0.6 to 1.0, and 
for diastolic blood pressure 0.3 mmHg/kg/m2, 95% CI 0.2 to 0.5. 
We further examined the finding of interaction using linear regression analysis 
within each of the tertiles of attained body mass index. This indicated that within the 
highest young adult tertile of body mass index an inverse relation was present 
between birth weight and systolic blood pressure (-2.6 mmHg/kg: -5.3 to 0.2) and 
diastolic blood pressure (-2.5 mmHg/kg: -4.3 to -0.6). No such relations were found in 
the lowest and middle tertile of body mass index. To substantiate this somewhat 
 
Table 4.1.1 General characteristics of the ARYA cohort 
 
 Overall (n=750) Men (n=352) Women (n=398) 
Birth characteristics       
Birth weight (kg) 3.418 (0.547) 3.479 (0.541) 3.365 (0.546) 
Birth length (cm) 50.8 (2.5) 51.3 (2.5) 50.4 (2.5) 
Ponderal index (kg/cm3) 26.2 (3.1) 25.9 (3.1) 26.5 (3.1) 
Gestational age (weeks) 39.8 (1.9) 39.8 (1.8) 39.8 (2.0) 
Adolescence       
Age (years) 13.5 (1.1) 13.5 (1.1) 13.4 (1.1) 
Systolic blood pressure (mmHg) 110.2 (11.9) 111.7 (12.5) 109.0 (11.3) 
Diastolic blood pressure (mmHg) 66.6 (9.9) 67.4 (9.6) 66.0 (10.1) 
Weight (kg) 49.6 (12.2) 49.2 (10.5) 49.9 (9.9) 
Height (cm) 162.4 (9.1) 163.0 (10.3) 161.2 (8.0) 
Body mass index (kg/m2) 18.6 (2.7) 18.3 (2.4) 18.9 (2.9) 
Young adulthood       
Age (years) 28.4 (0.9) 28.4 (0.9) 28.4 (0.9) 
Systolic blood pressure (mmHg) 125.4 (13.2) 130.8 (12.0) 120.6 (12.3) 
Diastolic blood pressure (mmHg) 71.9 (8.2) 73.1 (7.8) 70.9 (8.5) 
Weight (kg) 77.0 (15.6) 83.5 (13.6) 71.3 (14.9) 
Height (cm) 176.6 (9.4) 183.9 (6.7) 170.2 (6.4) 
Body mass index (kg/m2) 24.7 (4.4) 24.7 (3.7) 24.7 (5.0) 
 
Values are means with their standard deviation. 
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Table 4.1.2 Body mass index and the association between birth weight and blood 
pressure in adolescence and young adulthood 
 
 Adolescence Young adulthood 
Birth weight Systolic blood 
pressure 
Diastolic blood 
pressure 
Systolic blood 
pressure 
Diastolic blood 
pressure 
Crude 
 
-1.2 (-2.8 to 0.3) 0.4 (-0.7 to 1.7) -0.7 (-2.4 to 1.1) -0.4 (-1.5 to 0.7)
Adjusted for attained 
body mass index 
-1.5 (-3.0 to –0.01) 0.2 (-1.0 to 1.5) -0.9 (-2.5 to 0.8) -0.5 (-1.6 to 0.6)
 
Values are linear regression coefficients with 95% confidence intervals given in parenthesis. 
 
Table 4.1.3 Interaction between birth weight and attained body mass index in 
relation to adolescent and young adult blood pressure 
 
 Adolescence Young adulthood 
Model with systolic blood pressure    
Birth weight*body mass index (kg*kg/m2) -0.3 (-0.8 to 0.1) -0.4 (-0.7 to -0.1) 
    
Model with diastolic blood pressure    
Birth weight*body mass index (kg*kg/m2) 0.02 (-0.4 to 0.4) -0.3 (-0.5 to -0.1) 
 
Values are linear regression coefficients (95% confidence intervals) of interaction terms birth 
weight*body mass index, in models with blood pressure as dependent variable and birth weight, body 
mass index and birth weight*body mass index as independent variables. 
 
further, those who changed from the lowest quartile of birth weight (<3090 g) to the 
highest quartile of young adult body mass index (>27 kg/m2) had 7.2 mmHg (3.5 to 
10.9) higher systolic blood pressure and 3.6 mmHg (1.3 to 5.9) higher diastolic blood 
pressure than the rest of the population. For comparison, those who were in the 
highest quartile of birth weight (>3750 g) and in the highest quartile of attained body 
mass index (>27 kg/m2) had higher systolic blood pressure levels but not statistically 
different from the rest of the population (2.9 mmHg: -1.0 to 6.8), while diastolic levels 
were virtually the same. 
Regressing young adult systolic blood pressure on both birth weight and 
adolescent body mass index, showed that the coefficient of birth weight attenuated to 
-0.7 mmHg/kg, 95% CI –2.5 to 1.0, while the coefficient of adolescent body mass 
index was 0.4 mmHg/kg/m2, 95% CI 0.05 to 0.8. For young adult diastolic blood 
pressure, the findings were comparable (birth weight: -0.5 mmHg/kg, 95% CI –1.5 to 
0.6, adolescent body mass index: 0.2 mmHg/kg/m2, 95% CI -0.008 to 0.4). Similar 
findings were obtained in models with birth weight and body mass index change from 
adolescence to young adulthood in relation to young adult systolic blood pressure 
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Figure 4.1.2 Mean systolic blood pressure according to tertiles of birth weight and 
attained body mass index 
 
(birth weight: -0.7 mmHg/kg, 95% CI –2.4 to 0.9, post-adolescent body mass index 
change: 1.1 mmHg/kg/m2/15 years, 95% CI 0.8 to 1.3) and young adult diastolic 
blood pressure (birth weight: -0.5 mmHg/kg, 95% CI –1.5 to 0.6, post-adolescent 
body mass index change: 0.4 mmHg/kg/m2/15 years, 95% CI 0.2 to 0.6). 
Similar analyses with birth length instead of birth weight yielded similar but weaker 
relations. Although not the primary aim of this study, additional adjustment for 
characteristics at birth, of the parents and participant, like gestational age and socio-
economic status of the parents and participant, did not materially change the 
findings. 
 
4.1.6 Discussion 
Our findings suggest that an association between low birth weight and high blood 
pressure is largely restricted to those with high-attained relative body weights.  
To appreciate these findings some issues need to be addressed. The use of 
registered birth size data instead of parental recall and self-report data will have 
minimized misclassification. Data of adolescence were obtained from single routine 
health examinations, but measurement error may be presumed to be random. Our 
study population may be a selection of the general population as the response rate 
Lowest
BW MiddleBW Highest
BW
Lowest BMI
Middle BMI
Highest BMI
116
120
124
128
132
SBP (mmHg)
SBP: Systolic blood pressure at young adulthood, BW: Birth weight; BMI: Body mass index at young
adulthood. 
The linear regression coefficient for body mass index as effect modifier in the relation between birth
weight and blood pressure is: -0.4 mmHg/kg (95% confidence interval -0.7 to -0.1). 
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was low. However, there were no differences in birth and adolescent data between 
responders and non-responders. Moreover, it seems unlikely that selection of 
subjects occurred on the basis of specific relations between birth characteristics and 
adolescent and adult blood pressure levels.  
A large body of evidence seems to support the fetal origins hypothesis, in 
particular with respect to blood pressure. The initial hypothesis was that an adverse 
intrauterine environment, like a limited supply of nutrients, induces fetal and postnatal 
adaptation which itself leads to increased risk of chronic disease in later life.13,14 
However, from the earliest reports onwards, the hypothesis has been subject to 
concerns about validity, causality, and publication bias.10,15-18 
Criticism has also involved analytical procedures that may have led to flawed 
interpretation in favor of the hypothesis. Many studies have reported associations 
that were adjusted for indexes of attained body mass, while these associations were 
not clearly present without such adjustment.7,19-22 Invariably, adjustments were 
intended to obtain the best estimate of the true underlying relation between birth 
weight, as a resultant of intra-uterine environment, and blood pressure. From that 
perspective, theoretically, adjustment is justified if it confounds the true relation 
between birth weight and blood pressure. Attained body size should then be a risk 
factor for high blood pressure, which it is23, and be somehow related to birth weight, 
which it is also.24,25 It should not be an intermediate factor that causally links birth 
weight to blood pressure as adjustment for intermediate factors in simple analytic 
models will yield biased results.11 The possibility of body mass index being an 
intermediate factor has been previously suggested7,21, and later empirical evidence 
provided clues that (accelerated) postnatal growth and high-attained body mass are 
indeed important factors when relating birth size to cardiovascular risk factor profiles, 
coronary heart disease, or diabetes mellitus.7,26-29 However, in practice, effects of 
adjustment do not easily, if at all, distinguish between confounding or intermediate 
properties of a factor. 
 Following the recommended analytical procedure of Lucas et al.8, what do our 
findings mean? The authors state that there is support for the fetal origins hypothesis 
if results show the following: first, the ‘early model’ should have a statistically 
significant negative regression coefficient for birth weight, indicating that the lower 
the birth weight the higher the later blood pressure. In our study it was negative but 
not statistically significant. One reason might be lack of power as larger studies did 
show crude associations.30 Second, adjustment for attained body mass index in the 
‘combined model’ should further increase the negative coefficient of birth weight. This 
model is reported to actually study change of body weight as a determinant of blood 
pressure. Indeed, in our study it increased the negative coefficient. Third, the 
‘interaction model’ should show a negative coefficient for the interaction term of birth 
weight and attained body mass, which was also the case in our study. This is 
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particularly suggested to indicate that shifts from low birth weight rankings in the 
distribution to high-attained body mass index rankings (de-tracking or centile 
crossing) would yield higher blood pressure levels. Finally, application of the ‘late 
model’ should show that attained body mass index is strongly positively associated 
with blood pressure, which again was the case in our study. Considering that our 
study was perhaps too small to detect crude associations between birth weight and 
blood pressure, the general interpretation might thus be that our findings support the 
fetal origins hypothesis. 
However, further analysis indicates that both excess weight change and attained 
body mass level itself in later life is more important for blood pressure levels than 
intra-uterine causes of (too) low birth weight. Primary high blood pressure has 
various partly unknown origins, but high-attained body mass index is a well known 
strong determinant of high blood pressure levels, also in childhood.31 Thus, in a 
causative sense, youngsters with high blood pressure levels are a mix of those who 
grew to high-attained relative body weights from whatever their birth or later weights 
were, and of those with other reasons for high blood pressure. A specific group may 
be those who have excessively grown to high body mass coming from (too) low birth 
weights. The interaction model suggests that birth weight modifies the effect of body 
mass index on blood pressure, more in particular, that de-tracking of body weight to 
high levels would lead to high blood pressure. Indeed, those with the lowest birth 
weights in our study who de-tracked to the highest body mass index at young 
adulthood were part of those with the highest systolic and diastolic blood pressure 
levels. From our additional analyses, we infer that a relation between birth weight and 
blood pressure seems restricted to those with high-attained body mass. It was absent 
at lower body mass index levels. This would mean that there is no graded interaction 
between birth weight and body mass index, but that only babies who are light for their 
constitution or constitutionally small babies and become relatively heavy later are at 
risk of hypertension. Thus, it may be that (too) low birth weight babies, through high-
attained body mass as an intermediate process, are particularly vulnerable to 
develop high blood pressure. A more likely explanation seems to be that such babies 
are particularly vulnerable to develop high body mass in young adulthood, with high 
blood pressure as a mere consequence of the latter. 
The results of the recommended analytical procedure would generally support the 
fetal origins hypothesis. However, additional analyses show that a relation between 
birth weight and future blood pressure is largely restricted to those with high-attained 
relative body weights. 
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4.2.1 Abstract 
Background: Several studies in the young have shown that low birth weight is 
associated with increased levels of individual cardiovascular risk factors. However, 
no studies have reported on relations between birth size and clustered 
cardiovascular risk profiles. The aim of this study was to investigate the association 
between birth size and the 10-year risk in young adulthood of coronary heart disease 
using the Framingham risk score.  
Methods: The ARYA study is a population-based cohort that comprises 750 
(46.9% men) subjects born between 1970 and 1973. Birth characteristics were 
obtained from school health records. At young adulthood, a duplicate blood pressure 
was measured in sitting position and repeated after approximately three weeks. 
Anthropometry was newly measured. Fasting levels of total-, HDL-, triglycerides and 
LDL-cholesterol were determined. Data about smoking and diabetes were obtained 
by questionnaire. 
Results: In 723 subjects, the overall 10-year risk of coronary heart diseases in 
young adults was 1.6% (standard deviation=1.9), in men 3.0% (SD=1.9) and in 
women 0.3% (SD=0.2). Using a linear regression model, 1 SD lower birth weight 
(=0.54 kg) was associated with a 0.1% greater 10-year risk of coronary heart disease 
in the overall population (95% confidence interval: -0.19 to -0.004). A similar result 
was found with ponderal index at birth (β: -0.11% risk/SD ponderal index; 95% CI: -
0.21 to -0.002). The inverse relations were stronger in men than in women. 
Adjustment for other characteristics at birth, of the participant and parents did not 
affect the relations. 
Conclusion: Small birth size is associated with increased risk of coronary artery 
disease in young adulthood. 
 
4.2.2 Introduction 
One of the first reports supporting the “fetal origins hypothesis” was the observation 
that the highest rates of coronary heart disease were found in the area with the 
highest rate of neonatal mortality.1 As neonatal mortality is correlated with small birth 
size, studies have tried to find relations between low birth weight and increased 
cardiovascular morbidity2-4 and mortality5,6 in advanced adulthood. In healthy young 
people however, studies were restricted to current cardiovascular risk factor levels, 
which were studied separately.7-10 Invariably, the primary interest of studies 
examining a single risk factor as dependent variable was the causality of 
associations, for example to find out whether low birth weight causes future high 
blood pressure levels in healthy youngsters.11 However, if conclusions are to be 
expanded to the impact of birth size on an accurate estimate of future cardiovascular 
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disease risk in the young, clustering of risk factors is required. The use of risk scores 
has the advantage of combining the long-term contribution of several risk factors 
including their mutual relations and interactions, to an absolute risk of coronary heart 
disease. To our knowledge, using a risk score has not been done previously in young 
adults. 
We have analyzed data of 750 participants of the Atherosclerosis Risk in Young 
Adults (ARYA) study, to examine the relation between birth size and the absolute 10-
year risk of young adults for coronary heart disease. To that end, the Framingham 
risk score for risk factor categories was used, based on age, blood pressure, total- 
and high-density-lipoprotein cholesterol, diabetes and smoking.12 
 
4.2.3 Methods 
Data on birth weight was available in all 750 participants of the cohort of Utrecht. The 
ARYA study was approved by the Medical Ethical Committee of the University 
Medical Center, Utrecht, The Netherlands. Written informed consent was obtained of 
all 750 participating young adults. 
 
Registered risk factors at birth 
In The Netherlands, virtually all children regularly visit the child health facilities of the 
Home Care Organizations and Municipal Health Services, starting at the age of four 
weeks postpartum until leaving secondary school at the age of 16 to 19 years. 
Information is routinely collected by school doctors and nurses and written down in 
health records. Subjects of our study population were born between 1970 and 1973 
and attended secondary school in Utrecht. The records were selected on the 
presence of birth weight data and at least one adolescent blood pressure 
measurement, the latter for research questions outside the realm of this report. If 
birth weight was approximated in the record (sign ±), the subject was excluded. Out 
of the approximately 16,000 medical school records, 4208 fulfilled these criteria. All 
4208 subjects were invited by letter at the last known address at adolescence by the 
Municipal Health Service of Utrecht, of which 2017 (47.9%) returned. 726 letters 
were undeliverable, and 416 responders had no interest in participation, 36 lived too 
far from our outpatient clinic, 18 had other reasons and 821 subjects (19.5% of the 
4208) were willing to participate. Of the 821 subjects, pregnant women and women 
who gave birth less than 6 months before entering the study (n=14), were excluded. 
Despite initial agreement, 57 subjects did not enter the study, mostly due to lack of 
time and distance to the outpatient clinic. This resulted in a total of 750 participants in 
the Utrecht cohort. To evaluate selection, we compared data of responders and non-
responders of the 4208 invitations who were born in 1970 (n=967). The mean birth 
weight, adolescent blood pressure and anthropometry were similar.  
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We obtained information on birth weight (n=749), birth length (n=581), gestational 
age (n=599), delivery (n=688) and parity (n=736) noted one month after birth. 
 
Risk factors at young adulthood 
From October 1999 to December 2000 the participants underwent a physical 
examination during two visits at the outpatient clinic of the Julius Center. All 
investigators were similarly instructed and blinded for the birth characteristics. After a 
five minutes rest in sitting position, blood pressure was measured by Dynamap at the 
left upper arm, and repeated after 5-15 minutes rest. The same procedure was 
followed at the second visit with a mean interval of 20.4 days (SD 10.7). Body height 
was measured in standing position - without shoes - to the nearest 0.1 cm. Body 
weight was measured with indoor clothes - without shoes - to the nearest 0.5 kg. To 
compensate for clothes we subtracted 0.5 kg. 
Of the 750 participants, fasting blood of 730 participants and non-fasting blood of 8 
participants was drawn and stored at –20 oC. When all the participants finally visited 
our outpatient clinic, fasting serum levels of total cholesterol, high-density-lipoprotein 
(HDL-) cholesterol, triglycerides, low-density-lipoprotein (LDL-) cholesterol13 and 
glucose were determined by Vitros950 dry-chemistry analyzer (Johnson & Johnson, 
Rochester, New York, USA). In the non-fasting samples, total- and HDL-cholesterol 
were only assessed. 
We obtained further information of the participant and parents on ethnicity, 
smoking (yes/no, packyears), alcohol consumption (yes/no), use of oral 
contraception (yes/no), highest education level (low/middle/high) as a measure of 
socio-economic status, and known cardiovascular diseases of the participant and of 
the first degree family members (myocardial infarction, cerebrovascular event, type 2 
diabetes, hypertension, hypercholesterolemia (yes/no)), by a written questionnaire.  
In our young and healthy population, we used the Framingham risk score as a 
proxy for future coronary heart disease. The Framingham risk score using 
categorized cardiovascular risk factors12 was developed in a population based 
sample of 2489 men and 2856 women aged 30 to 74 years without overt coronary 
heart disease at the baseline examination. Study subjects were followed over a 12-
year period for the development of coronary heart diseases: angina pectoris, 
recognized and unrecognized myocardial infarction, coronary insufficiency, and 
coronary heart disease death, according to previously published criteria.14 The 
individual 10-year probability of coronary heart disease was calculated using the β-
coefficients from the Cox-proportional hazard models, using the continuous variables 
age and age-squared, the categorized variables total- and HDL-cholesterol and blood 
pressure, and the dichotomous variables diabetes and smoking. Cut-off values for 
total cholesterol (<200, 200 to 239, 240 to 279, and ≥280 mg/dl) and HDL-cholesterol 
(<35, 35 to 59, and ≥60 mg/dl) are similar to those used for the NCEP ATP II 
Chapter 4.2 
88 
guidelines.15,16 The mean of four blood pressure readings at young adulthood was 
calculated and blood pressure was categorized according to the JNC V definitions17: 
optimal blood pressure (systolic <120 mmHg and diastolic <80 mmHg), normal blood 
pressure (systolic 120 to 129 mmHg or diastolic 80 to 84 mmHg), high normal blood 
pressure (systolic 130 to 139 mmHg or diastolic 85 to 89 mmHg), hypertension stage 
I (systolic 140 to 159 mmHg or diastolic 90 to 99 mmHg), and hypertension stage II-
IV (systolic ≥160 or diastolic ≥100 mmHg). When systolic and diastolic blood 
pressures fell into different categories, the higher category was selected. Blood 
pressure categorization was made without regard to the use of antihypertensive 
medication. 
 
4.2.4 Data analysis 
Univariate linear regression models were used to study the relations between birth 
size and the absolute 10-year risks of coronary heart disease in these young adults. 
As the Framingham risk scores were only provided for men and women separately12, 
the relations with birth size measures in ARYA are given sex-specific. As the latter 
had reduced statistical power we added a multivariate linear regression analysis in 
the total ARYA population in which we adjusted for gender. To compare the results of 
the independent variables birth weight, -height and ponderal index, we used birth 
size divided by its standard deviation as independent variables. 
Analyses were carried out with the statistical analysis software SPSS 9.0. 
Statistical significance was concluded if p<0 05. 
 
4.2.5 Results  
Table 4.2.1 shows the characteristics at birth and young adulthood for the whole study 
population, and for men and women separately. At birth, male newborns had a 
statistically significantly higher birth weight and height and a lower ponderal index than 
female newborns. At young adulthood, blood pressure, body weight, height and waist-
hip ratio, levels of LDL-cholesterol, triglycerides and glucose were higher in men, and 
HDL-cholesterol was lower. Due to missing values the Framingham risk score was 
calculated in 723 subjects of the 750 subjects. Men had a higher risk score. 
 In young men, studying the relation between birth size and the 10-year risk of 
coronary heart disease, a decrease of 1 standard deviation in birth weight and 
ponderal index was statistically significantly associated with an increased risk of 0.2% 
(table 4.2.2). In young women, the 10-year risk of coronary heart disease showed a 
borderline statistically significant inverse relation with birth length. The analyses 
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Table 4.2.1. General characteristics ARYA cohort 
 
 Overall (n=750) Men (n=352) Women (n=398) 
Birth characteristics     
Birth weight (kg) 3.42 (0.55) 3.48 (0.54) 3.37 (0.55) 
Birth length (cm) 50.8 (2.5) 51.3 (2.5) 50.4 (2.5) 
Ponderal index (kg/m3) 26.2 (3.1) 25.9 (3.1) 26.5 (3.1) 
Gestational age (weeks) 39.8 (1.9) 39.8 (1.8) 39.8 (2.0) 
     
Young adulthood     
Age (years) 28.4 (0.9) 28.4 (0.9) 28.4 (0.9) 
Systolic blood pressure (mmHg) 125.4 (13.2) 130.8 (12.0) 120.6 (12.3) 
Diastolic blood pressure (mmHg) 71.9 (8.2) 73.1 (7.8) 70.9 (8.5) 
Heart rate (beats/min) 65.3 (10.4) 63.9 (10.7) 66.6 (9.9) 
Weight (kg) 77.0 (15.6) 83.5 (13.6) 71.3 (14.9) 
Height (cm) 176.6 (9.4) 183.9 (6.7) 170.2 (6.4) 
Body mass index (kg/m2) 24.7 (4.4) 24.7 (3.7) 24.7 (5.0) 
Waist-hip ratio 0.85 (0.07) 0.88 (0.06) 0.81 (0.06) 
Total cholesterol (mg/dl) 187.2 (34.8) 187.3 (37.6) 187.1 (32.2) 
HDL-cholesterol (mg/dl) 55.8 (14.0) 50.1 (11.5) 60.9 (14.0) 
Triglycerides (mg/dl) 114.0 (63.7) 120.6 (76.0) 108.2 (49.6) 
LDL-cholesterol (mg/dl) 108.4 (33.1) 112.9 (34.8) 104.5( 31.0) 
Glucose (mg/dl) 89.6 (9.3) 92.2 (10.7) 87.2 (7.0) 
Smoking (% yes) 31.0  35.9  26.6  
Diabetes mellitus (% yes) 0.8  0.9  0.8  
Framingham risk score* 1.56 (1.88) 3.02 (1.86) 0.27 (0.17) 
 
Values are means (standard deviation) unless mentioned otherwise. 
LDL: low-density-lipoprotein, HDL: high-density-lipoprotein. 
*Framingham risk score 12: 10-year risk of coronary heart disease using risk factor categories. 
 
concerning birth length and ponderal-index were performed in a subgroup of 581 
ARYA participants with available birth length measurements. These analyses have 
therefore less statistical power than those with birth weight. In order to gain statistical 
power we performed an additional analysis in the total ARYA population on the 
relation between birth characteristics and 10-year cardiovascular risk with adjustment 
for gender. This showed statistically significant inverse relations between and birth 
weight and risk (-0.10%/kg/SD; 95% CI –0.19 to –0.004), and with ponderal-index (-
0.11%/(kg/m3)/SD; 95% CI –0.21 to –0.002), while there was a non-significant 
relation with birth length (0.03%/cm/SD; 95% CI -0.08 to 0.14). 
 The relations were strengthened after adjusting for adult body mass index (data 
not shown). Other characteristics of pregnancy, at birth, for participants and parents 
such as parental smoking during pregnancy, gestational age, familiarity of disease, 
physical activity and socio-economic status, did not modify the relations. 
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Table 4.2.2 The percentage change in 10 year cardiovascular disease risk of young 
adults per standard deviation decrease in birth size 
 
 Framingham risk score* 
Birth size Overall (n=723) 
adjusted for gender 
Men (n=338) Women (n=385) 
Birth weight (kg/SD) -0.10 (-0.19 to –0.004) -0.20 (-0.40 to 0.001) -0.01  (-0.03 to 0.004) 
Birth length (cm/SD)  0.03 (-0.08 to 0.14)  0.08  (-0.15 to 0.32) -0.02 (-0.04 to <0.001)
Ponderal index (kg/m3/SD) -0.11 (-0.21 to –0.002) -0.22 (-0.44 to 0.004) -0.01  (-0.03 to 0.01) 
 
Values are linear regression coefficients with 95% confidence intervals. 
Birth sizes per standard deviation (SD) were used as independent variables. 
Coefficients for the overall group were obtained from models adjusted for gender. 
*Framingham risk score12: 10-year risk of coronary heart disease using risk factor categories.  
 
4.2.6 Discussion 
To our knowledge, this is the first study to show that a relative low birth weight is 
associated with an increase in the 10-year risk of coronary heart disease in young 
adults, based on all of the most important cardiovascular risk factors clustered in a 
risk score. 
One of the main advantages of this study is that measurement error of the 
determinants was limited by obtaining birth characteristics from the medical health 
records and not by parental recall or self-report. Birth weight and the risk factors were 
measured once and performed by several investigators, but if measurement error 
occurred it may be presumed to be random. Moreover, although the response rate 
was modest, it is not likely that selection of the participants, if any, was biased for the 
relation between birth- and adult characteristics. Birth weight was similar between the 
responders and non-responders. Furthermore, in our analysis we had to cope with 
the fact that the Framingham risk scores are sex-specific, while a pooled analysis of 
ARYA with gender in the risk score would have had more statistical power. The 
Framingham risk score was derived from a cohort that did also contain young adults, 
but was on average much older than the ARYA cohort. By using this score we 
assume that variable weights obtained from modeling in the Framingham cohort are 
constant over time and may thus be extrapolated to a cohort with only young 
individuals. We cannot exclude the possibility that this is not the case, but risk scores 
specific to the age group of ARYA are to our knowledge not available. 
Many of the known cardiovascular risk factors have been studied separately in the 
young. In the young, birth size was shown to be inversely related to blood 
pressure2,11, lipids8,18 and diabetes mellitus3,4, and positively with adult obesity.4,19 
Some of these findings were inconsistent 9,10 or even flawed according to some.20,21 
Obviously, manifest cardiovascular disease cannot be studied in the young, while 
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single risk factors can only partially describe the cardiovascular risk. Therefore, the 
ARYA study expands the available evidence as it has determined the relation 
between birth size and an aggregation of current risk factors, and consequently the 
most accurate available measure of risk. 
The Framingham risk score consists of risk factors which track over decades and 
which predict future coronary heart risk already at young adulthood; high blood 
pressure22-24, atherogenic lipid profile25,26, smoking27 and diabetes.28,29 It has 
repeatedly been demonstrated that the Framingham risk score is effective in 
predicting coronary heart disease in several western populations30-32, including a 
follow-up from the Framingham study.33 The Framingham risk score was developed 
for a population-based sample of men and women without overt coronary heart 
disease at the baseline examination, similar to our study population. We used the 
Framingham risk score with risk factor categories, which was shown to be as 
accurate as a score based on continuous values of risk factors.12 All the required risk 
factors for using this categorized score were measured in ARYA. Some 
cardiovascular disease risk factors however, are not included in the Framingham 
score although they do to some extent predict cardiovascular morbidity and mortality. 
One of these risk factors is obesity34-36, but it is excluded from the risk score because 
it is strongly associated with higher total cholesterol, lower HDL-cholesterol, higher 
blood pressure and diabetes37, implying a small residual impact. The familiarity of 
disease was not included in the Framingham risk score because it was not uniformly 
available in the Framingham study. Also, information of physical activity was not 
available at the baseline levels. Socio-economic status was not mentioned. We 
adjusted for these risk factors in the associations between birth size and coronary 
risk, and showed no material effect. 
Our main finding is that young adults born with low birth weights and low ponderal 
indexes had an increased 10-year risk of coronary heart disease. This relation with 
risk appeared - to some extent - to depend on gender. In men, both relations with 
birth weight and ponderal-index were particularly outspoken, indicating that those 
who were born light and thin, with low for height birth weights, were at the highest 
risk as young adults in developing cardiovascular disease. In women, it appeared to 
be those with low birth lengths, the small female newborns, who had the higher risk. 
It is of interest to note that not only young adult men had a higher risk than women, 
as is similarly shown in the literature38,39, but also that birth size in men appeared to 
be more strongly associated with cardiovascular risk. This may suggest that, 
particularly in men, a higher risk originates in prenatal life through a determinant that 
affects both birth size and cardiovascular risk. However, given that the 10-year risk in 
young adult women was much lower than in men, it is possible that associations 
between birth size and risk are more difficult to detect in women. Noteworthy is that 
none of the relations was materially affected by adjustment for gestational age, 
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indicating that it was not being small for date at birth that can be held accountable. 
Neither had socio-economic status and familiarity of disease any impact on the 
relations. 
Our findings in the overall study population indicate that with every standard 
deviation decrease in birth weight (0.54 kg), there was 1 excess coronary heart 
disease event out of 1000 young adults. In men, this decrease in birth weight was 
associated with 2 excess events. Although these numbers of events may not seem 
very high, it is emphasized that it concerns risk factor measurements in a young and 
healthy population. Cardiovascular disease generally becomes manifest after the age 
of forty, and therefore the number of diseased men will increase quickly with 
increasing age. Moreover, the event does not include only patients with angina 
pectoris, but also myocardial infarction, coronary insufficiency, and coronary heart 
disease death. 
In summary, our findings provide support for the view that a relative low birth size 
is associated with an increased risk of coronary heart disease in young adults. 
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5.1.1 Abstract 
Background: Increased blood pressure at young adulthood is associated with 
cardiovascular morbidity and mortality. Longitudinal studies at young age are, 
however, limited. Our aim was to study the relations of adolescent blood pressure 
and tracking of blood pressure into young adulthood with subclinical atherosclerosis, 
as assessed by carotid intima-media thickness (CIMT), at the age of 28 years. 
Methods: The ARYA study comprises of a community based sample of 750 
subjects aged 27-30 years. Of 352 men and 398 women, at least one blood pressure 
measurement was recorded at a mean age of 13 years in the school health records. 
Recently, all participants completed a questionnaire on cardiovascular risk factors, 
had a fasting blood sample drawn and underwent an ultrasound examination of both 
common carotid arteries to assess CIMT. 
Results: Linear regression showed that adolescent systolic blood pressure was 
associated with thickening of the intima-media (an increase of 7.5 µm in CIMT per 
standard deviation (SD) increase of systolic blood pressure; 95% CI 4.3 to 10.6). 
Similar relations were found for pulse pressure and mean arterial pressure. When 
gender, age and body mass index at adolescence and young adulthood and adult 
blood pressure were taken into account, the relations attenuated, but for pulse 
pressure remained statistically significant. Furthermore, subjects who tracked in the 
highest systolic blood pressure and pulse pressure levels from adolescence into 
young adulthood, showed the thickest CIMT. 
Conclusion: Our findings strengthen the notion that elevated blood pressure at 
adolescence and a relative increase in blood pressure from adolescence to 
adulthood unfavorably affect cardiovascular risk, as indicated by increased CIMT.  
 
5.1.2 Introduction 
Cardiovascular diseases are the main causes of morbidity and mortality in western 
countries, and the chronic development of atherosclerosis is the responsible 
underlying mechanism. Although cardiovascular disease only becomes manifest at 
the age of 45 years or older, its subclinical roots are already found in childhood.1 The 
progression of atherosclerosis is congruent with the level and number of 
cardiovascular risk factors, among which blood pressure is one of the main 
modifiable risk factors.2-4 It is known that blood pressure at childhood and 
adolescence is positively associated with blood pressure in early adulthood5-8 and 
that blood pressure at young adulthood is associated with cardiovascular morbidity 
and mortality after several decades.9-11 However, longitudinal studies on adolescent 
blood pressure and adverse events are lacking. Only limited studies on adolescent 
blood pressure and vascular damage at a young adulthood are available. In a 
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postmortem study, increased systolic blood pressure and diastolic blood pressure in 
subjects aged between 2 and 39 years, were related to postmortem measured 
atherosclerosis.12 Others found a positive relation between blood pressure and the 
CIMT in young adults, an intermediate measure of vascular damage, but these 
relations disappeared after adjustment for cardiovascular risk factors at 
adolescence.13 
To further explore the role of adolescent blood pressure on early atherosclerosis, 
we used data of the Atherosclerosis Risk in Young Adults (ARYA) study. In particular, 
we examined the relation of indices of adolescent blood pressure with arterial wall 
thickening. In addition, we studied the importance of (de)tracking of blood pressure 
from adolescence to young adulthood on achieved CIMT. 
 
5.1.3 Methods 
The overall aims of the Atherosclerosis Risk in Young Adults (ARYA) study are 
evaluating 1) whether it is possible to predict cardiovascular risk at young adulthood 
by routinely measured adolescent data, and 2) evaluating the role of birth 
characteristics and adolescent characteristics to the development of vascular 
damage at young adulthood. The study population of the ARYA study comprises two 
cohorts: a cohort from the Dutch city of Utrecht with 750 participants and a cohort 
from The Hague with 262 participants. This paper is based on the Utrecht data only 
because CIMT was not measured in the The Hague participants. The ARYA study 
was approved by the Medical Ethical Committee of the University Medical Center 
Utrecht, Utrecht, The Netherlands. Of all participants written informed consent was 
obtained. 
Eligible participants were born between 1970 and 1973 and attended secondary 
school in Utrecht between the ages of 11 to ±16 years. Of them, the school health 
records from the Municipal Health Service were screened. In The Netherlands 
virtually all children regularly visit the child health facilities of the Home Care 
Organizations and Municipal Health Service, starting at four weeks until leaving 
secondary school at the age of 16 to 19 years. Information on blood pressure 
(manually with a sphygmomanometer), height, weight, lifestyle, puberty stage and 
medical history is routinely collected and written down in health records by school 
doctors and nurses. Those health records were selected which contained information 
on the presence of birth weight and at least one blood pressure measurement when 
attending secondary school. Birth weight approximated with the sign ± was excluded. 
Out of 15,592 medical school records, 4208 subjects were invited by letter at the last 
known address at adolescence by the Municipal Health Service, of which 2017 
(47.9%) have returned. 726 (36.0%) returned due to unknown addresses, 416 
(20.6%) subjects had no interest in participation, 36 (1.8%) lived too far from our 
Blood pressure and atherosclerosis 
101 
outpatient clinic, 18 (0.9%) had other reasons, and 821 of the 4208 subjects (19.5%) 
were willing to participate. Pregnant women and women who gave birth less than six 
months before entering the study (n=14) were excluded from participation. 57 
subjects did not enter the study due to lack of time and distance to the outpatient 
clinic. This left a total of 750 participants in the Utrecht cohort. We compared birth 
data and adolescent data of responders and non-responders born in 1970. No 
differences were found. 
From October 1999 to December 2000 all Utrecht participants had a physical 
examination during two visits at the outpatient clinic of the Julius Center by two 
trained research nurses and two medical doctors. All were similarly instructed and 
blinded for data in the medical school health records, including previous blood 
pressure. After five minutes of rest in sitting position, blood pressure was measured 
using a Dynamap at the left upper arm. The measurement was repeated after 5-15 
minutes rest. The same procedure was followed at the second visit after a mean 
time-interval of 20.4 days (SD 10.7). The average of four readings was used in the 
analyses. Body weight was measured with indoor clothes - without shoes - to the 
nearest 0.5 kg. To compensate for clothes we subtracted 0.5 kg. Body height was 
measured in standing position - without shoes - to the nearest 0.1 cm. 
During the first visit at our outpatient clinic the CIMT of the right and left carotid 
artery was measured. This was performed by six trained sonographers using a 7.5 
MHz linear array transducer (Acuson Aspen). The CIMT was measured at eight 
different angles (right carotid artery: 180, 150, 120 and 90 degrees, left carotid artery: 
180, 210, 240 and 270 degrees) using the Meijer’s Arc (figure 5.1.1). When an 
optimal two dimensional (2-D) image of the distal part of the common carotid artery 
was obtained (figure 5.1.2), it was frozen on the top of the R-wave of the 
electrocardiogram and recorded on tape. Two readers measured the CIMT off line 
with an automated edge detection program, over a length of 10 mm starting at the 
beginning of the dilatation of the bifurcation.14 Of the sixteen CIMT-measurements 
per participant (near and far wall and four angles and right and left carotid artery) the 
average intima-media thickness was calculated and used in all analyses. The 
reproducibility was assessed by scanning 21 participants for a second time at the 
next visit by another sonographer. The absolute mean difference was 0.012 mm 
(standard error ±0.004). The intraclass correlation coefficient was 0.84. All 
sonographers and readers were blinded to the data in the medical health records and 
measurement results. 
Further information on risk factors was obtained by a written questionnaire. 
Participants were asked to contact (one of) their parents. The questions were on 
ethnicity, smoking (yes/no), alcohol consumption (yes/no), use of oral contraception 
(yes/no), and cardiovascular risk factors and diseases in the family (did the first 
degree family members suffer from a myocardial infarction, stroke, or developed 
Chapter 5.1 
102 
Figure 5.1.1 Acquisition of a B-mode image at angle 270, using the Meijer’s Arc 
 
Figure 5.1.2 Typical 2-dimensional longitudinal B-mode image of the distal part of 
the common carotid artery. CIMT is measured over a distance 10 mm to 
the right of the vertical dotted line 
The left side of the vertical line shows the carotid bifurcation. At the right site, the intima and media 
of the common CIMT are measured off line. 
lumen 
adventitia 
media 
intima 
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diabetes, hypertension and/or hypercholesterolemia (yes/no)). Socio-economic 
status at adolescence was estimated by the highest education level of father, and at 
young adulthood by the highest education level of the participant (low/middle/high). 
 
5.1.4 Data analysis 
We studied the role of blood pressure at adolescence and young adulthood and 
tracking of blood pressure on the development of atherosclerosis at young adulthood 
independent of gender, attained age and body mass index. 
First, we estimated the relation of adolescent systolic blood pressure per standard 
deviation (independent variable) with CIMT (dependent variable) using linear 
regression models. Similar models were used for the independent variables diastolic 
blood pressure, pulse pressure (= systolic blood pressure – diastolic blood pressure) 
and mean arterial pressure (= diastolic blood pressure + 1/3 (pulse pressure) per 
standard deviation. As adolescent blood pressure was significantly related to gender, 
adolescent age and adolescent body mass index, the models were additionally 
adjusted for these factors. 
Second, we estimated the association of adult blood pressure per standard 
deviation with CIMT, additionally adjusted for gender, adult age and adult body mass 
index. 
 
Table 5.1.1 General characteristics ARYA cohort Utrecht in adolescence and young 
adulthood 
 
 Men (n=352) Women (n=398) 
  Adolescence Young 
Adulthood 
Adolescence Young 
adulthood 
Age (years) 13.4(1.1) 28.4(0.9) 13.4(1.1) 28.4(0.9) 
Systolic blood pressure (mmHg) 111.7(12.5) 130.8(12.0) 109.0(11.3) 120.6(12.3) 
Diastolic blood pressure (mmHg) 67.4(9.6) 73.1(7.8) (10.1)66.0 70.9(8.5) 
Pulse pressure (mmHg) 44.2(11.3) 57.7(8.9) 42.9(9.6) 49.6(8.1) 
Mean arterial pressure (mmHg) 82.1(9.1) 92.3(8.5) 80.4(9.4) 87.5(9.2) 
Weight (kg) 49.2(10.5) 83.5(13.6) 49.9(9.9) 71.3(14.9) 
Height (cm) 163.0(10.3) 183.9(6.7) 161.2(8.0) 170.2(6.4) 
Body mass index (kg/m2) 18.3(2.4) 24.7(3.7) 18.9(2.9) 24.7(5.0) 
Waist-hip ratio  0.88(0.06)  0.81(0.06) 
Maturity 2.9(1.3)  3.7(1.4)  
Smoker (% yes) 4.0 35.8 5.8 26.6 
Education level (% low 
  (relative to middle and high)) 
39.7 15.5 32.6 10.9 
CIMT (mm)  0.49(0.05)  0.48(0.05) 
Tanner score (0-5) of pubic hair, Education level: of father during adolescence and of the participant at young 
adulthood. 
Values are means (standard deviation) unless otherwise indicated. 
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Third, we studied the impact of adult blood pressure on the relation of adolescent 
blood pressure to CIMT, independent of gender, age and body mass index at both 
adolescence and young adulthood. This was done by first estimating the individual 
adolescent blood pressures independent of gender, adolescent age and adolescent 
body mass index: the individual blood pressure per standard deviation was adjusted 
for these factors in a linear regression model, and the individual outcome was called 
the adolescent blood pressure-residual. The adult blood pressure-residuals were 
similarly calculated by adjusting the adult blood pressure for gender, adult age and 
adult body mass index. Using linear regression analysis we studied the relation 
between the adolescent blood pressure-residuals and CIMT, and subsequently this 
relation was additionally adjusted for adult blood pressure-residuals. 
Finally, we studied the relation between blood pressure tracking and CIMT. 
Tracking of blood pressure was defined as maintaining the same rank order in the 
blood pressure-distribution, and detracking of blood pressure as an increase or 
decrease of the rank order. We used the Spearman’s rank correlation coefficients to 
obtain correlation- and tracking coefficients. To study both tracking and detracking 
from adolescence to young adulthood in one model, we defined four groups of 
subjects: a group with tracking of blood pressure-residuals below the median from 
adolescence to young adulthood (LL), a group with detracking of blood pressure-
residuals from below the median to above the median (LH), a group of subjects with 
blood pressure-detracking from above the median to below the median (HL) and a 
group with blood pressure-tracking above the median (HH). A linear regression 
model was used to relate (de)tracking with CIMT, using dummy variables with LL as 
the reference group.  
All analyses were carried out with the statistical analysis software SPSS 9.0. 
Statistical significance was concluded if p<0.05. 
 
5.1.5 Results 
Table 5.1.1 shows the general characteristics of the ARYA cohort for men and 
women separately. The mean time-interval between the adolescent blood pressure 
measurement and CIMT measurement at young adulthood was 14.9 years (SD=1.3). 
At adolescence the blood pressure was higher in men, and body mass index and 
stage of sexual maturation were lower. The percentage of smokers and socio-
economic status of the fathers during adolescence were higher among the 
participating women. At young adulthood, blood pressure, weight, height, waist-hip 
ratio, the percentage smokers and CIMT were higher in men. 
Table 5.1.2 shows that systolic blood pressure, pulse pressure and mean arterial 
pressure at the age of 13 years are positively related to CIMT at young adulthood. 
The relations attenuated after adjustment for gender, adolescent age and adolescent 
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body mass index, but the associations with systolic blood pressure and pulse 
pressure remained statistically significant. Further adjustment for other factors did not 
affect the findings. 
At the age of 28 years, systolic blood pressure and pulse pressure were related to 
CIMT after adjustment for gender, adult age and adult body mass index (4.3 µm/SD 
systolic blood pressure mmHg (1.0 to 7.7) and 5.0 µm/SD pulse pressure mmHg (1.7 
to 8.4)). The relation with adult diastolic blood pressure and mean arterial pressure 
was smaller and not significant: 1.0 µm/SD diastolic blood pressure mmHg (-2.0 to 
4.0) and 2.5 µm/SD mean arterial pressure mmHg (-0.6 to 5.7), respectively. 
Our third question concerned the impact of adult blood pressure, measured by 
adjusting the relation between adolescent blood pressure and CIMT for adult blood 
pressure. Because blood pressure tracks from adolescence to young adulthood, an 
apparent association with adolescent blood pressure might appear, although the true 
relation exists between adult blood pressure and common carotid intima-media 
thickness. Therefore, we adjusted the relation between adolescent systolic blood 
pressure-residuals and CIMT, for adult systolic blood pressure-residuals. The 
relations between adolescent systolic blood pressure-residuals and CIMT attenuated 
slightly, and became statistically non significant. A similar finding was found for pulse 
pressure that, however, remained statistically significant (table 5.1.3).  
Blood pressure showed a moderate degree of tracking from adolescence into 
young adulthood in our population. Overall, the unadjusted correlation (r) was 0.22 
for systolic blood pressure (p<0.01), r=0.09 for diastolic blood pressure (p<0.05), 
r=0.14 for pulse pressure (p<0.01) and r=0.14 for mean arterial pressure (p<0.01). 
 
Table 5.1.2 Associations between adolescent blood pressure and CIMT at young 
adulthood 
 
 Adolescence 
 Systolic blood 
pressure 
Diastolic blood 
pressure 
Pulse pressure 
 
Mean arterial 
pressure 
Common  7.5(4.3 to 10.6) 2.6(-0.6 to 5.9) 5.4(2.4 to 8.4) 5.2 (1.9 to 5.8) 
     
Adjusted for gender, adolescent 
age and adolescent body mass 
index 
4.1(0.7 to 7.5) -0.9(-4.3 to 2.4) 4.7(1.6 to 7.8) 1.1 (-2.4 to 4.6)
Additionally adjusted for 
adolescent maturity, smoking and 
education level of father 
4.5(0.7 to 8.2) -0.9(-4.6 to 2.8) 4.8(1.5 to 8.1) 1.3 (-2.6 to 5.1)
 
Values are linear regression coefficients: change in mean CIMT (µm) per standard deviation blood pressure (95% 
confidence interval). 
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Table 5.1.3 Relation of adolescent blood pressure with adult CIMT, adjusted for 
adolescent and adult risk factors levels 
 
 Adolescence 
CIMT at young adulthood Systolic blood 
pressure 
Diastolic blood 
pressure 
Pulse pressure 
 
Mean arterial 
pressure 
Adjusted for adolescent and
adult risk factors* 
4.1 (0.6 to 7.7) -0.9(-4.4 to 2.6) 4.7(1.4 to 7.9) 1.1 (-2.5 to 4.7)
     
Adjusted for adolescent and
adult risk factors* and adult
blood pressure 
3.4 (-0.2 to 7.0) -1.1(-4.6 to 2.5) 4.7(1.4 to 7.9) 0.6 (-3.0 to 4.2)
 
Values are linear regression coefficients: change in mean CIMT (µm) per standard deviation blood pressure (95% 
confidence interval). 
*Gender, adolescent age, adolescent body mass index, adult age and adult body mass index (see data analyses 
for details). 
 
The correlation of the blood pressure-residuals was r=0.19 for systolic blood pressure 
(p<0.01), r=0.08 for diastolic blood pressure (p<0.05), r=0.12 for pulse pressure 
(p<0.01) and r=0.13 for mean arterial pressure (p<0.01). Of the 750 adolescents, 212 
(28.3%) showed tracking of the systolic blood pressure-residuals above the median 
(HH). The tracking groups HL, LH and LL consisted of 162, 160 and 207 subjects, 
respectively. A similar number of subjects was observed in the tracking groups of 
diastolic blood pressure, pulse pressure and mean arterial pressure. Figure 5.1.3 
shows that subjects tracking above the median of systolic blood pressure and pulse 
pressure (the HH group) had significantly larger CIMT than subjects tracking in the LL 
group. The subjects detracking between below and above the median (the LH and 
HL groups) had a comparable CIMT in between that of subjects tracking in either 
below or above the median. Pulse pressure showed similar results. 
 
5.1.6 Discussion 
We found that adolescent systolic blood pressure and pulse pressure levels are 
positively related to the thickening of the carotid arterial walls in healthy young adults. 
Furthermore, a high blood pressure at adolescence tracking into young adulthood 
was associated with the largest CIMT.  
To appreciate the results of this study, some issues need to be addressed. A 
single and routine blood pressure examination by school doctors does not provide a 
standardized blood pressure level of an adolescent due to within individual and 
between observer variability. Therefore, we believe that our results reflect an 
underestimation of the true relations of adolescent blood pressure and blood 
pressure-tracking with CIMT. Secondly, although CIMT is regarded as a valid 
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Figure 5.1.3 CIMT (mm) and (de)tracking of systolic blood pressure and pulse 
pressure from adolescence to young adulthood 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
indicator of generalized atherosclerosis and cardiovascular risk in the middle aged 
and elderly subjects, it has been argued that at lower degrees of CIMT, and thus at 
younger age, the thickening may reflect a non atherosclerotic adaptive response to 
changes in shear and tensile stress.15 However, postmortem observational studies 
showed that raised fatty streaks are present in subjects as early as 15 through 34 
years of age. These are regarded as the intermediate lesion in between the juvenile 
(flat) fatty streak and the raised lesion of atherosclerosis.2 The raised lesions are 
related to cardiovascular risk factors.2,16 Also, cross-sectional studies showed that 
blood pressure and lipid levels in healthy young adults are associated with increased 
CIMT3,4,17,18 and other measurements of vascular damage such as coronary artery 
calcification19 These observations indicate that an increased CIMT at young 
adulthood most likely reflects exposure to cardiovascular risk factors, and as such 
confers risk of cardiovascular morbidity and mortality later in life. 
Longitudinal data about the relation between cardiovascular risk factors and 
atherosclerosis in young adulthood are limited. In contrast to our findings, in the 
Muscatine study13 neither adolescent systolic or diastolic blood pressure were related 
to CIMT in healthy young adults after adjustment for adolescent total cholesterol in 
boys, and adolescent body mass index and total cholesterol in girls. Only when a 
time-weighted average of all (±six) diastolic blood pressure measurements were used 
in the multivariate analyses, a positive relation was found, in men only. The latter 
finding underlines the issue that variability in blood pressure measurements may 
attenuate the associations. In the Bogalusa Heart study12, systolic blood pressure 
and diastolic blood pressure showed a positive relation with atherosclerosis 
measured postmortem in subjects till 39 years of age, but other risk factors were not 
LL: tracking below the medians of adolescent systolic blood pressure- and pulse pressure-residuals 
into young adulthood, LH: detracking of blood pressure from below to above the median, 
HL: detracking from above to below the median, HH: tracking of blood pressure above the medians. 
Values represent the mean CIMT (mm) with standard errors. 
*CIMT of this marked group of subjects is significantly thicker than that of the reference group LL. 
**Systolic blood pressure- and pulse pressure-residuals: blood pressure per standard deviation 
adjusted for gender, age and body mass index at adolescence or young adulthood. 
0,47
0,48
0,49
0,5
Pulse pressure**
LL
LH
HL
HH
Pulse press **
* *
0,47
0,48
0,49
0,5
Systolic blood pressure**
*
Systolic blo d pressure
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taken into account. Our findings are in agreement with data in middle aged20-23 and 
elderly subjects24,25, showing that blood pressure is related to CIMT, measured after 
19 months till 15 years of follow-up. In general, systolic blood pressure was more 
strongly related to CIMT than diastolic blood pressure, and this may result from the 
consistent finding that the diastolic blood pressure measurements are more variable 
than systolic blood pressure. In the ARYA study the correlation for systolic blood 
pressure was 0.7 and for diastolic blood pressure 0.6 between the first and second 
visit at young adulthood. 
The ARYA findings expand the available evidence by indicating that adolescent 
pulse pressure is related to a thicker CIMT at the age of 28 years than adolescent 
systolic blood pressure. Studies on pulse pressure in adolescents and young adults 
are lacking, but longitudinal studies in middle aged and elderly subjects reported on 
pulse pressure21,25, and similarly showed that the relation between CIMT and pulse 
pressure was stronger than systolic blood pressure. The rise in pulse pressure at 
older age is caused by a fall in diastolic blood pressure due to increased arterial 
stiffness of the large arterial vessels26, and pulse pressure seems to be the best 
predictor of cardiovascular morbidity and mortality.11,27,28 In contrast, at young age 
both systolic blood pressure and diastolic blood pressure appear to be better 
predictors of cardiovascular morbidity and mortality than pulse pressure.9-11 Yet, it is 
difficult to investigate whether pulse pressure is independently associated with 
cardiovascular risk, or does associate due to a strong correlation with systolic blood 
pressure. In our study, pulse pressure is strongly correlated with systolic blood 
pressure (0.8) and not with diastolic blood pressure (0.1). The difference in impact of 
these two blood pressure indices on the CIMT has to be elucidated by further 
research. 
Previous studies demonstrated the presence of blood pressure-tracking in the 
young5-8. Yet, information on the relation between blood pressure-tracking and 
atherosclerosis is lacking at all ages. We showed that tracking in the highest systolic 
blood pressure and pulse pressure levels is related to the thickest CIMT and that 
subjects detracking have a mean CIMT in between that of subjects tracking in the 
lowest or highest levels. This might imply that in adolescents with a high blood 
pressure, whose adult blood pressure is below the median, exhibit a reduced rate of 
progression of the CIMT without abolishing the effect of the adolescent blood 
pressure on the arterial wall. 
In conclusion, the results of the ARYA study provide evidence that routinely 
measured high adolescent systolic blood pressure and pulse pressure are related to 
an increased CIMT at the age of 28 years, independent of other variables at 
adolescence and young adulthood; age, body mass index, gender and adult blood 
pressure. Our results strengthen the notion that the process of rise of cardiovascular 
risk is already initiated at adolescence. 
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5.2.1 Abstract 
Background: Studies with strongly controlled research settings suggest that 
childhood blood pressure predicts adult blood pressure. However, it is unknown if 
adolescent blood pressure as routinely measured by youth health care practices, 
predicts hypertension or total cardiovascular risk in adulthood sufficiently accurate to 
warrant blood pressure screening.  
Methods: In the cohort of Utrecht, a single and routinely measured blood pressure 
and anthropometry at the age of 13 years were collected from school health records. 
In the cohort of The Hague, adolescents were examined biennially in a standardized 
manner with measuring blood pressure three times per visit and anthropometry. 
Recently, 998 young adults aged 30 years of both cohorts were newly examined. The 
mean of a duplicate blood pressure at two different occasions was used as outcome. 
Adolescent predictors of hypertension and of 10-year cardiovascular risk in young 
adulthood by adolescent characteristics were assessed by logistic regression and by 
Receiver Operation Characteristics (ROC) curve analysis. 
Results: The Atherosclerosis Risk in Young Adults (ARYA) study comprised 167 
(38 women, 129 men) young adults with and 831 without hypertension, defined as 
the average of all measurements at two visits of systolic blood pressure ≥140 mmHg 
and/or diastolic ≥90 mmHg. Both single adolescent systolic and diastolic blood 
pressure were associated with hypertension at young adulthood: odds ratio (OR): 
1.04 per mmHg (95% confidence interval: 1.03 to 1.06), area under ROC-curve 
(AUC): 0.64 (0.59 to 0.69), and OR: 1.02 per mmHg (1.00 to 1.04), AUC: 0.54 (0.49 
to 0.59), respectively. Gender, body mass index, and age at adolescence combined 
improved the prediction: AUC: 0.71 (0.67 to 0.75). There was a statistically significant 
gain in predictive value by adding systolic blood pressure: AUC: 0.74 (0.70 to 0.77) 
and the difference in AUC: 0.03 (0.002 to 0.06). However, this gain was limited in 
magnitude given the strong predictive value of gender. Within men and women, 
systolic blood pressure was the only predictor of hypertension 15 years later. In men, 
the OR was 1.03 per mmHg (1.01 to 1.04) and AUC: 0.59 (0.53 to 0.65) and in 
women 1.08 per mmHg (1.05 to 1.11) and AUC: 0.74 (0.67 to 0.82). However, an 
adolescent blood pressure of 120 mmHg or higher did not efficiently detect later 
hypertensive men, while it detected 57.9% of later hypertensive women. Predictors of 
the 10-year cardiovascular risk of young adults could only be studied in men, who 
had by far the highest risks. Again, only systolic blood pressure predicted risk. For 
systolic blood pressure predicting the 10-year risk score being above the 95th 
percentile the OR was 1.04 per mmHg (1.02 to 1.07), AUC: 0.67 (0.60 to 0.75). 
Conclusion: A single routine blood pressure in young adolescent girls predicts 
hypertension in young adult women. In adolescent boys, blood pressure does not 
predict hypertension at young adulthood, but it predicts 10-year cardiovascular risk. 
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5.2.2 Introduction 
To date, there are no studies with sufficiently long follow-up to directly show relations 
between childhood blood pressure levels and the actual occurrence of ischaemic 
cardiovascular disease many decades later. There are long-term follow-up studies 
indicating that elevated blood pressure in young adulthood is associated with 
cardiovascular morbidity and mortality.1-6 Thus, elevated blood pressure in young 
adulthood is a marker for cardiovascular risk, which can be used as a meaningful 
surrogate endpoint in studies on childhood cardiovascular risk. Previous studies have 
shown that higher adolescent blood pressure levels are associated with higher blood 
pressure levels in young adulthood, and that combining several biennial blood 
pressure measurements improves prediction.7-9 However, these studies were 
performed under strongly controlled conditions both concerning research setting and 
measurements. Whether such results apply to common youth health care practice is 
unclear. It is specifically unknown if routinely measured blood pressure in children is 
sufficiently predictive for later hypertension to justify large-scale screening of blood 
pressure in childhood. Moreover, to our knowledge no studies on prediction with 
cardiovascular risk factors in children have taken total cardiovascular risk profiles in 
young adulthood as an endpoint. 
In The Netherlands, school doctors and nurses of the youth health care practices 
regularly screen children’s health states nationwide. Previously, routine blood 
pressure measurement was abandoned because its practical value in this screening 
was insufficiently known. The Atherosclerosis Risk in Young Adults (ARYA) study is a 
cohort of young adults of whom the medical records of the youth health care 
practices, including blood pressure, are still available. This provided a unique 
opportunity to study prediction of adult hypertension and total cardiovascular risk 
profiles by routinely measured blood pressure along with other simple and available 
screening characteristics at adolescence. Furthermore, ARYA includes a sub-cohort 
that enabled assessment of possible gain in predictive accuracy through using 
standardized and multiple blood pressure measurements at adolescence. 
The aim of this study was to determine whether routinely measured blood 
pressure of young adolescents accurately predicts hypertension and 10-year 
cardiovascular risk in young adulthood. We particularly questioned whether such 
blood pressure measurement has additional value to already routinely collected 
indicators of later hypertension and cardiovascular risk. The results were meant to 
support a discussion about the relevance of blood pressure screening in Municipal 
Health Services. 
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5.2.3 Methods 
The principal objective of the Atherosclerosis Risk in Young Adults (ARYA) study was 
to investigate early determinants of cardiovascular risk in the young. ARYA consists 
of a cohort from the Dutch city of Utrecht with 750 participants and a cohort from The 
Hague with 262 participants. The Medical Ethical Committee of the University 
Medical Center Utrecht, The Netherlands, approved the study. Written informed 
consent was obtained of all participants. 
 The enrolment schemes of both cohorts are shown in figure 5.2.1. In The 
Netherlands virtually all children regularly visit the child health facilities, starting at 
four weeks of age until leaving secondary school at the age of 16 to 19 years. 
Information is routinely collected in health records by school doctors and nurses. For 
the cohort of Utrecht, records of subjects born between 1970 and 1973 and attending  
secondary school in Utrecht were selected on the presence of birth weight data and 
approximated in the record (sign ±), the subject was excluded. A single routine blood 
 
Figure 5.2.1 Selection procedures of the ARYA participants 
 
  Cohort 
       
  Utrecht  The Hague 
       
Birth (1970-1973)  N = ±16,000    
       
Adolescence 
 Single routine 
screening MHS 
N = ±16,000 
 Third of 7 biennial 
screenings MHS 
N = 404 
       
 Complete data birth 
and blood pressure 
N = 4,208 
   
      
 Invitation letter  Invitation letter 
      
  Undeliverable: 726 
Refusals: 416 
Logistics: 36 
Other reasons: 18 
No response at all: 2191 
 
 Lost to follow-up: 31 
Refusals: 111 
 
 
      
 N = 821  N = 262 
      
 Pregnant/recent delivery: 14 
Secondary withdrawal: 57 
 Pregnant/recent 
delivery: 13  
 
      
Young adulthood 
 ARYA participants 
N = 750 
 ARYA participants 
N = 249 
 
MHS: Municipal Health Service. 
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pressure was measured by a sphygmomanometer, as well as body height, weight 
and sexual maturity according to the Tanner scale. Between responders and non-
responders born in 1970, there were no differences in mean birth weight, adolescent 
blood pressure and anthropometry. 
The Municipal Health Service of The Hague invited all first-year students starting 
in 1978 and 1979 at the Aloysius College, a secondary school. Of all invitees, 98% 
participated, one refused participation and five refused venipuncture. Information was 
biennially collected by school doctors. Standard examinations of the total cohort took 
place at the end of September and March of each year between 9.00 and 15.00 
hours within a time span of one week. This procedure was continued over seven 
years into later adolescence. Up to the age of 16 years, 11% of boys and 10% of girls 
were lost to follow-up, all due to changing school or moving to another city. 
Thereafter, loss to follow-up increased due to leaving school. At each examination, 
blood pressure was measured three times within three minutes in sitting position at 
the right upper arm. A dynamap (Physiometrics SR-2) with a cuff of 13x23.5 cm was 
used.10 Body weight and –height were measured without shoes. At visit 3, most of 
the adolescent pupils of two successive school years were examined (387 of 404). 
 
Our first endpoint was hypertension in young adulthood. At young adulthood, all 
ARYA participants of both cohorts underwent a physical examination during two 
visits. The Utrecht cohort was examined at the outpatient clinic of the Julius Center 
and the cohort of The Hague was examined either at the Julius Center or in their 
former secondary school in The Hague, by either of the first two authors (LEV, AO). 
All examinations took place between October 1999 and February 2001. All 
examiners were similarly instructed and blinded for all childhood data. After a five 
minutes rest in sitting position, a first blood pressure was measured by Dynamap at 
the left upper arm. After another 5 to 15 minutes rest the measurement was 
repeated. The same procedure was followed at the second visit that took place after 
a mean interval of 20.4 days (SD 10.7). Hypertension at young adulthood was 
defined according to the JNC V definitions11: systolic blood pressure ≥140 mmHg 
and/or diastolic ≥90 mmHg and/or use of anti-hypertensive medication (stages I-IV). 
We used the mean blood pressure of all measurements at two visits in the analyses. 
Our second endpoint was the total risk profile in young adulthood. In the cohort of 
Utrecht, fasting blood of 730 and non-fasting blood of 8 young adults was drawn and 
stored at –20 oC. At the last visit, serum levels of glucose, total cholesterol, 
triglycerides, high density lipoprotein (HDL)-cholesterol and low-density-lipoprotein 
(LDL-) cholesterol12 were determined by Vitros950 dry-chemistry analyzer (Johnson 
& Johnson, Rochester, New York, USA). In the cohort of The Hague, fasting blood 
was drawn of 240 young adults. Samples were kept at 4 oC and the lipid profiles and 
glucose levels were determined within 4 hours. Of these, 187 samples were 
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determined by using LX-20 (Coulter-Beckman, The Netherlands), 40 by Vitros950 
dry-chemistry analyzer, and 13 in laboratories elsewhere. Serum triglyceride values 
were logarithmically transformed to obtain normal distributions in the analysis. 
Information on smoking, alcohol use, medication use, highest educational level 
(low/middle/high), family history of cardiovascular disease, and hypertension, 
myocardial infarction, stroke, diabetes or hypercholesterolemia of first degree family 
members (n=859) was obtained by a written questionnaire. 
With the above mentioned measurements the total cardiovascular risk in young 
adulthood was calculated using a Framingham risk score.13 The score was 
developed in a population based sample of 2489 men and 2856 women aged 30 to 
74 years old without overt coronary heart disease at baseline. Over a 12 year follow-
up period the incidence of the following coronary heart diseases was recorded: 
angina pectoris, recognized and unrecognized myocardial infarction, coronary 
insufficiency, and coronary heart disease death, according to previously described 
criteria.14 The individual 10-year probabilities of coronary heart disease in ARYA 
participants was calculated using the β-coefficients from Cox-proportional hazard 
models fitted in the Framingham cohort, using continuous variables age and age-
squared, categorized variables total- and HDL-cholesterol and blood pressure, and 
dichotomous variables diabetes and smoking. Cut-offs for total cholesterol (<200, 
200 to 239, 240 to 279, ≥ 280 mg/dl) and HDL-cholesterol (<35, 35 to 59, ≥ 60 mg/dl) 
are similar to those used for the NCEP ATP II guidelines.15,16 The mean of blood 
pressure readings at young adulthood was calculated and blood pressure was 
categorized according to the JNC V definitions11: optimal blood pressure (systolic 
<120 mmHg and diastolic <80 mmHg), normal blood pressure (systolic 120 to 129 
mmHg or diastolic 80 to 84 mmHg), high normal blood pressure (systolic 130 to 139 
mmHg or diastolic 85 to 89 mmHg), hypertension stage I (systolic 140 to 159 mmHg 
or diastolic 90 to 99 mmHg), and hypertension stage II-IV (systolic ≥160 or diastolic 
≥100 mmHg). When systolic and diastolic blood pressures fell into different 
categories, the higher category was selected. Blood pressure categorization was 
made without regard to the use of anti-hypertensive medication. 
 
5.2.4 Data analysis 
Central estimators and variance measures were calculated for all relevant baseline 
characteristics for adolescence and young adulthood separately. The prediction of 
hypertension in young adulthood by adolescent characteristics was quantified using 
logistic regression analysis, and results expressed as odds ratios and areas under 
ROC curves with 95% confidence intervals. 
A full model with blood pressure, gender, body mass index and age was first 
evaluated with a backward stepwise procedure, with removal of terms from the model 
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at a p-value exceeding 0.10.17 Areas under ROC curves were calculated to evaluate 
discriminative values of models. These procedures were first used to assess whether 
comparison of data from the Utrecht cohort (routine blood pressure) and data from 
the cohort from The Hague (standardized blood pressure) showed predictive benefit 
of measurement standardization. Similarly, comparisons of models were used to 
evaluate if various combinations of repeated blood pressure measurements in the 
cohort from The Hague would increase predictive accuracy. Differences in 
discriminating value between models were estimated by differences in area under 
ROC curves (AUC) with 95% confidence intervals, taking into account the correlation 
between models as they were based on the same cases.18 Reliability (goodness of 
fit) of the models was estimated using the Hosmer & Lemeshow test.19 Next, the 
absolute numbers of hypertension cases and non-hypertension cases were 
evaluated among categories of adolescent risk. Analyses were performed both for 
hypertension and 10-year cardiovascular risk in young adulthood. Analyses were 
carried out using SPSS 10.1. 
 
5.2.5 Results 
In table 5.2.1 the characteristics of participants as adolescents are given for both 
cohorts of ARYA. Boys had higher systolic blood pressures and lower weight and 
body mass index than women. In the Utrecht cohort girls had higher maturity scores 
than boys. Table 5.2.2 shows characteristics of participants as young adults. Men 
had higher systolic and diastolic blood pressure, weight, height and waist-hip ratio, 
while body mass index was similar in both sexes. One young adult with hypertension 
did not attend visit 3 at adolescence and therefore most of the following analyses 
pertain to 998 participants. The study population comprised 167 young adults (38 
women and 129 men) with hypertension, 111 in the Utrecht cohort, 55 in the cohort 
of The Hague, and 831 without hypertension. 
When analyzing data of the cohort of Utrecht and The Hague separately, similar 
results were found for blood pressure. The routine single adolescent blood pressure 
in the Utrecht cohort showed an odds ratio of 1.04 (95% confidence interval: 1.02 to 
1.06) per mmHg increase of systolic and of 1.02 (95% CI: 1.00 to 1.05) per mmHg 
increase in diastolic blood pressure, when predicting adult hypertension. Within the 
cohort from The Hague, a single systolic blood pressure showed an odds ratio of 
1.04 per mmHg (95% CI: 1.01 to 1.07) and for diastolic blood pressure of 1.01 (95% 
CI: 0.97 to 1.05). These associations did not change when the mean blood pressure 
was taken of either two or three adolescent readings per visit, nor when using the 
overall mean of all 6 measurements from visit 3 and the visit one year later (systolic 
blood pressure: OR 1.04; 95% CI: 1.01 to 1.07), or years later (data not shown). As 
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Table 5.2.1 General characteristics ARYA participants in adolescence 
 
 
 
Cohort of Utrecht Cohort of The Hague: 
Visit 3 
Adolescence Boys 
(n=352) 
Girls 
(n=348) 
Boys  
(n=223/232) 
Girls 
(n=164/172) 
      
Age (years) 13.5 (1.1) 13.4 (1.1) 13.2 (0.7) 13.1 (0.7) 
Single/1st SBP (mmHg) 111.7 (12.5) 109.0 (11.3) 119.9 (12.4) 118.1 (11.9) 
Single/1st DBP (mmHg) 67.4 (9.6) 66.0 (10.1) 67.4 (8.4) 67.7 (7.3) 
Mean of 1st + 2nd SBP (mmHg) -  -  118.1 (12.1) 116.5 (11.2) 
Mean of 1st + 2nd DBP (mmHg) -  -  66.6 (7.9) 66.7 (7.1) 
Mean of 1st + 2nd + 3rd SBP (mmHg) -  -  117.1 (11.9) 115.2 (10.9) 
Mean of 1st + 2nd + 3rd DBP (mmHg) -  -  66.0 (7.9) 66.1 (6.9) 
Weight (kg) 49.2 (10.5) 49.9 (9.9) 46.8 (8.3) 47.9 (8.1) 
Height (cm) 163.0 (10.3) 161.2 (8.0) 159.3 (8.9) 159.3 (7.0) 
Body mass index (kg/m2) 18.3 (2.4) 18.9 (2.9) 18.3 (2.0) 18.8 (2.4) 
Maturity (Tanner score) 2.9 (1.3) 3.7 (1.4) -  -  
 
Values are means with standard deviation.  
SBP: systolic blood pressure, DBP: diastolic blood pressure.  
 
Table 5.2.2 General characteristics of ARYA participants in young adulthood 
 
 Cohort of Utrecht Cohort of The Hague 
Young adulthood Men 
(n=352) 
Women 
(n=398) 
Men 
(n=142) 
Women 
(n=107) 
      
Age (years) 28.4 (0.9) 28.4 (0.9) 34.3 (0.8) 34.3 (0.7) 
Systolic blood pressure (mmHg) 130.8 (12.0) 120.6 (12.3) 134.0 (13.9) 121.2 (14.2) 
Diastolic blood pressure (mmHg) 73.1 (7.8) 70.9 (8.5) 74.8 (8.6) 70.2 (8.6) 
Weight (kg) 83.5 (13.6) 71.3 (14.9) 85.4 (13.0) 69.5 (12.8) 
Height (cm) 183.9 (6.7) 170.2 (6.4) 182.9 (7.0) 169.0 (6.4) 
Body mass index (kg/m2) 24.7 (3.7) 24.7 (5.0) 25.5 (3.5) 24.3 (4.0) 
Waist-hip ratio 0.88 (0.06) 0.81 (0.06) 0.92 (0.06) 0.83 (0.07) 
Total cholesterol (mmol/l) 4.8 (1.0) 4.8 (0.8) 5.3 (1.1) 4.9 (0.8) 
HDL-cholesterol (mmol/l) 1.3 (0.3) 1.6 (0.4) 1.2 (0.3) 1.6 (0.3) 
Triglycerides (mmol/l) 1.4 (0.9) 1.2 (0.6) 1.1 (0.7) 0.9 (0.4) 
LDL-cholesterol (mmol/l) 2.9 (0.9) 2.7 (0.8) 3.6 (0.9) 3.0 (0.8) 
Glucose (mmol/l) 5.2 (1.2) 4.8 (0.4) 5.3 (0.7) 5.0 (0.5) 
 
Values are means with standard deviation. 
LDL: low-density-lipoprotein, HDL: high-density-lipoprotein. 
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Table 5.2.3 Multivariate predictors in adolescence of hypertension at young 
adulthood after backward stepwise procedure 
 
Adolescence Odds ratio (95% CI) 
per mmHg 
P-value 
Single/first systolic blood pressure (mmHg) 1.04 (1.02 to 1.05) <0.0001 
Gender (male=1, female = 0) 4.38 (2.93 to 6.54) <0.0001 
Age (years) 0.81 (0.67 to 0.97) 0.02 
BMI (kg/m2) 1.09 (1.01 to 1.17) 0.03 
 
In the full model diastolic blood pressure was included, but excluded in the backward stepwise 
procedure. 
 
the predictive values of single blood pressure measurements did not differ between 
the two cohorts all data were pooled for further analyses on single early adolescent 
blood pressure data. 
Table 5.2.3 shows results of multivariate logistic regression after a backward 
stepwise procedure. The full model included systolic and diastolic blood pressure, 
gender, age, and body mass index as possible predictors of young adult 
hypertension. The backward selection procedure removed diastolic blood pressure 
from the model. The area under the ROC curve (AUC) of gender, body mass index, 
and age at adolescence predicting hypertension at young adulthood was 0.71 (95% 
CI: 0.67 to 0.75), and with single adolescent systolic blood pressure added 0.74 
(95% CI: 0.70 to 0.77). The difference in AUC of these two models was 0.03 (95% 
CI: 0.002 to 0.06), showing that systolic blood pressure had added predictive value. 
Clearly, gender was a strong independent predictor. Therefore, further analyses were 
performed for men and women separately. 
Backward stepwise logistic regression was subsequently used in men and women 
separately starting with the same full model including systolic and diastolic blood 
pressure, age, and body mass index. Both in men and women, systolic blood 
pressure was the only remaining predictor of later hypertension. The odds ratio for 
male adolescent systolic blood pressure in mmHg was 1.03 (95% CI: 1.01 to 1.04) 
per mmHg. The corresponding ROC curve is shown in figure 5.2.2, with an AUC of 
0.59 (95% CI: 0.53 to 0.65). The odds ratio for female adolescent systolic blood 
pressure in mmHg was 1.08 (95% CI: 1.05 to 1.11) per mmHg. The corresponding 
ROC curve is shown in figure 5.2.3, with an AUC of 0.74 (95% CI: 0.67 to 0.82).  
Thus, systolic blood pressure in early adolescent boys although statistically 
significantly associated with later hypertension but, according to the low AUC, did not 
discriminate between hypertensives and false positives. Within girls, however, 
systolic blood pressure predicted reasonably well. Table 5.2.4 shows numbers of 
hypertensives and non-hypertensives by categories of adolescent systolic blood  
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Figure 5.2.2 Receiver Operation Characteristic curve for adolescent systolic blood 
pressure in men predicting hypertension in young adulthood (129 
hypertensives among a total of 365 men) 
 
Area under the ROC curve is 0.59 (95% confidence interval: 0.53 to 0.65). 
 
Figure 5.2.3 Receiver Operation Characteristic curve for adolescent systolic blood 
pressure in women predicting hypertension in young adulthood (38 
hypertensives among a total of 504 women) 
 
Area under the ROC curve is 0.74 (95% confidence interval: 0.67 to 0.82). 
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Table 5.2.4a Number of young adult men with and without hypertension across 
categories of adolescent systolic blood pressure 
 
Adolescent systolic blood 
pressure (mmHg) 
Total number of 
men (%) 
Young adults with  
hypertension (%) 
Young adults without 
hypertension (%) 
≤ 99 41   (8.3%)   8   (6.2%) 33   (9.0%) 
100 – 119 278  (56.3%)   60  (46.5%) 218  (59.7%) 
≥120 175  (35.4%)   61  (47.3%) 114  (31.2%) 
Total 494  (100%)  129  (100%) 365  (100%) 
 
Table 5.2.4b Number of young adult women with and without hypertension across 
categories of adolescent systolic blood pressure 
 
Adolescent systolic blood 
pressure (mmHg) 
Total number of 
women (%) 
Young adults with  
hypertension (%) 
Young adults without 
hypertension (%) 
≤ 99 63  (13.5%)   0   (0%) 63  (13.5%) 
100 – 119 307  (60.9%)  16  (42.1%) 291  (62.4%) 
≥120 134  (26.6%)   22  (57.9%) 112  (24.0%) 
Total 504  (100%)   38  (100%) 466  (100%) 
 
Figure 5.2.4 Receiver Operation Characteristic curve for adolescent systolic blood 
pressure in men predicting being above the 95% Framingham risk 
score in young adulthood 
 
Area under the ROC curve is 0.67 (95% confidence interval: 0.60 to 0.75). 
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pressure for boys (table 5.2.4a) and girls (table 5.2.4b). For instance, an adolescent 
systolic blood pressure of 120 mmHg or higher in girls detected 57.9% of later 
hypertensive women, although there were only 38 women with hypertension in the 
total ARYA population (23% of all hypertensives). A low adolescent blood pressure in 
girls excluded young adult hypertension; i.e. 0% of the girls with a systolic blood 
pressure ≤99 mmHg developed hypertension at young adulthood. In boys, 
adolescent blood pressure did not discriminate later hypertensive and non-
hypertensive men. However, the vast majority of young adult hypertensives were 
men, 129 of 167 (77%).  
We proceeded with predicting the 10-year cardiovascular risk as calculated with 
the Framingham risk score. Expectedly, this could only be performed for men as the 
top 20% of the Framingham risk distribution consisted of men only (n=199), while 
only 3 women exceeded the 70th percentile of the Framingham risk score. In men, 
backward stepwise logistic regression showed that from a full model with systolic and 
diastolic blood pressure, body mass index and age, only systolic blood pressure was 
retained. The odds ratio for systolic blood pressure predicting the 10-year risk score 
being above the 95th percentile was 1.04 (95% CI: 1.02 to 1.07). The corresponding 
AUC of 0.67 (95% CI: 0.60 to 0.75) is shown in figure 5.2.4. Thus, for every mmHg 
higher systolic blood pressure there was a 4% increased risk of being in the 5% 
highest risk group as young adult men.  
 
5.2.6 Discussion 
Our findings show that a single routine systolic blood pressure measurement in 
young adolescent girls does predict later hypertension in young adulthood. In young 
adolescent boys, systolic blood pressure does statistically predict hypertension, but 
this has no practical relevance for screening at that age. However, in adolescent 
boys systolic blood pressure better predicted 10-year cardiovascular risk in young 
adulthood than hypertension. 
A strong feature of ARYA is the use of data derived from clinical practice, which 
renders results that are directly relevant to that practice. We cannot exclude the 
possibility that there has been selection with regard to the prevalence of hypertension 
in our cohort. Non response of young adult hypertensives would probably imply an 
underestimation of predictive values. However, in the Utrecht cohort there was no 
difference between adolescent blood pressure and anthropometry of the responders 
and non-responders. Participation in the cohort of The Hague did not depend on 
adolescent data and several risk factors at young adulthood obtained by 
questionnaire. 
Dutch youth health care services have in the past abandoned screening of blood 
pressure in adolescence based on insufficient knowledge of its practical value. There 
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are many longitudinal studies on the predictive properties of childhood blood 
pressure measurements, but these were invariably conducted under strongly 
controlled settings, while results are often not expressed in practically applicable 
ways.7-9,20,21 Many such studies do indicate that childhood blood pressure 
measurement, particularly when repeated, statistically predicts later blood pressure, 
but the predictive performance of measurements under practical conditions might be 
anticipated to be much less accurate. However, the decision of youth health care 
services to stop screening by blood pressure measurements was not evidence 
based. Rather, it was taken in the absence of evidence for practical usefulness. 
ARYA was designed to provide such evidence. Basically, our findings indicate that 
with systolic blood pressure measurement in young female adolescents, school 
doctors are able to detect a substantial number of future female hypertensives, 
particularly given nationwide screening activities. Obviously, adolescent screening 
would miss some 40% of future hypertensives and some 25% will be false positives. 
In adolescent boys at the age of around 13 years, screening of blood pressure, 
although statistically associated, does not seem useful to detect future hypertensives. 
Although, systolic blood pressure better predicted 10-year cardiovascular risk in 
young adult men, its discriminative value was not sufficiently high to warrant 
elaborate screening. Possibly, 13-year-old boys have less stabilized blood pressures 
than girls of that age. In the Utrecht cohort of ARYA, girls were substantially more 
sexually mature at this age than boys, which may partly underlie this gender 
discrepancy. This does not exclude the possibility that blood pressure screening in 
somewhat older boys may prove to be worthwhile. In the prediction model in the total 
ARYA population, particularly gender played a major role and to a lesser extent body 
mass index and age. Male gender and adolescent body mass index are indeed 
known risk indicators for hypertension and cardiovascular risk at large.22 Adding 
systolic blood pressure to these predictors yielded statistical but still limited gain in 
accuracy. Apparently, prediction models in young adolescence require gender 
specific derivation and practical application. Somewhat surprising was that using 
repeated blood pressure measurements for prediction did not increase predictive 
power as compared to prediction based on only one measurement. Other studies 
showed that combining repeated blood pressure measurements improved the 
prediction of later high blood pressure levels.7,23,24 The gain in precision of estimating 
the true underlying adolescent blood pressure was anticipated to be larger in our 
study using data from clinical practice, with larger measurement error and blood 
pressure variation.  
It might be argued that further knowledge of hypertension risk factors in 
adolescence could further increase predictive possibilities. For instance, a family 
history of hypertension or cardiovascular disease has been shown by some to have 
predictive information concerning later hypertension,25 although not supported by 
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others.26 However, as these young adolescents are screened at school often without 
their parents being present, inquiring for a family history of hypertension or 
cardiovascular disease is probably too time consuming from a practical point of view 
and is likely to be subject to misclassification. In ARYA, the young adults were asked 
about a family history of hypertension, cardiovascular disease and diabetes mellitus. 
Data on family risk at the time of adolescence was not available and therefore could 
not be included in the predictive models. However, these data are likely subject to 
misclassification considering that it required recollection of data from more than 15 
years ago. Moreover, it was considered questionable if young adolescents 
themselves will be able to accurately respond to such questions in practice. 
Predictive models were deliberately kept parsimonious with variables that can be 
objectively measured by physicians or nurses. 
 
Cardiovascular disease is still the leading cause of morbidity and mortality in most 
Western countries and an increasing problem in many non-western societies.27 There 
is growing consensus that primary hypertension has its origins in early life.28 This had 
led many researchers to question whether or not prevention of hypertension and its 
sequelae, cardiovascular diseases, should be transferred from adult to early life. 
Except for population wide approaches, early prevention requires that high 
cardiovascular risk can be accurately estimated in early life. Moreover, it requires that 
health care systems have tools for effective and safe interventions in early life or for 
longer term monitoring of children at high risk. The most obvious intervention 
strategies are probably life style changes, as the efficacy and safety of long term 
aggressive interventions with medication are, for children, unknown. Sedentary 
lifestyles and obesity are increasingly threatening the health of youngsters.29 
Indicators of such lifestyles are shown to be predictors of obesity in later 
adolescence.30 Adolescent overweight is shown to track into young adulthood and 
related to adult cardiovascular risk factors, including repeated blood pressure 
measurements.31 Also in adulthood, overweight contributes strongly to cardiovascular 
risk.32 In The Netherlands, the prevalence of obesity among children has strongly 
risen in between 1980 and 1997.33 A recent systematic review shows that there is 
only limited data from intervention studies on obesity showing inconclusive results.34 
Small trials report effects of interventions on beneficial change in body mass index in 
adolescence, but these interventions do not seem suitable for large scale use by for 
instance youth health care workers in The Netherlands.35 In The Netherlands, an 
observational evaluation of preventive action with regard to obesity, and unhealthy 
behavior in general, through youth health care intervention has not been very 
promising.36 Still, the young adolescent body mass index was in our overall model a 
predictor of later hypertension. This, combined with our finding that of all 
hypertensives in ARYA more than 65% had a body mass index of 25 kg/m2 or more 
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at young adulthood, underscores that future efficacious interventions to prevent 
adolescent obesity also has the potential to lower the adolescent blood pressure. 
Even if efficacious risk lowering interventions in adolescence cannot be easily 
achieved, there may still be merit in early screening of cardiovascular risk. Detection 
of high-risk adolescents enables longer term monitoring and possibly later targeted 
lifestyle or drug interventions.  
One major distinction between our study and many other studies is that we have 
used routinely collected data in adolescence for prediction of carefully measured 
hypertension in young adulthood. Another important distinction with other studies is 
that a discussion on the relevance of early life screening cannot be solely based on 
for instance hypertension as a surrogate endpoint. The primary goal of 
cardiovascular screening at any age is to ultimately reduce the risk of disease, to 
which hypertension is only one contributor. The fact that in ARYA women the 
Framingham risk scores were so much lower than in men is not surprising. These 
were 10-year risk scores, while in women the actual occurrence of heart disease will 
on average be later in life than in men.5 In the year 2000 in The Netherlands, there 
were 151.570 hospital admissions for heart disease in men and 110.551 for women. 
Of these, 44% were younger than 65 years, but 49% of men versus 38% of women.37 
Notably, the Framingham risk score that we used was constructed for the prediction 
of coronary heart disease, while a higher percentage of Dutch women, compared to 
men, will get cerebrovascular disease.37 A risk score providing specific baseline 
hazards for young adults with follow-up for longer than 10 years is to our knowledge 
not available. This does in our view not discard the discussion on early life screening 
of cardiovascular risk factors in girls. Our findings do directly apply to Dutch youth 
health care practice and support in our view a new discussion about the relevance of 
blood pressure screening, particularly in girls. Nowadays, blood pressure is very 
easily measured, not necessarily by highly trained physicians, using automated 
devices at relatively low cost. According to our findings, such activity would detect in 
an early stage more than half of all young adult hypertensive women who are 
nowadays generally not detected at this age. Early detection and possibly 
intervention would likely contribute to the prevention of long term exposure to high 
blood pressure. Given our plea for a renewed discussion on blood pressure 
screening, our data may also support a discussion on the age at which youngsters 
are to be screened. In The Netherlands, youth health care is well organized with a 
good infrastructure. However, also from within this organization there are critical 
evaluations as many of its screening activities are not evidence based, while some 
are shown to be ineffective.38  
Given our findings and the fact that cardiovascular disease has a continuous large 
impact on individuals and on public health, we believe that youth health care should 
resume a discussion about blood pressure screening in adolescents. 
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6.1 Introduction 
The technical and medical ability to diagnose and treat manifest cardiovascular 
diseases have markedly improved in the previous century. However, the 
cardiovascular diseases are still the major cause of mortality in most western 
societies and an increasing health threat in developing countries, claim large parts of 
health budgets and are responsible for many quality adjusted years of life lost.1,2 
Whereas advances in myocardial infarction treatment have predominantly 
contributed to this decline in mortality, a trade-off is a concurrent rise in 
hospitalizations for heart failure, also in The Netherlands.3 A thus continuing large 
impact on health commits us to next generations to search for new possibilities to 
reduce the burden of cardiovascular disease. 
 Atherosclerosis is the primary process responsible for the clinically manifest 
cardiovascular diseases. Postmortem studies and some studies in healthy 
adolescents indicate that this process already starts in childhood and is accelerated 
by cardiovascular risk factors, like high blood pressure, obesity and dislipidemia. A 
relatively new and potentially fruitful area of further research on cardiovascular risk 
reduction is birth weight. 
 Preventive strategies aim to lower the incidence of cardiovascular disease. In 
general, there are two complementary primary preventive strategies. The whole 
population approach aims to influence risk in all individuals of the population for 
instance by general lifestyle measures. While the population at large would strongly 
benefit from such measures, the individual member of this population will only 
marginally benefit. In contrast, the high risk approach aims to lower risk in those with 
high disease risks only. High risk preventive approaches have been successful in 
adults, particularly by lowering blood pressure and elevated cholesterol levels.4 A 
marked decline in mortality from coronary heart disease between 1980 and 1990 in 
the United States of America, could be attributed to treatment for 50%, to secondary 
prevention for 25%, and to primary prevention for 25%.2 Prevention here refers to 
measures taken in adults. However, as coronary heart disease originates in 
childhood, the concept of prevention in childhood may be considered. 
 In this chapter I will discuss issues regarding etiology and predictive capacity of 
cardiovascular risk factors at a young age. The role of low birth weight as a putative 
cardiovascular risk factor is discussed. Next, the predictive ability of adolescent blood 
pressure for hypertension and future coronary heart disease risk is studied. 
 
Fetal origins hypothesis 
One decennium ago, the “fetal origins hypothesis” was postulated5, based on the 
finding that low birthweight as a possible indicator of an unfavorable intra-uterine 
environment, was associated with chronic disease in later life, particularly 
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cardiovascular disease. The hypothesis was that fetal undernutrition in critical phases 
of pregnancy may initiate fetal adaptations. These adaptation were suggested to 
optimize the fetus’ survival resulting in a small birth size with the adverse 
consequence of an increased risk of chronic diseases in the long term. Initially, a 
shortage of intra-uterine nutrients was considered to be responsible for the 
adaptation programming of the fetus by affecting the differentiation of the 
hypothalamic centers.6 Even before this hypothesis evolved, there were observations 
to support it. For example, a Dutch famine study on children who were fetuses at 
different phases of pregnancy during the great famine in the second world war in 
1944, showed that nutritional deprivation in the first half of pregnancy resulted in 
relative adiposity in young men.7 Recently, it was found that small variations in the 
balance of macro-nutrients in the maternal diet during gestation may adversely affect 
blood pressure.8 
 
6.2 Fetal origins hypothesis revisited 
Although many reports have subsequently provided support for the fetal origins 
hypothesis, there was also increasing criticism as to whether the relation between 
birth size and cardiovascular risk truly exists. Critics were concerned about selection 
bias, confounding variables, publication bias and statistical errors in supportive 
reports.9-11 For instance, the impact of body mass on the relation between birth 
weight and blood pressure in the young was discussed. Some longitudinal studies 
reported an intermediate role for attained body size, as a causal link in the chain of 
events leading from low birth weight to later high blood pressure.12 Thus, adjusting 
for attained body size, if indeed an intermediate factor, would be statistically 
unjustified. Others found that babies born with a low birth weight and a relatively high 
body size at later age, also called catch-up growth or accelerated postnatal body 
growth, developed the highest blood pressure levels.13,14 These studies suggest that 
catch-up growth may partially or fully explain the relation between birth size and 
increased blood pressure, rather than decreased prenatal body growth reflected in 
low birth size itself. 
 Also, critics questioned the very nature of the fetal origins hypothesis.15 Research 
showed that an unfavorable intra-uterine environment other than caused by an 
imbalance of nutrients also could affect birth weight and disease in later life. In 
particular, maternal factors may induce an adverse intra-uterine environment, due to 
toxins of cigarettes, pregnancy complications and diseases like pre-eclampsia, or 
maternal genes. For instance, newborns of smokers are smaller and have a higher 
blood pressure in later life.16 Women with an increased risk of ischaemic heart 
disease more often had preterm deliveries, pre-eclampsia and small newborns.17 
Moreover, maternal hyperglycemia may modify the birth weight of the newborn.18 
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 Alternatively, the genes of the fetus itself could directly affect birth weight and 
future adverse outcomes. This concept has been confirmed by the finding that non-
carriers of a polymorphism in the promoter region of the insulin-like growth factor-I 
(IGF-I) gene was related to low birth weight and increased risk of diabetes type 2 and 
myocardial infarction.19,20 Also, a glucosekinase mutation of the newborn which 
causes hyperglycemia in later life, has been associated with a decreased birth size.18  
 Moreover, an interaction between genetic factors of the fetus and an unfavorable 
intra-uterine environment caused by maternal factors, may underlie the nature of the 
fetal origins hypothesis.  
 
Findings in the ARYA study 
Our analyses described in chapters 4.1 and 4.2 appear to generally support the fetal 
origins hypothesis. They confirm previous findings that birth size may be related to 
future cardiovascular risk, but also show that birth weight may be less important for 
elevated blood pressure than excess change to a relative high body weight in later 
life. In chapter 4.1 we used the analytical recommendations of Lucas to assess the 
impact of body size.9 We observed a relation between low birth weight and increased 
blood pressure. Also, a change of body mass from adolescence to young adulthood 
was more strongly related to systolic blood pressure than birth weight. Similarly, body 
mass index levels at young adulthood were stronger related to adult blood pressure 
than birth weight. 
 Our additional analyses expand current knowledge, that a particular risk group 
may be those who have excessively grown to high body mass coming from (too) low 
birth weights. The interaction model from Lucas suggests that birth weight modifies 
the effect of body mass index on blood pressure, more in particular, that de-tracking 
of body weight to high levels would lead to high blood pressure. Indeed, those in our 
study with the lowest birth weights who de-tracked to the highest body mass index at 
young adulthood were part of those with the highest systolic and diastolic blood 
pressure levels. However, from additional analyses we infer that a relation between 
birth weight and blood pressure seems to be restricted to those with high attained 
body mass; it was absent at lower body mass index levels. This would mean that 
there is no graded interaction between birth weight and body mass index, but that 
only babies who are light for their constitution or constitutionally small babies and 
become relatively heavy later are at risk of hypertension. Thus, it appears that (too) 
low birth weight babies, through high attained body mass index as an intermediate 
process, are likely to develop high blood pressure. A more likely explanation seems 
to be that such babies are particularly vulnerable to develop high body mass in young 
adulthood, with high blood pressure as a mere consequence of the latter. 
 In chapter 4.2 we explored the existence of the fetal origins hypothesis, by using 
an aggregation of current risk factors as a comprehensive measure of cardiovascular 
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risk at young age. Obviously, clinically manifest cardiovascular disease cannot be 
studied in the young, while single and individual risk factors only partially describe the 
cardiovascular risk. In almost all previous reports on this subject only one 
cardiovascular risk factor in the young adult was studied. We feel that assessment of 
early determinants in relation to total cardiovascular risk is essential. In this chapter 
we describe a relation between low birth size and an increased Framingham risk 
score21 at young adulthood. The Framingham risk score uses several cardiovascular 
risk factors - such as age, blood pressure, lipids, diabetes and smoking – in 
combination to predict the 10-year risk of coronary heart disease accurately. 
 
Furthermore, we examined the genetic explanations as an alternative for the fetal 
origins hypothesis. By way of example, we determined a polymorphism in the 
promoter region of the IGF-I gene which has recently been described as a possible 
modulator of birth size and risk of cardiovascular disease. In chapter 3.1, 
homozygous carriers of this polymorphism showed a more favorable profile of 
cardiovascular risk factors in adolescence and young adulthood, compared to 
heterozygous carriers and non-carriers. A relation between the polymorphism and 
arterial wall thickness or stiffness could not be found at this young age. Contrary to 
previous reports, no relation was observed between this polymorphism and birth size, 
suggesting that the polymorphism may not directly influence fetal growth. 
 However, when we further investigated the genotypes of the young adults in 
relation to the birth weight of their first newborns, we found that homozygous 
maternal and paternal carriers of the polymorphism in the promoter region of the IGF-
I gene, had offspring with a decreased body weight (chapter 3.2). This latter report 
supports the view that parental genotype may influence fetal growth and 
subsequently the risk of cardiovascular disease in later life. 
 
Comment 
Data in this thesis provide some support to the fetal origins hypothesis, but also 
modifies the initial concept. In chapter 4.1 we show that a decreased birth size is 
associated with increased blood pressure levels at young adulthood, but is restricted 
to young adults with a high attained body mass index. This suggests that the 
hypothesis pertains to a select group of subjects. In chapter 4.2, we expand the 
available evidence by using a cluster of several individual cardiovascular risk factors 
as outcome variable, predicting 10-year risk of coronary heart disease. We observed 
that low birth size is associated with an increased risk score. However, we could not 
study the impact of body size in the relation between birth size and the Framingham 
risk score, as in chapter 4.1. The Framingham risk score is calculated by a formula 
which has included several risk factors. Although body mass is not one of them, the 
future cardiovascular risk modified by body mass index is taken over by these other 
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risk factors.21 Adjusting the relation between birth weight and the risk score for body 
mass index, and studying whether the association was restricted to particular 
subjects, is therefore difficult to interpret.  
 Next, our results suggest that the fetal IGF-1 gene is not directly involved in the 
fetal origins hypothesis, but parental IGF-1 genes may. These findings merit further 
research on genetic and environmental causes. For instance, we investigated only 
one single polymorphism on the promoter region of the IGF-I gene. It was previously 
shown that other mutations located near the IGF-I gene also affect birth weight and 
cardiovascular risk22, and other genes are described to be associated as well.15 
 In support of the current criticism, we consider the relative impact of birth weight 
on blood pressure in later life limited. We only found support for the hypothesis in 
particular subjects. In fact, an increased cardiovascular risk, i.e. high blood pressure, 
was limited to those who were born small and developed the highest body mass 
index. It is not known which mechanism is responsible for the latter finding. It may be 
that a child that is born (too) small is more vulnerable for excessive weight gain than 
babies born with a normal or heavy birth size. Perhaps overcompensatory 
mechanisms play a role in this vulnerability, for instance concerning the parental 
nourishment of (too) small babies. A second criticism is that the relation with blood 
pressure seems predominantly modified by postnatal body growth. Similarly, body 
mass index at later age is stronger related to blood pressure, than birth weight to 
blood pressure. These data indicate that postnatal risk factors, such as excessive 
change of body size and increased body mass index at later age, mainly explain the 
relation between birth weight and cardiovascular risk. Therefore, postnatal risk 
factors at young age seem to provide better tools for preventive strategies than birth 
weight. 
 
6.3 Cardiovascular risk prediction in children 
Several long-term follow-up studies have shown clear associations between elevated 
blood pressure level in late adolescence or young adulthood, and cardiovascular 
morbidity and mortality.23-28 This indicates that hypertension at young adulthood may 
be regarded as a surrogate outcome when studying cardiovascular risk in children for 
whom such long-term studies do not yet exist. Follow-up studies such as the 
Muscatine study and the Bogalusa Heart study, have shown that blood pressure 
levels measured in childhood and adolescence are positively associated with blood 
pressure in early adulthood.29-31 Combining several biennial blood pressure 
measurements improved these associations.32-34 The finding that an elevated 
adolescent blood pressure is related to hypertension and thus increased 
cardiovascular risk at young adulthood, suggests that adolescents with a high risk of 
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future cardiovascular disease may be selected by measuring their blood pressure 
level.  
 However, the Muscatine and Bogalusa Heart study are epidemiogical studies 
using similar research settings and measurements for each participant. Whether the 
results can be extrapolated to medical health care in general, remains to be 
determined, as practice itself generates variation. More in particular, it is unknown 
whether routinely measured blood pressure in children is sufficiently predictive for 
later hypertension and cardiovascular risk, to justify large-scale screening of blood 
pressure in adolescence. The ARYA study was designed to shed more light on these 
issues. 
 
The Dutch health care system and ARYA study 
In The Netherlands, virtually all children regularly visit the facilities of the Home Care 
Organizations and Municipal Health Service, starting at four weeks old until leaving 
secondary school at the age of 16 to 19 years. This system may provide a unique 
opportunity to screen subjects at young age and select those with an elevated risk of 
cardiovascular disease. 
 The ARYA study consists of two Dutch cohorts with predictor data from youth 
health care practices. The cohort of the Municipal Health Service of the city of The 
Hague was set up for specific research purposes and consists of standardized and 
biennial data on cardiovascular risk factors obtained at adolescence. The cohort of 
the city of Utrecht consists of routinely measured data from birth to late adolescence. 
At young adulthood, several cardiovascular risk factors were re-measured in 
participants of both cohorts. This provided the data to study the relative impact of 
routine versus standardized blood pressure measurement in the prediction of future 
risk of hypertension and the individual 10-year probability of coronary heart disease 
of young adults. The 10-year probability was assessed by calculating the 
Framingham risk score21 which clusters the impact of several cardiovascular risk 
factors.  
 
Findings of the ARYA study 
The findings presented in chapter 5.2 show that a single routine systolic blood 
pressure measurement in young adolescent girls predicts hypertension in young 
adulthood. In other words, measuring blood pressure once and non-standardized at 
adolescence distinguishes the female young adults with and without hypertension in 
the future. Adolescent screening of girls would select 60% of future hypertensives 
and some 25% will be false positives. This indicates that blood pressure screening in 
girls may be effective. In young adolescent boys, systolic blood pressure does predict 
hypertension, in statistical terms. However, the ability to adequately distinguish male 
young adults with and without hypertension is limited. This suggests that there is little 
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practical relevance of blood pressure screening in boys, at least at the age of 13 
years. 
 We used as a second endpoint an assessment of the cardiovascular risk profile in 
young adulthood: the 10-year risk of coronary heart disease calculated on the basis 
of a Framingham risk score. Expectedly, the top 20% of this risk distribution 
consisted of males only, while only 3 women exceeded the 70th percentile. 
Therefore, we could only assess in men the relation between adolescent blood 
pressure and 10-year risk of coronary heart disease. A statistically significant 
association was found between an increased systolic blood pressure in adolescent 
boys and an increased risk score at young adulthood. Moreover, adolescent blood 
pressure in boys could distinguish young men with a 10-year risk score above and 
below the 95th percentile. This suggests that blood pressure screening to assess 
cardiovascular risk may not only be important in girls, but also in boys. 
 
Comment 
Currently, the only factors of cardiovascular relevance that are obtained by school 
doctors of the Dutch Municipal Health Services are gender and anthropometry as 
both were associated with cardiovascular risk in ARYA. In retrospect, both the 
introduction of blood pressure screening and its termination some years ago by 
Municipal Health Services were not based on accurate scientific evidence about 
cardiovascular risk screening in children. The results in chapter 5.2 indicate that the 
Municipal Health Service might reconsider the importance of screening for blood 
pressure as it predicts risk of hypertension in girls and coronary heart disease in 
boys. Obviously, an actual re-introduction of blood pressure screening requires more 
information for Municipal Health Services than health benefits alone (see Future 
research). 
 To appreciate the results of chapter 5.2, some issues need to be further 
addressed. Our findings show that blood pressure screening in boys aged 13 years 
had no relevance in predicting hypertension at young adulthood. It is possible that 
this relation was not observed due to less stabilized blood pressures of boys, 
compared to girls aged 13 years. In the Utrecht cohort, girls were more sexually 
mature at this age than boys, which may partly underlie this gender discrepancy. 
Therefore, blood pressure screening in somewhat older boys - at late adolescence - 
may prove to be worthwhile. The fact that only male adults had a high 10-year 
coronary heart disease risk was the reason to study its relation with adolescent blood 
pressure in boys only. This does not exclude the existence of a relation between 
adolescent blood pressure and risk of coronary heart disease in women. The 
cardiovascular risk in women increases after the fourth decennium in life, and this 
may result in an increased 20-year or 30-year Framingham risk score. If so, studying 
the relation between adolescent blood pressure and 20 or 30-year risk of coronary 
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heart disease in women would be indicated. However, to our knowledge, 20 or 30-
year hazards are as yet not available in the literature. 
 
6.4 Future research 
The large impact of cardiovascular morbidity and mortality should be decreased 
worldwide, and improvement of primary prevention at young age could help to lower 
the burden. Studies on early determinants of cardiovascular risk presented in this 
thesis, show that the prediction capacity of cardiovascular risk by small birth size is 
low, as the relation is of limited magnitude and probably mainly explained by 
postnatal catch-up growth. Also, we show that blood pressure at adolescence 
predicts hypertension in female young adults and seems to predict coronary heart 
disease in men. Because of the latter, a renewed discussion on the introduction of 
blood pressure screening at adolescence may be worthwhile. However, several 
further questions concerning large-scale screening need to be answered. 
 First of all, in the ARYA studies the adolescent prediction of high risk of 
cardiovascular disease was solely based on blood pressure. Predictions based on 
more elaborate adolescent cardiovascular risk profiles might be investigated as well. 
Body mass index is of interest in that respect as it is a rational target for preventive 
interventions and is related to blood pressure and lipids. Another possibility to 
improve prediction, is to obtain additional data such as parental hypertension or a 
parental history of cardiovascular disease and the lipid and glucose levels at 
adolescence. However, most parents of the adolescents, are aged between 30 and 
50 years and have no manifest cardiovascular disease or are in a subclinical stage. 
Nevertheless, children of the limited number of young parents with manifest 
cardiovascular disease are at increased risk themselves. Collecting further 
information about risk factors in school health care is hampered because invasive 
procedures are required to collect lipid and glucose levels at adolescence. This is in 
our view not applicable in large-scale screening programs, unless it could be shown 
that such measurements have marked additional predictive value. Nevertheless, 
such invasive procedures might be justified in the high-risk adolescents already 
selected by elevated blood pressure levels. 
 The prediction of cardiovascular risk may be further improved by more knowledge 
about prediction at different ages. We already mentioned that a blood pressure 
measurement in boys older than 13 years of age may improve the prediction of future 
hypertension. 
 Furthermore, we might optimize the knowledge about the best risk estimate at 
young adulthood to be predicted at adolescence. In the ARYA study we have used 
cardiovascular risk profiles and arterial wall properties in young adulthood as 
estimates of the risk of cardiovascular disease occurrence decades later. Such risk 
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estimates are commonly used in studies in the young in order to prevent to follow-up 
these young adults, for observing the actual disease to occur. However, although 
there are studies showing that high blood pressure levels at late adolescence and 
young adulthood are related to cardiovascular mortality, it is relevant to provide 
evidence about blood pressure in children and adolescents and future cardiovascular 
events. Like for young adult hypertension it is known that vascular damage measured 
by arterial wall thickening and stiffness in subjects above 35 years of age is related to 
cardiovascular mortality. Data suggest that such a relation likely exists at younger 
ages also, and ARYA participants were only slightly younger. However, studies might 
be performed to confirm the relation between vascular damage measured at younger 
ages with later cardiovascular events. It might also be attempted to find out whether 
a combination of classical cardiovascular risk factors and measurements of vascular 
damage provides a better predictor of cardiovascular morbidity. 
 From the point of view of mere disease prevention, our findings suggest that a 
renewed discussion on screening of blood pressure in adolescents may be 
worthwhile. However, this discussion cannot be solely supplied by data concerning 
health implications. These implications must be in balance with the economical costs. 
A particular question is whether nationwide screening of adolescents is more cost-
effective than the current Dutch policy of case finding of for instance hypertensive 
adults. One strong argument for early nationwide adolescent screening is that it 
would probably detect a substantial number of future hypertensives that would 
otherwise be missed, as there are no national cardiovascular risk screening 
programs for adults in The Netherlands. Intervention on determinants of high 
adolescent blood pressure, particularly overweight and obesity, will lead to direct 
benefit of the child, as it will not only reduce cardiovascular risk directly but also risk 
of other diseases such as diabetes mellitus or diseases of the locomotor system. 
Information on cardiovascular risk in adolescence may be helpful in changing lifestyle 
behavior such as weight reduction which is shown to be currently difficult to achieve 
in the school health care setting.35 Early effective intervention may be taken to 
reduce life-long exposure to high levels of risk factors. This in itself will expectedly 
contribute to a reduction of the occurrence of cardiovascular disease. A more 
practical argument for screening is that nowadays blood pressure is very easily 
measured using automated devices at relatively low cost, not necessarily by highly 
trained personnel. Thus, there are a number of positive arguments for screening 
adolescent risk. However, whether it will be more cost-effective than current case-
finding practice in adults is a question that is still to be answered. A first step that we 
would consider is to find out at what economical costs young adolescent 
hypertensives would be detected, that would otherwise be missed by the current 
health care system. 
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 Alongside economical costs, there are obviously other unintended effects of 
screening. Some 25% of girls in our study were wrongly predicted to be future 
hypertensives, while 40% of true hypertensives were not predicted as such in 
adolescence. One problem with implementation of cardiovascular screening in early 
life is that it concerns disease that will on average not occur before 4 to 5 decades 
later in life. However, the proposition that such disease can already be predicted in 
childhood should in our view lead to more awareness in school doctors and 
pediatricians that cardiovascular disease originates to a large extent in childhood. 
Therefore, it is important to show an etiological relation between adolescent blood 
pressure and actual damage of vessel walls in the young (chapter 5.1). Such a 
relation shows that early screening of blood pressure does not concern some remote 
disease, but concerns a process leading to disease that is already going on in youth. 
In our view, neither right nor wrong predictions should lead to stigmatization as high-
risk children. Much more at issue here is that physicians should, by prediction, be 
helped to take evidence based decisions about intervention strategies, which may 
well include further monitoring of blood pressure. The latter implies that decisions 
about active interventions can be delayed until further insight in the development of 
blood pressure is obtained in an initially designated high-risk child. Early screening 
will obviously miss a substantial part of later true hypertensives. While an inherent 
problem of almost any type of screening activities, a solution will have to come from 
gain in predictive precision. Such gain may be derived from a reduction of 
measurement error, repeated measurements at much larger time interval for the 
purpose of monitoring high risk (early and late adolescence) and careful planning of 
the developmental stage of children at which measurements are performed. Another 
solution to missing high risk children is a population approach implying that general 
measures in childhood concerning healthy lifestyles will be taken. Given a recent 
worrisome rise in The Netherlands of the number of overweight and obese 
individuals, particularly including children, the necessity of such large scale measures 
can hardly be neglected. 
 
Summarizing, even a simple routine measurement in childhood predicts the most 
important disease in our society. We feel that our findings support a renewed 
discussion with Dutch Municipal Health Services about the relevance of screening of 
blood pressure in adolescence. There are still several issues that have to be studied 
to further improve the predictive accuracy of cardiovascular risk and further 
information is required about cost-effectiveness of screening. ARYA findings justify 
such further endeavors towards early life prevention of cardiovascular disease. 
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Early determinants of cardiovascular risk in the young: Two Dutch 
cohorts. 
Cardiovascular disease is the major cause of death in westernized societies, 
responsible for 35.5% of the total mortality in The Netherlands. Also, it claims large 
parts of health budgets and is responsible for many quality-adjusted years of life lost. 
Cardiovascular disease is based on thickening and hardening of the arterial walls – a 
process named atherosclerosis – and becomes clinically manifest after the fourth 
decade in life. The technical and medical abilities to diagnose and treat manifest 
cardiovascular diseases have markedly improved in the previous century. However, a 
trade-off is a concurrent rise in hospitalizations for heart failure, also in The 
Netherlands. The continuing marked impact on health commits us to next 
generations to search for new possibilities to reduce the burden of cardiovascular 
disease. 
Preventive strategies aim at lowering incidence of cardiovascular disease. High-
risk preventive approaches have been successful in adults, in particular for lowering 
blood pressure and cholesterol levels. The marked decline in mortality from coronary 
heart disease between 1980 and 1990 in the United States of America, has been 
attributed for 50% to treatment, for 25% to secondary prevention and for 25% to 
primary prevention. So far, prevention has primarily been targeted on adults. 
However, the roots of cardiovascular disease are in early life. Consequently, the 
possibilities for prevention in childhood may be considered. 
There are several cardiovascular risk factors which may contribute to the early 
onset and early development of atherosclerosis. Low birth weight and an adverse 
intra-uterine environment are two possible new risk factors. However, the causality of 
the relation between birth weight and cardiovascular risk is heavily discussed and the 
presence of selection bias, confounding variables, publication bias and statistical 
errors have been proposed as alternative explanations. Furthermore, results from 
epidemiological studies suggest that childhood blood pressure may predict adult 
blood pressure. Yet, it is unknown whether adolescent blood pressure as routinely 
measured in school health care, predicts hypertension or cardiovascular risk in 
adulthood sufficiently accurate to warrant blood pressure screening. 
 
To explore the early determinants of cardiovascular risk in adolescence and young 
adulthood, data of the Atherosclerosis Risk in Young Adults (ARYA) study was used 
(chapter 2). This observational study is based on data in young adults around 30 
years of age selected from the general population, and comprises two Dutch cohorts. 
All children in The Netherlands, regularly visit the Home Care Organizations and 
Municipal Health Services at birth, childhood and adolescence for routine 
examinations. The findings are recorded in school health records. In the Utrecht 
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cohort 750 subjects participated. Members of this cohort were invited when birth 
weight and blood pressure were available in records from the youth health care 
practice. The second cohort – the cohort of The Hague - included 262 young adults. 
During secondary school, they participated in a longitudinal study on cardiovascular 
risk factors coordinated by the Municipal Health Service of The Hague. The 
adolescents were biannually measured in a standardized way. Recently, 
cardiovascular risk factors were remeasured in all young adults of both cohorts. 
Additionally, in the cohort of Utrecht the extent of early vascular damage was 
measured by two non-invasive techniques. 
 
Since the nineties, there has been ample debate regarding small size at birth as a 
marker for an increased risk of cardiovascular disease. This concept is also known as 
the “fetal origins hypothesis”. It is thought that a fetus changes its physiology to adapt 
to an adverse nutritional environment, primarily to optimize the fetus’ survival, with 
unfavorable consequences occurring on the long term. However, critics suggested 
that, among others, the underlying cause of a relation between birth size and 
cardiovascular disease is genetic. Recently, a study showed that a polymorphism in 
the promoter region of the insulin-like growth factor-I (IGF-I) gene, is related to both 
low birth weight and increased risk of cardiovascular diseases. Therefore, we studied 
in chapter 3.1 the relation between a functional polymorphism in the promoter region 
of the IGF-I gene, birth weight and cardiovascular risk in adolescence and young 
adulthood. Homozygous carriers of the polymorphism show a more favorable profile 
of cardiovascular risk factors and an increased height in adolescence and young 
adulthood, compared to heterozygous carriers and non-carriers. No relation between 
the IGF-I gene and birth size nor with arterial wall thickness or stiffness could be 
found. This indicates that the IGF-I gene may be associated with increased 
cardiovascular risk factor levels at young age. Contrary to the ARYA study, in which 
birth weight was not an intermediate factor in the relation between the polymorphism 
and cardiovascular risk, it has been suggested in previous studies that parental 
genes do underlie the fetal origins hypothesis. In chapter 3.2 we examined the 
association between a polymorphism in the promoter region of the IGF-I gene in 
young parents and their first child’s birth weight. The first born children of non-carrier 
parents weighed on average 584 gram lower than of homozygous parents. This was 
especially found in the newborns of the female participants in the ARYA study. This 
present report provides evidence for the view that parental genotype may influence 
fetal growth of their newborns. 
 
A second criticism on the “fetal origins hypothesis” is that an inverse relation between 
birth weight and blood pressure artificially results from adjustment for attained body 
size. When body size is an intermediate factor rather than a confounder, the 
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adjustment may induce error. In chapter 4.1 we further analyzed the impact of body 
mass index. The analysis of our data, as proposed by other investigators, seems to 
support the fetal origins hypothesis, as low birth weight appear to be associated with 
increased blood pressure. However, additional analysis showed that the relation is 
restricted to those with low birth weight and high attained relative body weights. In 
agreement with other studies, we observed that an unfavorable intra-uterine 
environment may be less important for future hypertension than an excess gain in 
body weight in later life. 
Reports in the young have shown that low birth weight is associated with 
increased levels of particular cardiovascular risk factors. However, to our knowledge, 
no studies have reported on the relation between birth size and the overall 
cardiovascular risk profile, the most comprehensive measure of risk. In chapter 4.2 
we describe that a lower birth size is continuously related with an adverse risk profile 
in young adulthood, supporting the fetal origins hypothesis. A standard deviation 
decrease in birth weight (540 g) was associated with one excess coronary heart 
disease event in 1000 subjects. 
 
Postmortem studies showed that the subclinical process of atherosclerosis starts 
already in childhood, and was more pronounced in the young with increased risk 
factor levels, among which blood pressure is one of the main modifiable. However, 
these studies are limited in healthy young subjects. Therefore, we studied adolescent 
blood pressure levels and blood pressure tracking into young adulthood in relation to 
vascular damage (chapter 5.1). Vascular damage was measured by the common 
carotid intima-media thickness, a marker for generalized atherosclerosis. Systolic 
blood pressure and pulse pressure at adolescence and arterial thickening were 
positively associated, independent of blood pressure, gender, age and body mass 
index. Furthermore, adolescents of whom the systolic blood pressure and pulse 
pressure tracked above the medians into young adulthood had the thickest arterial 
walls. These findings strengthen the evidence that atherosclerosis develops at early 
age and that the development is enhanced by elevated blood pressure. 
Epidemiological studies have suggested that childhood blood pressure predicts 
adult blood pressure. It is, however, unknown whether adolescent blood pressure as 
routinely measured in school health care, predicts hypertension or total 
cardiovascular risk in adulthood sufficiently accurate to warrant blood pressure 
screening. In chapter 5.2 we show that adolescent blood pressure in boys and girls 
predicts hypertension 15 years later. Measuring the blood pressure once, multiple 
times, routinely or standardized did not affect the data. A single routine blood 
pressure measurement in young adolescent girls could distinguish 60% of the 
hypertensive women at young adulthood. In young adolescent boys, blood pressure 
did not distinguish young adults with and without hypertension, but an elevated blood 
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pressure predicted 10-year cardiovascular risk in young adulthood as estimated by 
the cardiovascular risk profile. 
 
In chapter 6 we conclude that there is evidence to support the fetal origins 
hypothesis. The direct effect of a small birth weight is, however, too limited to justify 
preventive strategies only targeted at the intrauterine environment. The impact of 
postnatal change of body size and attained body mass index at young adulthood 
seems to have a bigger impact on future cardiovascular risk. 
Furthermore, we confirm relations between elevated blood pressure at 
adolescence and hypertension at young adulthood. In addition, in girls the adolescent 
blood pressure is able to distinguish those with and without future hypertension. 
Thus, blood pressure screening at adolescence could select those with an increased 
risk of cardiovascular disease. The Municipal Health Service may therefore 
reconsider the option to re-introduce the blood pressure measurement at 
adolescence, to assess future cardiovascular risk.  
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Vroege determinanten van cardiovasculair risico bij jongeren: Twee 
Nederlandse cohorten. 
Cardiovasculaire ziekten zijn de belangrijkste oorzaak van sterfte in westerse landen. 
In Nederland zijn deze ziekten verantwoordelijk voor 35.5% van de totale sterfte. Ook 
eisen cardiovasculaire ziekten grote delen van het budget voor gezondheidszorg op, 
en zijn ze verantwoordelijk voor vele jaren met verminderde kwaliteit van leven. 
Cardiovasculaire ziekten worden primair veroorzaakt door verdikking en verharding 
van de arteriële vaatwanden, een proces dat atherosclerose wordt genoemd. De 
ziekten manifesteren zich klinisch meestal na het vierde decennium. De technische 
en medische mogelijkheden om cardiovasculaire ziekten in de kliniek te 
diagnosticeren en te behandelen zijn sterk verbeterd in de vorige eeuw. Echter, de 
keerzijde is een stijging van het aantal hospitalisaties door hartfalen, ook in 
Nederland. Deze voortschrijdende en grote invloed op de gezondheid is een 
belangrijk argument om te zoeken naar nieuwe mogelijkheden om ook het ontstaan 
van cardiovasculaire ziekten te verminderen. 
 Preventieve maatregelen kunnen bijdragen aan het verlagen van de incidentie van 
cardiovasculaire ziekten. In volwassenen is de hoog risico benadering succesvol 
gebleken, voornamelijk door een verlaging van het bloeddruk en cholesterol niveau. 
Een opvallende sterftedaling door coronaire hartziekten tussen 1980 en 1990 in de 
Verenigde Staten, is voor 50% toegeschreven aan behandeling, voor 25% aan 
secundaire preventie en voor 25% aan primaire preventie. Tot nu toe zijn preventieve 
maatregelen voornamelijk toegepast bij volwassenen. Echter, de oorsprong van 
cardiovasculaire ziekten begint al op jonge leeftijd. Preventie bij kinderen zou daarom 
overwogen kunnen worden. 
Er zijn verschillende cardiovasculaire risicofactoren die bijdragen aan een vroege 
start en ontwikkeling van atherosclerose. Het geboortegewicht en daaraan 
gerelateerd de intra-uteriene omgeving is mogelijk een nieuwe risicofactor. Niettemin 
wordt er hevig gediscussieerd over wat de werkelijke oorzaak is van de relatie tussen 
geboortegewicht en cardiovasculair risico. Er is geopperd dat selectie bias, 
confounding, publicatie bias of statistische fouten alternatieve verklaringen kunnen 
zijn voor de relatie. Verder suggereren epidemiologische studies dat de bloeddruk, 
gemeten bij kinderen, de bloeddruk op volwassen leeftijd voorspelt. Het is echter 
onbekend of een routinematig gemeten bloeddruk door de Jeugdgezondheidszorg, 
hypertensie of cardiovasculair risico bij volwassenen voorspelt en voldoende 
accuraat is om op bloeddruk te screenen. 
 
Om vroege determinanten van cardiovasculair risico bij adolescenten en 
jongvolwassenen te onderzoeken, werden de gegevens van de Atherosclerosis Risk 
in Young Adults (ARYA) studie geanalyseerd (hoofdstuk 2). Deze observationele 
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studie bestaat uit 2 Nederlandse populatiecohorten en is gebaseerd op 
jongvolwassenen in de leeftijd van rond de 30 jaar. Alle inwoners van Nederland 
worden vlak na de geboorte, als kind en als adolescent door de Thuiszorg en de 
Jeugdgezondheidszorg routinematig onderzocht. De medische gegevens worden in 
statussen genoteerd. In het cohort van Utrecht namen 750 jongvolwassenen deel. Ze 
werden uitgenodigd als het geboortegewicht en een bloeddruk tijdens de 
adolescentie genoteerd stond in de status van de Jeugdgezondheidszorg. Het 
tweede cohort, het cohort van Den Haag, bestond uit 262 jongvolwassenen. Tijdens 
de middelbare school namen zij deel aan een longitudinale studie over 
cardiovasculaire risicofactoren, gecoördineerd door de afdeling 
Jeugdgezondheidszorg van de GG&GD Den Haag. Als adolescent werden zij twee 
keer per jaar op een gestandaardiseerde manier onderzocht. Recent werden de 
cardiovasculaire risicofactoren bij de jongvolwassenen in beide cohorten weer 
gemeten. Tevens werd in het cohort van Utrecht de vroege vasculaire schade 
bepaald met behulp van twee niet invasieve technieken. 
 
Sinds de negentiger jaren zijn er veel discussies geweest over een laag 
geboortegewicht als marker voor een toegenomen risico op cardiovasculaire ziekten. 
Dit fenomeen is ook wel bekend als de “fetal origins hypothesis”. Er wordt 
verondersteld dat een foetus zijn fysiologie aanpast aan zijn slechte 
voedingsomgeving, in eerste instantie om zijn eigen overleving te optimaliseren, 
maar met ongunstige consequenties op de lange termijn. Echter, critici suggereren 
dat bijvoorbeeld ook de genen de relatie tussen een geboortegewicht en 
cardiovasculaire ziekten verklaren. Recent toonde een studie aan dat een 
polymorfisme in de promoter regio van het insulin-growth factor-I (IGF-I) gen, 
geassocieerd is met zowel een laag geboortegewicht als met een verhoogd risico op 
diabetes type 2 en hartinfarct. Daarom bestudeerden wij in hoofdstuk 3.1 de relatie 
tussen het polymorfisme in de promoter regio van het IGF-I gen, geboortegewicht en 
cardiovasculair risico bij adolescenten en jongvolwassenen. Homozygote dragers 
van het wildtype polymorfisme toonden een verbeterd profiel van cardiovasculaire 
risicofactoren en een toegenomen lichaamslengte tijdens adolescentie en 
jongvolwassenheid, vergeleken met de heterozygote dragers en degenen die het 
wildtype polymorfisme niet droegen. Een relatie tussen het polymorfisme, 
geboortegewicht en arteriële wanddikte en wandstijfheid werd niet aangetoond. Dit 
geeft aan dat het polymorfisme geassocieerd kan zijn met een verhoogd 
cardiovasculair risico op jonge leeftijd, maar dat geboortegewicht geen intermediaire 
factor lijkt te zijn in deze relatie. In tegenstelling tot de ARYA studie, waarbij het 
geboortegewicht geen intermediaire factor bleek te zijn in de relatie tussen het 
polymorfisme en cardiovasculair risico, is er gesuggereerd dat de genen van de 
ouders de fetal origins hypothesis kunnen verklaren. In hoofdstuk 3.2 onderzochten 
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wij de associatie tussen een polymorfisme in de promoter regio van het IGF-I gen bij 
jongvolwassen ouders en het geboortegewicht van hun eerstgeboren kind. De 
eerstgeborenen van de ouders die het wildtype polymorfisme niet droegen, wogen 
gemiddeld 584 gram minder dan van de homozygote ouders. Deze relatie werd 
vooral gevonden bij de eerstgeborenen van een vrouwelijke deelnemer van de ARYA 
studie. Deze bevinding levert aanwijzingen voor de visie dat het genotype van de 
ouders de foetale groei van hun kinderen kan beïnvloeden. 
 
Een tweede punt van kritiek op de foetale origine hypothese is dat een inverse relatie 
tussen geboortegewicht en bloeddruk artificieel kan ontstaan door te corrigeren voor 
lichaamsomvang. Wanneer lichaamsomvang een intermediaire factor is in plaats van 
een confounder, kan het corrigeren een statistische fout induceren. In hoofdstuk 4.1 
analyseren wij de invloed van body mass index nader. Wanneer wij de data 
analyseerden zoals voorgesteld door andere onderzoekers, steunden de resultaten 
in het algemeen de foetale origine hypothese, aangezien een laag geboortegewicht 
geassocieerd was met een verhoogde bloeddruk. Echter, de relatie tussen een laag 
geboortegewicht en een verhoogde bloeddruk bleek alleen aanwezig te zijn bij 
jongvolwassenen met een hoog lichaamsgewicht. In overeenstemming met andere 
studies toonden wij ook aan dat een ongunstige intra-uteriene omgeving minder 
belangrijk is voor de ontwikkeling van hypertensie, dan een buitensporige toename 
van de lichaamsomvang op latere leeftijd. 
 Artikelen over jongeren hebben aangetoond dat een laag geboortegewicht 
geassocieerd is met verhoogde niveaus van individuele cardiovasculaire 
risicofactoren. Er zijn echter aan ons geen studies bekend die een relatie tussen het 
geboortegewicht en het cardiovasculair risicoprofiel beschreven. In hoofdstuk 4.2 
beschrijven wij dat een kleine geboorteomvang geassocieerd is met een verhoogd 
risico op coronaire hartziekten bij jongvolwassenen. Dit ondersteunt de foetale 
origine hypothese. In de onderzoeksgroep was een daling van één standaarddeviatie 
van het geboortegewicht (540 gram) geassocieerd met één geval van coronaire 
hartziekte op de 1000 jongvolwassenen. 
 
Postmortale studies toonden aan dat het subklinische proces van atherosclerose al 
op jonge leeftijd begint, en vooral aanwezig was bij jongeren met meerdere 
risicofactoren. Echter, het aantal studies bij jonge en gezonde personen is beperkt. 
Daarom bestudeerden wij de bloeddrukniveaus bij adolescenten en tracking van 
bloeddruk van adolescentie naar de jongvolwassenheid, in relatie tot vasculaire 
schade (hoofdstuk 5.1). Vaatschade werd gemeten door de intima-media dikte van 
de grote halsslagader, een marker voor gegeneraliseerde atherosclerose. De 
systolische bloeddruk en polsdruk bij adolescenten waren positief geassocieerd met 
arteriële wandverdikking, onafhankelijk van de bloeddruk bij jongvolwassenen, 
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geslacht, leeftijd en body mass index. Ook blijken de adolescenten bij wie de 
systolische bloeddruk en polsdruk boven de mediaan bleef tijdens adolescentie én 
jongvolwassenheid, de dikste arteriële wanden te hebben. Deze bevindingen 
bevestigen dat atherosclerose zich al op jonge leeftijd ontwikkelt en dat de 
ontwikkeling versterkt wordt door een verhoogde bloeddruk. 
 Epidemiologische studies suggereren dat de bloeddruk gemeten bij kinderen, de 
bloeddruk op volwassen leeftijd voorspelt. Het is echter onbekend of een door de 
Jeugdgezondheidszorg routinematig uitgevoerde bloeddrukmeting tijdens de 
adolescentie, hypertensie of cardiovasculair risico voorspelt bij jongvolwassenen en 
voldoende accuraat is om te screenen op bloeddruk. In hoofdstuk 5.2 tonen wij aan 
dat een adolescente bloeddrukmeting bij meisjes en jongens, geassocieerd is met 
hypertensie 15 jaar later. Het eenmalig, meervoudig, gestandaardiseerd of 
routinematig meten van de bloeddruk veranderde de gegevens niet. Een eenmalige 
bloeddrukmeting bij meisjes maakte het mogelijk om 60% van de jongvolwassen 
vrouwen die hypertensie kregen te selecteren. Bij jongens maakte een 
bloeddrukmeting geen onderscheid tussen de jongvolwassen mannen met of zonder 
hypertensie, maar voorspelde wel het 10-jaars risico op coronaire hartziekten op 
jongvolwassen leeftijd. 
 
In hoofdstuk 6 concluderen wij dat onze bevindingen de fetal origins hypothesis 
steunen. Het effect van een laag geboortegewicht is echter te beperkt om preventie 
alleen te richten op de intra-uteriene omgeving. De invloed van postnatale 
verandering van het lichaamsgewicht en het gewicht op jongvolwassen leeftijd, lijkt 
meer impact te hebben op het cardiovasculair risico in het latere leven.  
Vervolgens tonen wij de relatie aan tussen een verhoogde bloeddruk tijdens de 
adolescentie en hypertensie bij jongvolwassenen. Bovendien kan de adolescente 
bloeddruk bij meisjes onderscheid maken tussen degene die wel of geen hypertensie 
ontwikkelen in de toekomst. Concluderend, screenen van bloeddruk tijdens de 
adolescentie maakt het mogelijk om jongeren te selecteren met een verhoogd risico 
op cardiovasculaire ziekten. De Jeugdgezondheidszorg kan met deze gegevens 
heroverwegen of zij de bloeddrukmeting tijdens de adolescentie zouden willen 
herinvoeren om toekomstig cardiovasculair risico te bepalen. 
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Dankwoord 
Een proefschrift schrijven doe je niet alleen. Aan het tot stand komen van dit 
proefschrift hebben dan ook veel mensen bijgedragen. Graag wil ik iedereen bij deze 
hartelijk bedanken voor de inzet, steun en enthousiasme die ik tijdens het onderzoek 
heb ondervonden. 
 
Ik dank de meer dan 1000 deelnemers van de ARYA studie: zonder jullie was het 
project gewoonweg niet mogelijk geweest. Sinds de middelbare school zijn velen 
verhuisd naar alle hoeken van Nederland en de wereld, en toch waren jullie bereid 
mee te werken aan het project in Utrecht en Den Haag. Mede door jullie 
enthousiasme en inzet werd het verzamelen van de data niet alleen een nuttige, 
maar bovenal een gezellige periode. Bedankt! 
 
Veel dank ben ik verschuldigd aan Anath Oren, met wie ik het ARYA project heb 
opgezet. Anath, mede door je onuitputtelijke inspanning en inzet, is het gelukt om 
ARYA succesvol en op tijd af te krijgen. Het belang van onze deelnemers en de 
kwaliteit van de ARYA studie heb je daarbij altijd in het oog gehouden. Anath, petje 
af en bedankt! 
 
Dr. C.S.P.M. Uiterwaal, geachte co-promotor, beste Cuno, het idee om ARYA op te 
starten werd door jou geïnitieerd en je enthousiasme voor dit project heb je op mij 
overgebracht. Veel dank voor de vele keren dat ik spontaan even binnen kon lopen 
om een korte vraag te stellen. Vaak kon ik dan weer aan de slag. Ook dank ik je voor 
de vernieuwende ideeën voor de manuscripten, de tekstuele opmerkingen en de 
methodologische en epidemiologische suggesties, die uiteindelijk mede geleid 
hebben tot de artikelen in dit proefschrift. 
 Prof. dr. D.E. Grobbee, geachte promotor, beste Rick, hartelijk bedankt voor de 
doortastende begeleiding bij het schrijven van de artikelen en de immer aanwezige 
steun en vertrouwen. Ook dank ik je voor de mogelijkheid om de NIHES cursus te 
volgen. De basisbeginselen van de klinische epidemiologie had ik niet alleen bij het 
analyseren en schrijven nodig, maar zal ik ook in de toekomst goed kunnen 
gebruiken. 
 
Dr. M.B. Bots, beste Michiel, het ARYA project werd uitgebreid met de vaatschade 
metingen door jouw inspanningen. Bedankt voor je steun, begeleiding, commentaar 
en adviezen. Je ontwapende en optimistische uitspraak: “Dag dames van het goede 
leven” als je onze kamer binnenkwam, zal ik missen. 
 Dr. W.H.M. Gorissen, beste Wim, ook jij stond aan de wieg van het ARYA 
project. Door jouw hulp konden tienduizenden dossiers van de 
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Jeugdgezondheidszorg (JGZ) bestudeerd worden op aanwezigheid van 
geboortegewicht en bloeddruk, en werden de deelnemers van cohort Utrecht door de 
JGZ schriftelijk uitgenodigd. Bedankt voor je enthousiasme, belangstelling, kritisch 
commentaar en logistieke aansturing. 
 Dr. A.A.A. Bak, beste Annette, in het eerste jaar hadden wij frequent overleg over 
de logistiek van het ARYA project in het Van Geuns gebouw. Onder jouw hoede 
konden de vele deelnemers van ARYA op de polikliniek geïncludeerd worden. 
 Prof. dr. C.M. van Duijn, beste Cock, door het bepalen van het IGF-I gen bij de 
ARYA deelnemers, heeft een hoofdstuk uit dit proefschrift een genetische zijweg 
genomen. Bedankt voor het opbouwend en kritisch commentaar. 
 Beste Ingrid Rietveld, bedankt voor je kritisch commentaar op de IGF-I artikelen 
en de gezellige gesprekken op de 22e verdieping van het Hoboken. Veel succes met 
je proefschift! 
 Mw. dr. R.R. Huxley is gratefully acknowledged for her critical revision of an early 
version of chapter 4.1. Dr. J.A.M.J.L. Jansen dank ik voor zijn commentaar op 
hoofdstuk 3.  
 
Marjon van der Meer en Janneke van de Brink, twee keien van vrouwen en 
vakkundige onderzoeksverpleegkundigen, bedankt voor jullie fantastische inzet voor 
de ARYA studie, overdag en ’s avonds. Van secretaresse tot het afnemen van bloed 
en het bedienen van de pulse wave velocity; jullie stonden Anath en mij in alles bij. 
Bovenal wil ik jullie hartelijk danken voor de gezellige momenten in het Van Geuns. 
De oorkonde voor de wel zeer gemotiveerde deelnemer, zal ik niet snel vergeten…… 
Yvonne Azzara, ook jij bedankt voor je inzet. Verder dank ik de artsen, 
verpleegkundigen en het secretariaat op de 5e verdieping van het Van Geuns voor de 
samenwerking en gezelligheid. 
 Rudy Meijer wil ik bij deze bedanken voor het overdragen van zijn kennis en 
vaardigheden om kwalitatief goede CIMT en FMD opnamen te maken. De 
echografisten Marjan de Boer, Gea Boschker, Binnur Gürsoy en Lillian Havekes 
dank ik voor hun ondersteuning bij deze echometingen. Tycho Vuurmans en Corinne 
Lebrun bedank ik voor het doceren van de pulse wave velocity-vaardigheden. 
 De medewerkers van de afdeling datamanagement hebben er voor gezorgd dat 
het grootste deel van de vragenlijsten gescand kon worden en dat de enorme 
hoeveelheid ARYA data werd beheerd. Hiervoor dank ik Carla Tims, Rutger van 
Petersen, Ronald van Lom, Frank Leus en Hanneke den Breeijen. 
 Ingeborg van der Tweel en Rogier Donders dank ik voor de statistische 
ondersteuning. 
 De medewerkers van het bedrijfsbureau dank ik voor de financiële assistentie 
omtrent de ARYA studie. Gerard Horsting, bedankt voor de gezellige praatjes en in 
de wandelgangen. 
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 De heren van de helpdesk wil ik bedanken voor de hun altijd aanwezige 
hulpvaardigheid en inzet. 
 Van het secretariaat wil ik Heini Meegdes graag bedanken voor het overnemen 
van de tijdrovende klus van het versturen van de manuscripten naar de tijdschriften, 
sinds ik niet meer werkzaam ben bij het Julius Centrum. Verder wil ik ook Asmarinda 
van Zanten en Tamara van Batenburg bedanken voor hun inzet. 
 Monique den Hartog dank ik hartelijk voor het lay-outen van dit proefschrift. 
 
Ook dank ik bij deze dr. J.J. Gemund (met emeritaat) van de JGZ te Den Haag. Hij 
initieerde onderzoek bij adolescenten van het Aloysius College in 1978. Dr. J.J.M. 
Borsboom dank ik voor het beheren van de data van het cohort Den Haag. Verder wil 
ik mw. dr. M.A.T.W. Zwartendijk-Schats en mw. dr. T. Flu van de JGZ te Den Haag 
bedanken voor de samenwerking bij het opstarten van de ARYA studie in Den Haag. 
 Ook bedank ik de medewerkers van het Aloysius college, waaronder mw. R. 
Hulsbergen, dhr. H. Freitag, dhr. K. Kok en dhr. R. ten Hagen voor de gastvrijheid, 
hulpvaardigheid en het beschikbaar stellen van een locatie waar onze deelnemers en 
hun oud-leerlingen ontvangen konden worden. 
 De medewerkers van het klinisch chemisch laboratorium van het Bronovo 
Ziekenhuis te Den Haag, met name dr. A. Castel en mw. C. Poot, wil ik bij deze 
danken voor de goede samenwerking. Net als de (ex)medewerkers van U-
diagnostics van het UMC Utrecht waaronder dhr. H. Wisse. Ook dank ik Jeannette 
Vergeer van de Genetische Epidemiologie te Rotterdam voor het bepalen van de 
IGF-I genotypen. 
 
De staf en alle arts-assistenten van de afdeling Dermatologie van het LUMC wil ik 
van harte bedanken voor de ruimte die ik kreeg om de laatste maanden aan dit 
proefschrift te werken. 
 
Alle collega’s van het Julius Centrum en met name de jonge onderzoekers bedank ik 
hartelijk voor de gezelligheid en interesse tijdens de cursussen, bijeenkomsten en de 
etentjes.  
 Ik dank mijn kamergenoten Marlies, Anath, Charlotte, Lisette, Tali, Linda en 
Carole, en ook Irene en Marijke voor de gezelligheid en steun. Tali, bedankt voor je 
vriendschap en je adviezen. Ik hoop dat ik het proefschrift net zo goed ga verdedigen 
als jij. Carole, je mascotte heeft mij door dik en dun gesteund. Lisette en Irene, 
bedankt voor jullie optimisme en steun. Marijke, bedankt voor de gezellige etentjes 
en gesprekken. 
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Linda, we zijn op het Julius Centrum ongeveer op dezelfde manier en begonnen en 
geëindigd. Ik wil je graag danken voor je belangstelling en je luisterend oor op de 
goede en minder goede momenten. Ik ben er trots op dat je mijn paranimf wilt zijn. 
Nog even en ook jij gaat met ferme je proefschrift verdedigen. En daarna……feest! 
 Ingrid, met jou als paranimf heb ik geen betere keus kunnen maken. Je blijft nu 
eenmaal een dagje ouder dan ik, en ik steek altijd veel op van je “wijze” 
levensverhalen. Je nuchtere en relativerende kijk op het leven werkt erg aanstekelijk. 
Ook wil ik mijn andere middelbare schoolvriendinnen, Helinde, Marieke en Bianca 
bedanken voor de gezellige emails, uitjes en vakanties. Helinde, veel dank voor je 
gezelligheid en steun, en niet alleen op 6 september j.l. 
 Fred en Ada, heel veel dank voor jullie vriendschap en steun in de afgelopen 
jaren. Jullie zijn twee hartelijke en bijzondere mensen met veel oog voor 
maatschappelijke en persoonlijke gebeurtenissen. Ik kijk al weer uit naar de 
wandelingen en de (altijd iets uitlopende) gezellige gesprekken.  
 
Graag wil ik bij deze mijn familieleden bedanken. Fred en Janny, bedankt voor de 
attente telefoontjes en opbeurende adviezen. Bas, Pieter en Felicia, en Hanna; als 
enige ben ik in het westen blijven steken. Ook al kan ik niet alle etentjes bijwonen, ik 
vind het reuze gezellig als ik jullie aan de telefoon krijg. Bas, bedankt voor jouw 
mentale en fysieke support. Hanna, ik bewonder je inzet voor de medemens. Pieter, 
je humor maakt menigeen aan het lachen en bedankt voor het maken van de kaft, hij 
is prachtig! 
 
Lieve Lex, ook al leek het soms anders, jij bent het allerbelangrijkste in mijn leven. In 
de afgelopen jaren was je onvoorwaardelijke steun onmisbaar. Ik heb veel geleerd 
van je relativerende kijk op het leven (en werk). Samen kunnen we er tegenaan en ik 
kijk alweer uit naar ons volgend weekendje op stap! 
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